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Abstract
Over the last ten years, genome-wide association studies (GWAS) have been used
to identify genetic variants associated with many diseases as well as quantitative
phenotypes, by exploiting naturally occurring genetic variation in large cohorts
of individuals. More recently, the GWAS approach has also been applied to high-
throughput RNA sequencing (RNA-seq) data in order to find loci associated with
different levels of gene expression, called expression quantitative trait loci (eQTL).
Because of the large amount of data that is required for such high-resolution
eQTL studies, most of them have so far been carried out in humans, where the
cost of data collection could be justified by a possible future impact in human
health. However, due to the rapidly falling price of high-throughput sequencing it
is now also becoming feasible to perform high-resolution eQTL studies in higher
model organisms. This enables the study of gene regulation in biological contexts
that have so far been beyond our reach for practical or ethical reasons, such as
early embryonic development.
Taking advantage of these new possibilities, we performed a high-resolution
eQTL study on 80 inbred fruit fly lines from the Drosophila Genetic Reference
Panel, which represent naturally occurring genetic variation in a wild population
of Drosophila melanogaster. Using a 30 Tag RNA-sequencing protocol we were able
to estimate the level of expression both of genes as well as of different 30 isoforms
of the same gene. We estimated these expression levels for each line at three
different stages of embryonic development, allowing us to not only improve our
understanding of D. melanogaster gene regulation in general, but also investigate
how gene regulation changes during development.
In this thesis, I describe the processing of 30 Tag-Seq data into both 30 isoform
expression levels and overall gene expression levels. Using these expression levels
I call proximal eQTLs both common and specific to a single developmental stage
with a multivariate linear mixed model approach while accounting for various
confounding factors. I then investigate the properties of these eQTLs, such as their
location or the gene categories enriched or depleted in eQTLs. Finally, I extend
the proximal eQTL calling approach to distal variants to find gene regulatory
mechanisms acting in trans.
Taken together, this thesis describes the design, challenges and results of per-
forming a multivariate eQTL study in a higher model organism and provides new
insights into gene regulation in D. melanogaster during embryonic development.
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1. Introduction
In 1865, Gregor Mendel laid the foundations for the systematic study of inher-
itance with his famous experiments on pea plants. In the 150 years since then,
techniques such as linkage mapping and genome-wide association studies have
identified genetic variation associated with thousands of different traits and dis-
eases. Yet, despite this extensive amount of research, the molecular mechanisms
through which differences between genomes result in differences between whole
organisms remain poorly understood.
To bridge this gap between genotype and phenotype, we need to understand
the consequences of genetic variation at the cellular level. A major factor in this
is gene regulation, in which the expression level of genes is adjusted according to
regulatory signals encoded in the genome. Over the last decade, high-resolution
expression quantitative trait locus (eQTL) studies, based on new methods for
quantifying gene expression, have emerged as a major avenue for studying this
process.
To date, most such eQTL studies have been conducted in humans, in particular
in the context of human health. However, the same concepts are also applicable
to model organisms kept in the laboratory, where breeding patterns and envi-
ronmental conditions can be tightly controlled. This enables the study of gene
regulation not only in different environmental conditions, but also in different
stages of an animal’s life.
A crucial stage of life is embryonic development, when the body plan of the
organism is laid out and cells begin to form different tissues. Genetic differences
that affect these fundamental processes can have major consequences on the adult
organism, even if the processes themselves are no longer active later in life. Thus,
by studying model organisms during early development, we can uncover important
mechanisms that lie beyond the reach of studies in humans.
In this dissertation, I will describe an eQTL study across multiple stages of
embryonic development in the model organism Drosophila melanogaster. I will
begin this introduction by giving an overview of the history of genetics with a
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particular focus on the role played by Drosophila in many important discoveries.
This will be followed by a closer description of the topics relevant to this project,
including Drosophila embryo development, gene regulation, the estimation of gene
expression levels, genetic association studies and the Drosophila Genetic Reference
Panel. Finally, I will describe, in detail, the experimental design of this project.
1.1. From yellow peas to quantitative genetics
1.1.1. The principles of inheritance
InOn the Origin of Species (Darwin, 1859), Charles Darwin proposed the theory of
evolution, which rests on the principles that natural variation between individuals
provides differential reproductive advantages, and that this variation is heritable.
While his theory could beautifully explain the adaptation of a population to its
environment and the development of new species, the mechanisms by which such
variation might occur and how it could be passed on from generation to generation
was not clear. In the words of Darwin in On the Origin of Species: “Our ignorance
of the laws of variation is profound” and “[t]he laws governing inheritance are quite
unknown”.
Unbeknownst to Darwin, the Austrian friar Gregor Mendel had started working
on exactly this problem in 1853. By carefully breeding pea plants with different
traits (such as seed colour and shape) in a controlled environment, Mendel was
able to study how these traits were passed on from parent generations to their
offspring. For example, he bred plants with yellow and with green seeds and
then observed the seed colour of their offspring. In the first (F1) generation, all
of the seeds were yellow. However, when he bred the plants from the yellow F1
generation with each other, he observed that approximately a quarter of the next
generation (F2) had green seeds, while the rest of the seeds were yellow. Thus,
he discovered the principle of (and coined the terms for) dominant (yellow) and
recessive (green) traits.
His research led Mendel to propose his famous Laws of Inheritance: the Law
of Segregation (which describes how each individual contains a pair of alleles for
any given trait, one of which is passed on to its offspring at random) and the Law
of Independent Assortment (which describes how different traits are inherited
independently from each other).
Unfortunately, while Mendel published this work in his 1866 paper Versuche
über Pflanzenhybriden (Mendel, 1866), it stayed largely unnoticed and Darwin
16
is said to have been unaware of it. It took several more decades until, in 1900,
Hugo de Vries and Carl Correns independently rediscovered and popularised the
principles Mendel had described. After this, the school of Mendelianism became
increasingly popular and scientists started to work on identifying the molecular
basis of Mendel’s laws.
In December 1901, William Bateson, who had learned of Mendel through de
Vries’s publications, introduced Mendel’s laws at the Royal Society’s Evolution
Committee. It was in this lecture that he introduced some fundamental terms
of genetics that are still in use today, such as “allelomorph” (allele), “zygote”,
“homozygous”, “heterozygous” and, indeed, the word “genetics” itself.
An important step towards reconciling Mendel’s laws of inheritance with Dar-
win’s theory of evolution was made in 1902, when Theodor Boveri showed, in sea
urchin, that different chromosomes contained different hereditary material and
an organism required a full haploid set of them to function. In 1903, Walter
Sutton published a paper proposing how these principles, together with the ran-
dom segregation of paternal and maternal chromosomes during gamete formation
could form the molecular basis for Mendel’s Laws of Inheritance (Sutton, 1903).
Importantly, he also noted how the number of traits was much larger than the
number of chromosomes, which meant that some traits had to be located on the
same chromosome and be transmitted together.
1.1.2. Drosophila and the birth of modern genetics
These discoveries sparked a whole new era of biology, with attempts being made
to find both the molecular mechanisms that could bring about genetic variation
(mutations) as well as the mechanisms that could lead to their inheritance.
Due to its quick generation time of 12 days, the ease with which it could be
bred and the simplicity of identifying differences in traits, the fruit fly Drosophila
became an organism of choice for the study of mutations. The first experiments
with this model organism were reported in 1906 (Castle et al., 1906) but the most
important studies of Drosophila in the early 20th century were conducted in the
famous fly room of Thomas Hunt Morgan.
In 1909, Morgan was attempting to induce mutations in flies using different tem-
perature ranges, as well as X-rays and radium (Sturtevant, 1959, page 293). He
was sceptical of both Darwin’s theory of natural selection and Sutton’s proposal
of chromosomes for the transmission of heredity, and was particularly critical of
the suggestion that chromosomes could be involved in sex determination. This
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changed, however, in 1910, when he discovered a single male fly with white eyes
instead of the normal red eye colour. Initially, he did not think much of this
mutation as mating this fly with red-eyed females resulted in very few white-eyed
flies in the F1 generation (only 3 out of 1,240 offspring, which he attributed to
further random mutations). However, breeding the white-eyed male with females
from the F1 generation resulted in an F2 generation with approximately 25%
white-eyed and 75% red-eyed flies, as Mendel’s laws would have predicted for a
dominant red and a recessive white eye colour trait (Morgan, 1910). The discov-
ery of this Mendelian trait itself was already interesting, but the most important
discovery was that it occurred exclusively in males.
In his 1911 paper (Morgan, 1911a) Morgan proposed how this sex-limited in-
heritance could be explained if the factor leading to white eye colour was not
only recessive but also attached, or linked, to the sex-determining factor on the
X chromosome. This theory perfectly explained how all the female flies in the
F2 generation had to have red eye colour, as one of their X chromosomes must
have come from a male F1 fly, all of which carried the dominant red factor. At
the same time, the male flies, only receiving one copy of the X chromosome from
their mother, would randomly receive either the copy inherited from their red-eyed
grandmother or the copy inherited from their white-eyed grandfather, resulting
in half of them having red and half of them having white eyes. Today, the gene
implicated in this mutation is still known as white (w) and is, of course, located
on the X chromosome.
Together with his students Hermann Muller, Alfred Sturtevant and Calvin
Bridges, Morgan went on to discover and investigate many more mutations in
Drosophila, which helped to uncover several important principles of genetics still
relevant today. Among these was the observation that the offspring of female
flies with two X-linked mutations on separate chromosomes sometimes carried
both mutations on a single X chromosome. This lead him to propose the concept
of crossing over, the exchange of genetic material between homologous chromo-
somes during meiosis (Morgan, 1911b). Morgan also reasoned that the degree
of coupling between two regions would be relative to their linear distance on the
chromosome. He and his students used this phenomenon to develop the technique
of gene mapping, using the recombination rate between different traits to estimate
the relative distances of the genes from each other.
The first genetic map, which described the arrangement of genes on the X
chromosome, was published in 1913 (Sturtevant, 1913). Two years later, Morgan,
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Sturtevant, Muller and Bridges published a map covering chromosomes X, 2 and 3
as part of their text book entitled The Mechanism of Mendelian Heridity (Morgan
et al., 1915). Bridges continued to focus on gene mapping in the following years
(Bridges, 1916), developing standardised reagents to allow increasingly detailed
mapping. Many of the genes and their alleles that these pioneers discovered are
still actively under investigation today. For example, one of the genes Bridges
discovered as a reference point for his work was Dichaete (Bridges and Morgan,
1923), which would become the first SOX domain protein to be identified in
Drosophila (Russell et al., 1996).
Muller, together with Altenburg, another student of Morgan’s, went on to use
genetic linkage to show that a mutation leading to truncated wings was actu-
ally caused by multiple factors on different chromosomes, with the effect of one
“master” mutation being modulated by additional mutations on different chromo-
somes, all of which were inherited in a Mendelian fashion (Altenburg and Muller,
1920). This discovery is an example of the concept of quantitative traits, which
were formalised by R.A. Fisher in 1918 (see Section 1.1.3).
Due to the tremendous success Morgan had had with Drosophila, it quickly
became the model organism of choice for many geneticists around the world.
In 1933, Morgan received the Nobel Prize in Physiology or Medicine “for his
discoveries concerning the role played by the chromosome in heredity”.
1.1.3. Biometrics and population genetics
While Mendel was studying the inheritance of traits in peas in the 19th century,
others were trying to quantify inheritance in the context of human traits.
One investigator among them was Francis Galton, a half-cousin of Darwin’s,
who started working on Darwin’s theory of evolution and its implications shortly
after its publication. He was particularly fascinated by the question of how evolu-
tion applied to humanity and how its effects could be used to improve the human
race. To this end, Galton applied himself to the study of biometrics, trying to
measure and estimate the heritability of human traits such as height and mental
capabilities. Some of the concepts and methods he developed during these studies
are still fundamental to genetics today (Galton, 1909). These include the concepts
of correlation, regression toward the mean and the regression line, which Galton
used to compare the heights of children to those of their parents. Galton’s protégé
was the mathematician Karl Pearson, who worked together with Galton to make
several more important contributions to statistics. Among others, he introduced
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the concepts of the p-value and the 2 test (Pearson, 1900) and proposed principal
component analysis (PCA, Pearson, 1901).
In 1918, building on the work of Galton and Pearson, the statistician Ronald
A. Fisher described how Mendelian inheritance could result in the continuous
variation of a trait (Fisher, 1918). This work not only introduced the concepts
of variance and analysis of variance (ANOVA) but also laid the foundation for
the concept of quantitative traits and quantitative genetics. While working as
a statistician at the Rothamsted Experimental Station, Fisher employed these
concepts to study a large set of data that had been produced by the agricultural
research institute over many decades. For example, he investigated the effects of
different types of fertiliser on wheat yield, using a data set that covered the yield
of 13 differently treated plots of land over more than 60 years. This work resulted
in his series of publications entitled Studies in Crop Variation (see for example
Fisher, 1921; Fisher and Mackenzie, 1923).
In 1930, Fisher published his seminal work The Genetical Theory of Natural Se-
lection, which finally united the fields of Mendelian genetics and evolution through
natural selection (Fisher, 1930). Thus, together with J.B.S. Haldane and Sewall
Wright, Fisher essentially founded the field of population genetics in the 1930s.
1.2. Drosophila melanogaster as a model for development
Since the days of Morgan, Drosophila has remained an important model organism,
particularly in the context of genetics and heritability. Initial studies were mostly
concerned with mutations in adult flies until, in 1937, D. F. Poulson described how
genetics (in the form of chromosomal deficiencies) affected the development of the
Drosophila embryo (Poulson, 1937). This not only established the concept that
early development in Drosophila was affected by genetics, but also established the
framework in which these effects could be studied. Poulson and others continued
to use this approach to study embryogenesis. However, Drosophila embryology
remained a niche field for several more decades, largely due to the difficulties
involved in working with the small embryos.
The study of Drosophila embryogenesis only truly became popular in the 1970s
and 1980s, when technical improvements enabled the fixation of eggs for histo-
logical analysis without damaging them. This made it possible to study early
embryogenesis in much greater detail than before (Turner and Mahowald, 1976).
These improvements enabled Christiane Nüsslein-Volhard and Eric Wieschaus,
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while working at EMBL Heidelberg in 1980, to perform a genetic screen for muta-
tions that changed the segmentation pattern of the Drosophila embryo (Nüsslein-
Volhard and Wieschaus, 1980). In this historic screen, Nüsslein-Volhard and
Wieschaus identified 15 mutations (including famous loci such as even-skipped,
engrailed and Krüppel), which they associated with three different types of effects
on segmentation patterns — segment polarity mutants (deletions of parts of each
segment that are replaced by a mirror-image of the remainder), pair-rule mu-
tants (deletions in alternating segments) and gap mutants (deletions of a whole
stretch of segments). In 1995, Edward B. Lewis, Christiane Nüsslein-Volhard and
Eric F. Wieschaus received the Nobel Prize in Physiology or Medicine for “their
discoveries concerning the genetic control of early embryonic development”.
Drosophila development has been extensively studied in the years since then
and is now very well described. Under normal conditions, it takes approximately
22 h from fertilisation for the Drosophila embryo to develop into a larva. During
this period, the cells of the embryo rapidly divide and differentiate, forming the
precursors for the organs and appendages of the adult fly. The fly then develops
for a further 4–5 days as a larva, followed by 5 days of metamorphosis as a pupa
and finally the hatching of the adult fly (Weigmann et al., 2003).
1.2.1. The development of the D. melanogaster embryo
In the following sections, I will give an overview over the development of the
D. melanogaster embryo in 2 h intervals, based on detailed descriptions available
in Campos-Ortega and Hartenstein (1997), Brody (1999) and Weigmann et al.
(2003). For each 2 h interval I will list the corresponding morphological stages1
described in Campos-Ortega and Hartenstein (1997).
0–2h: Fertilisation and the syncytium (morphological stages 1–4)
In the first 2 h after fertilisation, the nucleus of the D. melanogaster embryo
goes through a series of 13 mitotic cell divisions. The time taken for each cell
division increases with every cycle, with cycle 13 requiring approximately 21min
(Foe and Alberts, 1983). Only the nuclei are duplicated at each of these cycles,
which are all contained inside a single shared cytoplasm. This body is called the
1In this work, I will use the term “morphological stage” to refer to a stage defined by the
morphology of the embryo and the term “stage” and “developmental stage” to refer to a
stage defined by the time since fertilisation.
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Figure 1.1.: Drosophila melanogaster embryo, lateral view, morphological stage 4.
Colours inverted, microscopy by Dr. F. Rudolf Turner, Indiana University. Used with
permission.
syncytium. After the fifth division, the nuclei move toward the periphery of the
shared cytoplasm, where they form the syncytial blastoderm (Figure 1.1).
Patterning of the Drosophila embryo occurs within these first 3 h of development
(St Johnston and Nüsslein-Volhard, 1992), and takes advantage of the fact that the
syncytium allows for the free diffusion of molecules along the embryo. The shared
cytoplasm allows maternal morphogens such as the proteins Bicoid and Nanos to
form gradients, with Bicoid diffusing from the anterior (future location of head)
and Nanos diffusing from the posterior (future location of tail). These gradients
enable the establishment of the anteroposterior axis by differential regulation of
transcription factors (see Section 1.3.1) such as Hunchback, Krüppel and Knirps
(St Johnston and Nüsslein-Volhard, 1992). In addition, local activation of the
transmembrane receptors Toll (Anderson et al., 1985) and Torso (Casanova and
Struhl, 1989) help define the terminal areas at the anterior and posterior end as
well as the dorsoventral axis, which spans from the back to the belly.
In this early phase of development, the vast majority of transcripts in the embryo
come from the mother. Only around the 11th cycle of cell division does widespread
transcription of zygotic genes begin in what is called the maternal-to-zygotic
transition (MZT) (Edgar and Schubiger, 1986). This activation of zygotic genes
is linked to the rapid degradation of maternal RNA, involving both maternal
RNA-binding proteins (Benoit et al., 2009) as well as zygotic non-coding RNA
(see Section 1.3.3). The MZT is completed with the midblastula transition (MBT)
after the 13th cell cycle, when zygotic gene products are required for development
to proceed.
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2–4h after fertilisation: Cellularisation and gastrulation (morphological
stages 5–9)
Figure 1.2.: Drosophila melanogaster embryo, lateral view, morphological stage 6.
Colours inverted, microscopy by Dr. F. Rudolf Turner, Indiana University. Used with
permission.
2–4 h after fertilisation is the first time point which I will be investigating in this
study. It represents a very early stage in D. melanogaster embryo development,
covering the transition from the syncytial blastoderm to the cellular blastoderm
followed by gastrulation.
At 2 h 10 min after fertilisation and 13 cycles of mitosis, cellularisation of the
embryo begins. The plasma membrane of the embryo grows inward, engulfing
each individual syncytial nucleus to form a cellular blastoderm.
This process is then followed at 2 h 50 min by major cell shape changes and
movements which mark the beginning of gastrulation (Figure 1.2) (Leptin, 1999).
This process will separate the embryo into its three germ layers — the endoderm,
mesoderm and ectoderm. The endoderm, starting from the terminal ends at the
anterior and posterior, will give rise to the midgut. The mesoderm, which forms
from ventral cells that invaginate inwards, will give rise to, among others, the
muscles and the fat body. The ectoderm will give rise to the nervous system,
epidermis, fore- and hindgut, the trachea and more.
Together, the ectoderm and mesoderm make up the germ band, with the ec-
toderm on the outside and the mesoderm on the inside. Starting from the 3 h
10 min mark, this germ band quickly elongates, folding back upon itself on the
dorsal side.
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Figure 1.3.: Drosophila melanogaster embryo, dorsal view, morphological stage 9.
Colours inverted, microscopy by Dr. F. Rudolf Turner, Indiana University. Used with
permission.
4–6 h after fertilisation: Germ band elongation (morphological stages 9–11)
During this time point, the germ band elongates further (Figure 1.3), but more
slowly. It reaches its maximum length at approximately 5 h after fertilisation,
having folded back upon itself for about ¾ of the embryo. Neuroblasts, which
form from the neurogenic region of the ectoderm, begin to divide, forming ganglion
mother cells which will give rise to the central nervous system.
6–8 h after fertilisation: The extended germ band (morphological stages
11–12)
Figure 1.4.: Drosophila melanogaster embryo, lateral view, morphological stage 11.
Colours inverted, microscopy by Dr. F. Rudolf Turner, Indiana University. Used with
permission.
This is the second time point I am investigating in this study. During this middle
stage of embryogenesis, the cells arrange to form more clearly visible segments
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(Figure 1.4). These segments, delineated by parasegmental furrows, will give rise
to different parts of the adult fly.
At 7 h 20 min after fertilisation, the germ band begins to retract. Around this
time, cells in specific locations start to undergo programmed cell death. This
phenomenon of deliberate, coordinated removal of cells will continue to occur in
different parts of the embryo throughout its development (Abrams et al., 1993).
8–10h after fertilisation: Germ band retraction (morphological stages 12–13)
Figure 1.5.: Drosophila melanogaster embryo, lateral view, morphological stage 12.
Colours inverted, microscopy by Dr. F. Rudolf Turner, Indiana University. Used with
permission.
The main event during this time point is the continued retraction of the germ
band (Figure 1.5), which finishes at approximately 9 h 20 min after fertilisation.
In the process of this shortening, the segments of the germ band also become
more clearly visible. At the same time, the anterior and posterior midgut extend
toward each other, until they meet in the middle of the embryo.
10–12h after fertilisation: Tissue differentiation and dorsal closure
(morphological stages 13–15)
10–12 h after fertilisation is the last time point that I am investigating in this
study, covering the end of germ band retraction and the beginning of cell differ-
entiation.
After retraction of the germ band, organ precursor cells (primordia) begin to
express cell-type specific markers and differentiate. The segments of the germ
band are now clearly separated into 12 parts, with segments T1–3making up the
future thorax and segments A1–9 forming the abdomen (Figure 1.6). This results
in a mix of cells that are now specialising, with large cell-type specific differences.
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Figure 1.6.: Drosophila melanogaster embryo, lateral view, morphological stage 13.
Colours inverted, microscopy by Dr. F. Rudolf Turner, Indiana University. Used with
permission.
The type of body part that these segments develop into are controlled by the
Hox (homeobox-containing) transcriptional regulators (see Section 1.3.1). These
eight DNA-binding proteins are split up into the Bithorax complex, which con-
trols the differences between abdominal and thoracic segments, and the Antenna-
pedia complex, which controls the differences between thoracic and head segments
(McGinnis et al., 1984). Mutations in these genes can have major effects on the
adult body structure. For example, Ultrabithorax is responsible for regulating
the differences between the T2 and T3 segments (Struhl, 1982; Weatherbee et al.,
1998). A loss of this gene will result in the T3 segment developing like T2, pro-
ducing a second pair of wings instead of halteres. On the other hand, a mutant
with a gain of function of this gene in T2 will grow into a wingless fly with two
pairs of halteres.
At 10 h 20 min after fertilisation, the head structures begin to move into the
interior of the embryo in a process called head involution. Dorsal closure begins
after approximately 11 h after fertilisation. During this process, the hole that has
been left in the dorsal epithelium by the retraction of the germ band is closed
by lateral epithelium, which is coming up from both sides of the embryo and
merges at the dorsal midline. This is the last major morphogenetic movement of
Drosophila embryogenesis.
12–22 h after fertilisation: End of embryogenesis (morphological stages
15–17)
Dorsal closure completes around 13 h after fertilisation (Figure 1.7), followed by
the completion of head involution. At the same time, the outer layer of the larva,
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Figure 1.7.: Drosophila melanogaster embryo, dorsal view, morphological stage 15.
Colours inverted, microscopy by Dr. F. Rudolf Turner, Indiana University. Used with
permission.
the cuticle, begins to form. This layer protects the larva from the outside and
is required for its structural integrity (Ostrowski et al., 2002). Approximately
21–22 h after fertilisation, the larva hatches.
1.3. Gene regulation
In order to provide proteins and other products required by an organism, genes are
transcribed into complementary molecules of RNA, which can act as both carriers
of information for further processing as well as functional molecules themselves.
Transcription of a gene begins at the transcription start site (TSS) at its 50 end
and then proceeds towards its 30 end. Many genes give rise to messenger RNA
(mRNA), which will be translated by ribosomes to produce proteins. In addi-
tion, there are also genes that are transcribed into non-coding RNA (ncRNA),
which may be further processed but not translated. This process of reading the
information contained in a gene to synthesise a functional product is called gene
expression. The amount of functional product that is being produced can differ
from gene to gene, resulting in different levels of gene expression. The process
that integrates information from genetic features and other signals to give rise to
these differences is called gene regulation.
While all of the cells in an organism contain the same DNA (except in unusual
circumstances) and thus the same genes, the expression level of a gene can also
vary greatly between different cells or conditions. This is possible because gene
regulation can be affected by a variety of different factors, including the presence
of certain kinds of proteins, cell-cell interactions or environmental stimuli. Cru-
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cially, regulatory changes can also be passed on to the mitotic offspring of cells,
through processes such as the auto-regulation of transcription factors (Harding
et al., 1989), the transmission of structural DNA features (Ringrose and Paro,
2004) or non-coding RNA (Pauli et al., 2011). Thus, a cell lineage can become
committed to a certain developmental programme and pass this programme on
to its offspring, even when the original stimulus is no longer present. During
embryogenesis it is these processes that establish the different cell types in the
organism.
The expression of a protein-coding gene can be regulated at each of the steps
from the DNA to the fully functional product. In eukaryotes, the major lev-
els of this process, shown in Figure 1.8, are: (1) transcription of DNA into
precursor-mRNA (pre-mRNA); (2) processing of pre-mRNA into capped, spliced,
polyadenylated mRNA and its export into the cytosol; (3) post-transcriptional
degradation of mRNA; (4) translation of mRNA into protein; and (5) post-
translational modification of proteins.
DNA
pre-mRNA
mRNA
protein
active protein
degradation
30
50
50
30
50 30
A+50 30
Figure 1.8.: Schematic of the path from DNA to an active protein. Region of DNA
shown in white, exons of a gene shown in black, introns shown in grey, 50 cap as a white
circle. A+, poly(A) tail.
Each of these steps can be sped up, slowed down or completely inhibited by reg-
ulatory mechanisms. The first step, transcription, can be regulated by affecting
the function of RNA polymerase, which transcribes DNA into RNA. An exam-
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ple of this is the pair-rule gene even-skipped (eve), which is expressed in seven
stripes along the anteroposterior axis (Nüsslein-Volhard and Wieschaus, 1980).
The expression of each stripe is constrained to a small subset of cells in the em-
bryo, based on the gradients of multiple transcriptional regulators such as Bicoid,
Hunchback, Krüppel and Giant (Small et al., 1992).
At the level of processing, the protein-coding sequence of mRNA can be altered
through, among others, the regulation of splicing or changes to the location of its
30 end. The regulation of the gene e(r), which is important in the female germ
line of Drosophila, is an example of such regulation through RNA processing
(Gawande et al., 2006). I will expand on this example in Section 1.3.2.
By regulating the translation of mRNA by ribosomes, the amount of protein
that is produced from a molecule of mRNA can be modified. For example, trans-
lation of mRNA from the gene oskar, which is a maternal mRNA important for
posterior body patterning in Drosophila, is repressed by the protein Bruno (ar-
rest), ensuring that Oskar is only produced at the posterior pole of the embryo
(Kim-Ha et al., 1995).
In addition, the sequence-specific binding of ncRNAs has also been shown to
repress translation of mRNAs as well as promote their degradation. For example,
the bantam gene in Drosophila codes for a ncRNA that can target a region in the
30 untranslated region (30 UTR) of the pro-apoptotic gene hid, downregulating its
expression and thus preventing apoptosis (Brennecke et al., 2003).
Finally, proteins can be modified in various ways after they have been trans-
lated, which can affect or even be required for their function. A classic example
of this from Drosophila is the phosphorylation of Period, which undergoes a daily
cycle and is important for maintaining the circadian rhythm (Edery et al., 1994).
Although regulation of translation and post-translational modification are im-
portant processes, gene expression is often measured at the level of steady-state
mRNA concentration, as the quantification of protein concentrations is signifi-
cantly more complex (Vogel and Marcotte, 2012; Csárdi et al., 2015). In line with
this, I will be using steady-state mRNA levels estimated using the 30 Tag-Seq
high-throughput sequencing protocol to determine gene expression levels for this
project. In the following section, I will describe in more detail the major ways in
which gene regulation can affect these steady-state levels of mRNA.
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1.3.1. Transcriptional regulation
In eukaryotes, all pre-mRNAs as well as many ncRNAs are transcribed by the
second RNA polymerase, RNA Pol II (reviewed in Fuda et al., 2009). With
the aid of other proteins, called general transcription factors, RNA Pol II binds
to the core promoter of a gene to begin the process of transcription (Smale and
Kadonaga, 2003). Once it has bound to the promoter, RNA Pol II must undergo a
conformational change which releases it from the general transcription factors and
allows it to start moving along the DNA, producing a complementary molecule of
RNA (Phatnani and Greenleaf, 2006). This elongation phase of transcription can
be further regulated through processes such as RNA Pol II pausing (reviewed in
Zhou et al., 2012).
Many parts of this process can be either supported or hindered by different
factors, which are called transcriptional regulators or transcription factors. These
regulators are mainly DNA-binding proteins which recognise specific motifs in reg-
ulatory regions, usually approximately 6–12 bp in size (Spitz and Furlong, 2012).
The regions bound by transcriptional regulators are called cis regulatory modules
(CRMs). The term cis indicates that the regulator binds the same molecule of
DNA from which the gene will be transcribed. A regulator that can affect the
expression of genes on different molecules of DNA is said to be acting in trans.
Unlike in prokaryotes, where CRMs are usually located close to the promoter
region, eukaryotic CRMs can be tens and even hundreds of kilobases away from
the promoter, even inside the gene itself (Bulger and Groudine, 2011). This is
made possible by the formation of DNA loops, which can bring the CRMs phys-
ically close to the promoter region in 3D space, even when they are located far
away on the linear chromosome (Ghavi-Helm et al., 2014). Genes can have many
different CRMs, which will all act in concert to determine the level of transcrip-
tion, integrating the signals from multiple individual transcriptional regulators
(Spitz and Furlong, 2012). At the same time, a single CRM can also affect the
expression of multiple genes (Link et al., 2013).
There are two main kinds of transcriptional regulators — activators and repres-
sors. Some of them act directly on RNA Pol II or its transcription factors, but
most of them recruit secondary proteins called co-activators and co-repressors
(such as the Mediator complex, see Conaway and Conaway, 2011), which then
either activate or repress transcription through further interactions.
Activators increase the level of transcription, often by recruiting Pol II to the
promoter, or by releasing a Pol II that has paused at the promoter or further along
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the gene body. Repressors decrease the level of transcription, by either hindering
the action of activators, or interacting with the general transcription factors.
Many regulatory sequences have been identified through reporter assays, in
which a putative regulatory region is cloned in front of a reporter gene (Bulger
and Groudine, 2011). If the levels of the reporter gene are higher when the
sequence is present than in a control, this sequence is called an enhancer. If they
are lower, the sequence is called a silencer. Enhancer and silencers are likely
to contain CRMs bound by an activator or repressor respectively, but as they
are experimentally defined, the exact mechanism and location are not necessarily
known. The first enhancer was described in 1981, a 72 bp repeat sequence from
simian virus 40 (SV40) that was found to increase the expression level of the
-globin gene in cis (Banerji et al., 1981).
The binding affinity of RNA Pol II, as well as transcriptional regulators, is also
associated with the accessibility of the DNA (Knezetic and Luse, 1986). Eukary-
otic DNA is usually tightly packed in a complex called chromatin, with DNA
wrapping around histones to form structures called nucleosomes (Felsenfeld and
Groudine, 2003). These nucleosomes allow for an efficient packing of the DNA,
but also make the DNA less accessible to RNA Pol II and other DNA-binding pro-
teins, influencing the rate of transcription. Chromatin structure can be changed
through a variety of ways, including by transcriptional regulators called pioneer
factors, which can alter the accessibility of chromatin and recruit downstream
regulators (Magnani et al., 2011). In addition, epigenetic modifications such as
the acetylation and methylation of histones (Bannister and Kouzarides, 2011) are
commonly observed in regions associated with expressed genes, such as active
promoters (Barski et al., 2007). However, whether these epigenetic modifications
actually affect transcription or are merely a symptom of it remains controversial
(Ptashne, 2013).
1.3.2. Regulation of RNA processing
After transcription, the pre-mRNA of eukaryotic protein-coding genes still needs
to be processed into mature mRNA and exported to the cytoplasm before it can be
translated into protein. These processing steps often happen cotranscriptionally,
while the RNA is still being transcribed by RNA Pol II (reviewed in Proudfoot
et al., 2002; Moore and Proudfoot, 2009).
An important mRNA processing step in eukaryotes is splicing, during which
non-coding regions of the pre-mRNA (introns) are excised, leaving only the cod-
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ing regions (exons) (Padgett et al., 1986). Introns almost always contain the
dinucleotides GU and AG at their 50 and 30 splice sites, respectively. The process
of splicing starts with the formation of a 50 to 20 bond between a specific A nu-
cleotide near the 30 end of the intron and the 50 splice site. This cuts the bond
between the 50 exon and the 50 end of the intron, and joins the intron to itself
forming a lariat (loop). The released 30 end of this exon then forms a new bond
with the exon at the 30 splice site, joining the two exons and releasing the intron
lariat. The inclusion or exclusion of individual exons during splicing, a process
called alternative splicing, is a major gene regulatory mechanism in eukaryotes,
and allows a single gene to give rise to many different transcript isoforms (Shin
and Manley, 2004; Kornblihtt et al., 2013).
In addition, each eukaryotic mRNA has a cap added to its 50 end and a tail of
multiple A nucleotides (poly(A) tail) added to its 30 end, which mark the mRNA
as a functional transcript and prevent its degradation (see Section 1.3.3). Only
complete, successfully spliced mRNAs are allowed to leave the nucleus and move
to the cytosol, where they will be translated into proteins (Stutz and Izaurralde,
2003).
Particularly relevant to the experimental design of my study is the addition of
the poly(A) tail (reviewed in Proudfoot, 2011). The two main proteins involved
in this process are called CstF (cleavage stimulation factor) and CPSF (cleav-
age and polyadenylation specificity factor). These two proteins are carried on
the tail of RNA Pol II, allowing them to read the RNA nucleotides as they are
being transcribed from the DNA. CPSF recognises the canonical poly(A) motif
AAUAAA2, which is located approximately 10–30 bp upstream of the cleavage
site at the 30 end of the transcript. At the same time, CstF binds to a GU- or
U-rich region located up to 30 bp downstream of the 30 end, which is called the
downstream sequence element (DSE). Once these two proteins are bound, they
recruit additional cleavage factors, which cleave the transcript at the 30 end.
After cleavage, PAP (poly-A polymerase) is recruited to add A nucleotides to
the 30 end of the transcript, forming the poly(A) tail. Crucially, the poly(A) tail
is not encoded on the DNA but added by PAP without a template. The length
of this poly(A) tail can vary between genes and conditions, but is usually around
200–300 bp long (Colgan and Manley, 1997).
Differences in the composition of the DSE or a region upstream of the canonical
motif called the upstream sequence element (USE) have been shown to modulate
2In this dissertation I also refer to this motif by its DNA equivalent, AATAAA
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the affinity of the poly(A) machinery to the poly(A) site (see for example Gil and
Proudfoot, 1987; Carswell and Alwine, 1989). Consequently, a single gene can
have multiple poly(A) sites of varying strength, each of which has a certain chance
of terminating transcription every time a new molecule of RNA is transcribed. If
a poly(A) site is weak, CPSF and CstF will often fail to bind to it, resulting in Pol
II “reading through” to the next poly(A) site. This will result in the transcription
of two different 30 isoforms of the mRNA at different levels, one shorter and one
longer. Such alternate use of poly(A) sites is called alternative polyadenylation
(APA, Di Giammartino et al., 2011).
Usually, APA does not affect coding regions of genes and the different transcript
isoforms will only differ in the length of their 30 UTR. This can be used to regulate
the steady-state levels of RNA, as longer 30 UTRs may contain more miRNA
binding sites, which can have a large effect on mRNA stability (see Section 1.3.3).
However, there are also cases where APA is associated with alternative splicing
and results in the inclusion or omission of part of the protein structure of a gene.
An example of this is the IgM gene in humans, where the use of alternate poly(A)
sites results in either a membrane-bound or a secreted protein isoform (Takagaki
et al., 1996).
In Drosophila, an example of APA is the expression of a sex-specific isoform of
the e(r) gene in the female germ line (Gawande et al., 2006). A schematic of this
gene and its two primary poly(A) sites is shown in Figure 1.9. The promoter-
proximal poly(A) site uses a weak version of the canonical poly(A) signal, in
which the first A nucleotide is replaced by a T. The second poly(A) site, located
221 bp downstream, uses the exact canonical signal, and thus has a higher affinity
for the poly(A) machinery. The proximal poly(A) site is followed by a GU-rich
DSE region, which allows CstF-64 (a component of the CstF complex) to bind.
In males, the proximal poly(A) site is used exclusively, suggesting that the weak
poly(A) site together with the binding of CstF-64 enables strong polyadenylation.
This poly(A) site usage can be switched by the product of the Sex-lethal (Sxl)
gene, which is crucial for sex determination (Samuels et al., 1991). The functional
isoform of this splicing regulator, which can bind to U-rich sequences in RNA,
is only expressed in female individuals. In the female germ line, this regulator
binds to the GU-rich element downstream of the proximal poly(A) site of e(r).
There it competes for binding with CstF-64, decreasing the affinity of the poly(A)
machinery to this proximal poly(A) site. As polyadenylation is thus prevented
from occurring at the proximal poly(A) site, this interaction results in an increase
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Figure 1.9.: Schematic of the gene structure of e(r), not drawn to scale. Exons shown
in black, introns shown in grey.
in the production of transcripts ending at the distal poly(A) site.
APA has also been shown to occur transcriptome-wide, with 30 UTRs globally
increasing in length during mouse development. It has been suggested that this
is a deliberate process, allowing for increasingly fine-grained post-transcriptional
control through regulators such as miRNA as development progresses (Ji et al.,
2009).
1.3.3. Post-transcriptional regulation
mRNAs lacking the 50 cap or the 30 poly(A) tail are rapidly degraded by the cell
(reviewed in Parker and Song, 2004). This process serves a variety of purposes,
including quality control of mRNA (Maquat and Carmichael, 2001), removal of
side-products of transcription such as debranched spliced introns, and removal
of foreign RNA (Anderson and Parker, 1998). As the poly(A) tail of mRNA is
gradually shortening during its lifetime, the degradation machinery also ensures
the eventual degradation of all mRNAs, with the speed of degradation dependent
on the length of their poly(A) tail (Decker and Parker, 1993).
In addition, over the last few years, more and more non-coding RNAs (ncRNAs)
have been discovered, which can repress the translation and initiate degradation
of mRNA in a sequence-specific manner in a process called RNA interference
(RNAi). The types of ncRNAs that are involved in this process include microR-
NAs (miRNAs), small interfering RNAs (siRNAs) and Piwi-interacting RNAs
(piRNAs) (Valencia-Sanchez et al., 2006; Ghildiyal and Zamore, 2009; Jonas and
Izaurralde, 2015). Some of these ncRNAs have been shown to be key regulators
during animal development (Stefani and Slack, 2008).
When miRNAs and other ncRNAs associate with a member of the Argonaute
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protein family, they form a RNA-induced silencing complex (RISC). The RISC is
guided to the target mRNA through complementary base-pairing of the ncRNA
sequence with the mRNA sequence. The binding of RISC to the target mRNA
then leads to downregulation of the gene, through repression of translation and/or
cleavage of the mRNA, which is then degraded through the normal mRNA degra-
dation pathways (Djuranovic et al., 2012).
The regions bound by miRNAs are often located in the 30 UTR of mRNA
(Bartel, 2009). For example, the degradation of maternal mRNAs in the MZT
has been associated with zygotic miRNAs binding to the 30 UTR of maternal
mRNAs (Bushati et al., 2008). Thus, a change in the length of the 30 UTR
region, caused by APA, can result in an increase or decrease in regulation by
miRNAs.
1.4. Estimation of gene expression levels with RNA
sequencing
Early methods to estimate the RNA levels of genes were the Northern blot (Al-
wine et al., 1977) and quantitative reverse transcription polymerase chain reac-
tion, qRT-PCR (Gibson et al., 1996). In a Northern blot, RNA is separated by
gel electrophoresis and then visualised by hybridisation with labelled probes. In
qRT-PCR, RNA is reverse transcribed into complementary DNA (cDNA) using
a reverse transcriptase and then amplified using PCR, after each cycle of which
the concentration of DNA is measured using a fluorescent dye. However, both
of these methods are very low-throughput, not very accurate and would require
large amounts of starting material to estimate the expression level of all the genes
expressed in a higher organism.
In 1995, a method for estimating the expression levels of many genes simul-
taneously using DNA microarrays was introduced (Schena et al., 1995). Like
qRT-PCR this method relies on the reverse transcription of RNA into cDNA.
This cDNA is then labelled with a fluorescent dye and hybridised to a DNA mi-
croarray containing complementary DNA for thousands of known transcripts at
known locations. The RNA levels can then be estimated by measuring the in-
tensity of fluorescence at each location and either normalising it using spike-ins
of known concentration or directly comparing it to a second sample on the same
microarray using two different fluorescent dyes. Towards the end of the 20th
century, microarrays became the most commonly used method of measuring gene
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expression levels. However, since microarrays only allow the measurement of RNA
for which the sequence is known, they are not suitable for the detection of novel
transcripts or novel splice isoforms. They are also often unable to measure the
expression of transcripts with low abundance due to background noise (Gautier
et al., 2004) and are not necessarily suitable for studying the absolute expression
of genes in a single sample (Allison et al., 2006).
Recent improvements to high-throughput sequencing now allow for the direct
sequencing and quantification of cDNA libraries (Mortazavi et al., 2008). This
method, called RNA-seq, has since been shown to be superior to microarrays in
almost all regards except cost (Marioni et al., 2008). In addition to the mere
quantification of known transcripts, RNA-seq also enables the discovery of new
transcript isoforms or entirely unknown genes.
1.4.1. Standard poly(A)+ RNA-seq
In standard poly(A)+ RNA-seq (Mortazavi et al., 2008), polyadenylated RNA is
captured using an oligo-dT primer that will bind to the complementary poly(A)
tail. This selection for polyadenylated RNA is performed to increase the fraction
of mRNA (which are usually the molecules of interest) in the overall sample.
Without this step, any signal generated by the mRNAs in the sample would be
overshadowed by the large amounts of ribosomal RNA (rRNA) present in every
cell, which accounts for most of the cell’s total RNA.
Once captured, the polyadenylated RNA is fragmented into parts of approx-
imately 200–300 bp in size. These fragments are then reverse transcribed into
cDNA and sequenced using high-throughput short-read sequencing. Before se-
quencing, the cDNA is usually amplified using PCR to allow quantification even
from small starting quantities of RNA. A diagram of RNA-seq is shown in Fig-
ure 1.10.
The data generated by RNA-seq consists of short (often approximately 100 bp)
reads giving the sequence of either one end (single-end) or both ends (paired-end)
of the RNA fragments. Depending on the exact protocol used, reads will either
always be generated from the same or opposite strand as the RNA (stranded) or
from a random strand (unstranded). When mapped back to the reference genome
of the organism, these reads will cover all expressed exons of transcripts, since
fragmentation occurs at random. Reads that span a splice junction between two
exons will contain a gap when mapped to the genome, which makes it possible to
identify introns. In addition, alternative splicing can be observed by comparing
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Figure 1.10.: The poly(A)+ RNA-seq protocol.
the number of reads mapping to different exons of the gene.
As the number of reads per annotated transcript will be approximately pro-
portional to the number of RNA fragments present in the sample, the count of
reads mapped to a transcript can be used to estimate its expression level. For
comparisons between genes, this count needs to be normalised by the length of
the transcript to account for the number of fragments generated from a single
molecule of RNA. In addition, the count is usually normalised by the overall
number of sequencing reads mapped to the genome, to allow for comparisons
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between samples with different numbers of sequenced reads (sequencing depth).
The expression level of a transcript, after accounting for these factors, is usu-
ally expressed in fragments per kilobase of transcript per million reads mapped
(FPKM) or transcripts per million (TPM).
1.4.2. 30 Tag-Seq
In this study, I use a different but largely similar protocol to standard RNA-
seq, called 30 Tag-Seq (Yoon and Brem, 2010; Wilkening et al., 2013). Instead
of sequencing whole transcripts as in RNA-seq, in 30 Tag-Seq only fragments
ending with the 30 poly(A) tail (the 30 tags) are sequenced. This is achieved
by first fragmenting the RNA and then performing reverse transcription using
an anchored oligo-dT primer, which will produce cDNA only for fragments that
end in poly(A). Thus, only the 30 ends of polyadenylated RNAs will be available
for sequencing and each molecule of RNA will only yield a single fragment. A
diagram of 30 Tag-Seq is shown in Figure 1.11.
In the variant of 30 Tag-Seq that I will be using for my project, each of these
cDNA fragments is sequenced using stranded, single-end reads starting from the
50 end of the fragment, towards the 30 end. When mapped to the genome, these
reads will not cover the entire transcript, but will instead be concentrated at the
30 end of transcripts, forming a peak shape. As each sequencing read can be
assumed to represent one molecule of RNA, the number of reads mapped to this
peak region (or the height of the peak) can be used to estimate the expression
level of the transcript, without normalising for transcript length. However, as in
standard RNA-seq, normalisation by the total number of mapped reads is still
required to account for different sequencing depths between samples.
In addition to being suitable for the determination of overall gene expression
levels, 30 Tag-Seq also provides an additional level of detail over standard RNA-
seq, as different 30 poly(A) sites can be identified as separate peaks of 30 Tag-
Seq reads. This is not always possible with RNA-seq, where signal coming from
a short transcript isoform is difficult to distinguish from signal coming from a
longer one. This feature of 30 Tag-Seq and its variants (e.g. 3P-seq, see Jan et al.,
2011) has been used to perform genome-wide screens of polyadenylation sites in
organisms such as zebrafish (Ulitsky et al., 2012), yeast (Wilkening et al., 2013)
and Drosophila (Smibert et al., 2012). On the other hand, as reads are obtained
only from the 30 ends of transcripts, 30 Tag-Seq cannot provide any information
about alternative splicing of internal exons.
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Figure 1.11.: The 30 Tag-Seq protocol.
An important source of artefacts in 30 Tag-Seq is the potential for the oligo-dT
primer to capture fragments of RNA that contain a poly(A) sequence, but are
not actually real poly(A) tails (Nam et al., 2002). If not filtered out, the reads
generated by these segments can form a shape just like a real 30 end peak, resulting
in the identification of false positive 30 ends. In Chapter 2, I will describe how I
accounted for this problem.
1.5. Genomic variation
When Darwin proposed his theory of evolution, it was unclear which processes
gave rise to variation in populations. Today we know of course that the main
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driver of biological variation is mutation of DNA. Mutations can arise sponta-
neously, but can also be induced through environmental factors, such as exposure
to radiation (Muller, 1927). A mutation that affects a cell of the germ line will
be passed on to the offspring, resulting in inheritance of variation.
Locations in the genome that differ between individuals in a population are
called polymorphisms or variants and the different stretches of DNA associated
with them are called alleles. Nearly all animals are diploid, which means that
they carry two sets of homologous chromosomes. The collection of homologous
alleles that an individual carries comprises its genotype and is usually written
as a string of two letters. If both copies of the allele in an individual are the
same, the individual is said to be homozygous for the polymorphism, otherwise
it is said to be heterozygous. For example, an individual with genotype AA is
homozygous for (carries two copies of) allele A, while an individual with genotype
Aa is heterozygous for alleles A and a. The allele that is less common in the
population is called the minor allele, and its frequency is the minor allele frequency
(MAF).
The most common type of polymorphism is the single-nucleotide polymorphism
(SNP), in which a single base pair of DNA differs between individuals in a popula-
tion (The 1000 Genomes Project Consortium, 2012). Despite such a small change,
a difference of a single nucleotide can still have a variety of effects. For exam-
ple, polymorphisms in sequences recognised by DNA- or RNA-binding proteins
can cause a decrease or increase in the binding proteins’ affinity, which can have
various effects on the regulation of gene expression (see Section 1.3). In addition,
changes to the coding region of genes can alter their amino acid composition,
by changing the identity of a single amino acid or by causing translation of the
transcript to terminate early or extend beyond the normal 30 end.
Most SNPs are biallelic, with only two possible alleles (and three possible geno-
types) found in the population (The International HapMap Consortium, 2005).
This is because two separate mutation events would have had to occur at the ex-
act same location for more than two alleles to arise. While such polyallelic SNPs
are known to exist, they are often more likely to be the result of genotyping errors
rather than real biological variation (MacArthur et al., 2012).
In addition to changes of single nucleotides, stretches of DNA can also be in-
serted into or deleted from the genome (The 1000 Genomes Project Consortium,
2012). By convention, if these variants are 2–200 bp long they are called in-
sertions/deletions (indels). Like SNPs, indels can have various effects on the
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organism. For example, they can result in the deletion or introduction of an en-
tire regulatory region, which can have a major effect on the regulatory landscape
(Mullaney et al., 2010). While indels are usually not long enough to completely
delete a gene from the genome, they can essentially disable it by removing its core
promoter element or parts of the coding sequence (MacArthur et al., 2012). In
particular, an insertion or deletion in the coding region of a gene with a length
not divisible by three will change the interpretation of all following DNA triplets
(codons) during translation, as it causes a shift in the reading frame. Such frame-
shift mutations almost always result in a non-functional protein with an altered
amino acid structure and an abnormal length.
Longer insertions or deletions, as well as other structural rearrangements such
as duplications, are called structural variation (SVs, Feuk et al., 2006). A type
of SV that has played a major role in the study of Drosophila is the inversion,
which can arise when a chromosome breaks and subsequently reassembles, with
some of the fragments having become inverted. Inversions can be visualised on
the oversized polytene chromosomes of salivary glands in Drosophila, allowing for
their direct observation under the microscope (Painter, 1933). Since inverted re-
gions of a chromosome are no longer homologous to their uninverted counterparts,
recombination between the two alleles will be suppressed (Sturtevant, 1921). Be-
cause of this, inversions have played an important role in Drosophila mutagenesis
screens, as chromosomes carrying inversions can be used as balancer chromo-
somes to maintain a heterozygous stock carrying a recessive mutation (Muller,
1927; Hentges and Justice, 2004).
1.6. Linkage and genetic association studies
A common task in genetics is to identify genetic differences between individuals
that are associated with differences in their phenotypes. Historically, such ques-
tions have been answered by linkage mapping, as introduced by Sturtevant in 1913
(see Section 1.1.2). Briefly, this involves crossing lines carrying genetic markers
with those carrying a phenotype of interest and then studying the frequency of
cosegregation between each marker and the phenotype in the offspring. If the
traits are on different chromosomes, this frequency is expected to follow Mendel’s
Law of Independent Assortment. However, if the genes underlying the traits are
located on the same chromosome, their cosegregation rate will decrease with de-
creasing distance between them. Thus, by studying the cosegregation rate with
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many different markers, a gene can be pinpointed to a small region of the genome.
This concept was first applied to dichotomous traits but was soon also extended
to quantitative traits. For example, in 1923, Karl Sax published a study of the
linkage between seed colour, colour pattern and seed weight in genetic crosses of
Phaseolus vulgaris (Sax, 1923).
Linkage mapping is often conducted in inbred strains of laboratory organisms.
These inbred strains are usually generated through at least 20 generations of
brother-sister mating, which results in a group of individuals that are genetically
almost identical (isogenic) and near-homozygous at all loci in the genome. By fur-
ther inbreeding, these strains can be maintained for many generations, providing
a theoretically infinite stock of genetically identical individuals. This allows spe-
cific crosses to be set up that can be used to study individual genes in a targeted
way.
In humans, such inbreeding and designed crosses are of course not possible.
However, similar studies can be conducted by tracing the transmission of pheno-
types as well as genetic markers through a family tree. Using naturally occurring
DNA variation as genetic markers (Botstein et al., 1980), such pedigree studies
facilitated the discovery of genetic factors underlying Mendelian diseases such as
Huntington’s disease (Gusella et al., 1983).
1.6.1. Genetic association studies
An alternative approach for studying common diseases is the genetic association
study, which compares the frequency of genetic variants between individuals with
and without a certain trait in a population (reviewed in Altshuler et al., 2008).
An important assumption behind association studies is that, given a freely
mating population, the genotypes at the vast majority of variants will be randomly
distributed with respect to the phenotype, even if they are located on the same
chromosome as the causal variant. Only the genotypes of causal variants and
variants very close to it are correlated with the phenotype. This is due to linkage
disequilibrium (LD), the non-random distribution of genotypes of nearby variants
between individuals due to a combination of the local recombination rate and the
population history of these variants. When genotyping costs were high, a high
degree of LD in a population was thus advantageous for an association study,
as it decreased the number of variants that had to be genotyped. However, this
came at the cost of being unable to fine map associations to single variants, as
the strength of association between a phenotype and the causal variant can be
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indistinguishable from the strength of association with other variants in LD.
There were some early successes using genetic association studies, including
the identification of the ApoE-4 allele as a risk factor for Alzheimer’s disease
(Corder et al., 1993). However, early genetic association studies were limited to
few variants in small candidate gene regions, due to the challenges involved in the
identification and genotyping of individual variants. Identifying an appropriate
candidate region was difficult, and such studies were also susceptible to false
positives caused by population structure. Only when techniques such as DNA
microarrays (Wang et al., 1998) enabled high-throughput genotyping of many
variants at the same time, did it become possible to solve these limitations by
extending genetic association studies to the whole genome.
Shortly after, efforts such as the International HapMap project (The Interna-
tional HapMap Consortium, 2005) showed that the genotypes of many variants in
the human population are indeed strongly correlated with other nearby variants,
confirming earlier assumptions about LD. Together, these variants form so-called
haplotype blocks inside which recombination appears to have been limited. By
selecting a representative variant from each haplotype block, a reduced set of
variants that “tag” most of the diversity in a population can be defined. Thus,
the number of variants that need to be genotyped and tested to survey the whole
genome is greatly reduced. However, as described above, this high degree of LD
also means that fine mapping of the exact causal locus is not always possible.
These developments started the age of genome-wide association studies (GWAS),
in which thousands of variants across the entire genome were genotyped and tested
for association in a population. The first GWAS in humans, on Age-Related Mac-
ular Degeneration (AMD), was published in 2005 (Klein et al., 2005). Consistent
with previous studies, this GWAS identified a significant association between a
mutation in the coding region of the CFH gene and AMD. Two years later the
Wellcome Trust Case Control Consortium (WTCCC) published their landmark
paper reporting results of GWAS on seven different diseases (The Wellcome Trust
Case Control Consortium, 2007). Since then, many more GWAS have been con-
ducted in humans, numbering more than 1,500 studies to date (Welter et al.,
2014). In addition to dichotomous traits, GWAS have also been applied to find
loci associated with quantitative traits (QTLs), for example height (Gudbjartsson
et al., 2008) or blood pressure (Newton-Cheh et al., 2009).
While most large-scale GWAS to date have been conducted in humans, the
same principles can also be applied to other organisms. Thus, over the last few
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years, GWAS have also been performed in a large variety of other species, such
as Arabidopsis thaliana (Atwell et al., 2010), rice (Huang et al., 2011) and mouse
(Valdar et al., 2006). The populations used for such studies are often closed
outbred populations, which are bred for maximum heterozygosity and genetic
variability (Chia et al., 2005). However, despite major efforts to generate geneti-
cally diverse individuals, the degree of LD in closed, outbred populations can still
be large and their variability may not reflect the true genetic diversity present in
a wild population. Thus, it is challenging to fine map traits to causal loci and
draw conclusions about the effects a polymorphism would have in the wild based
on such a GWAS.
1.7. Statistics for association studies of quantitative traits
Both linkage mapping and association studies rely heavily on statistics to ascertain
the significance of observations.
Ideally, the underlying model used in such a study should be able to capture all
possible associations between all genotypes at a given variant and the phenotype.
However, two common simplifications are often applied in large-scale trait associ-
ation studies (reviewed in Bush and Moore, 2012, see for example Gudbjartsson
et al., 2008, Newton-Cheh et al., 2009). First, only biallelic variants are tested,
which means that only two different alleles and three different genotypes need to
be considered. Secondly, variants are only tested for additive effects, without ex-
plicitly considering dominant or recessive effects. This means that each additional
copy of the minor allele is considered to have the same effect, with the difference
between the homozygous major and the heterozygous genotype being half the
difference between the homozygous major and the homozygous minor genotype.
In a QTL study this makes it possible to calculate, for a given variant, the minor
allele count (the number of copies of the minor allele) in each individual i and
then test for association between this value xi 2 h0; 1; 2i and a quantitative trait
yi. While this is only accurate for true additive effects, additive models have been
shown to still be a good choice to detect dominant effects, although they are less
powered to detect weak recessive effects (Lettre et al., 2007).
In a quantitative trait association study, one could test for such an association
by calculating the Pearson correlation coefficient r between xi and the phenotype
yi of each individual i and then testing the alternative hypothesis that r 6= 0
against the null hypothesis that r = 0. A low probability of observing the given
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or a more extreme effect under the null hypothesis (a small p-value) would indicate
that the count of the variant’s minor allele was associated with the phenotype and
the variant might thus be a QTL.
A more robust approach is to use the Spearman’s rank correlation coefficient 
instead (see for example Montgomery et al., 2010), which measures the correlation
between the ranks of the data instead of the raw values. This makes it less
sensitive to outliers and non-normality of the data than Pearson’s correlation
coefficient. Again, the alternative hypothesis that  6= 0 can be tested against the
null hypothesis that  = 0 to identify significant associations.
However, in practice there are usually several known and hidden confounders
in any genetic association study, which need to be considered in the association
test to prevent loss of power and false positives introduced by experimental noise.
Thus, a more desirable option is to model the phenotype as a sum of a genetic
and additional confounding effects using a linear mixed model (Yu et al., 2006;
Zhang et al., 2010), for example:
y  + x+ c1 + c2 + : : :+ (1.1)
Using this approach, one can model a vector of observed phenotypes y as the
sum of the intercept vector , a genetic effect of the minor allele count x with
effect size , terms accounting for additional covariates ci and the noise  . The
strength of association in such a model can be estimated by the p-value from a
likelihood ratio test comparing a model with  6= 0 against a model with  = 0.
Mixed models make it possible to model the genetic effect as a fixed effect
(i.e. the effect of a factor which we have measured in each individual), while the
covariates can be modelled as random effects. In contrast to fixed effects, random
effects allow us to model the effects of factors which we could not measure in our
samples. Instead, we account for them in the model by assuming that they come
from a certain random distribution with a certain covariance structure, which we
can typically estimate from the data. In this way, covariates such as the effect of
population structure on gene expression can be integrated directly as a term into
the model.
More recently, this univariate approach has also been extended to multivariate
models, with which multiple, potentially correlated, phenotypes can be tested for
association at the same time (Korte et al., 2012; Zhou and Stephens, 2014). This
not only allows for the study of several related phenotypes, but also makes it
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possible to test for association of a variant to a single phenotype under multiple
conditions. Thus, one can distinguish variants that have an effect in all conditions
from those that have an effect in only some conditions in a statistically rigorous
manner. The LIMIX software package, which I will be using for this study, pro-
vides an efficient way of specifying and testing such multivariate linear mixed
models (Lippert et al., 2014).
1.7.1. Multiple testing
A major consideration in GWAS is the number of false positive associations in-
troduced by multiple testing. In a single association test, values of p < 0:05 or
p < 0:01 are often considered significant associations, corresponding to a 5% or
1% probability of observing the given or a more extreme effect under the null hy-
pothesis (of there being no association). However, if we apply this test to a million
independent variants in a genome, we can expect to find 0:01  106 = 10000 false
associations at a 1% significance threshold, even if there is no true association.
There are several methods to account for this multiple testing problem. The
most conservative is to apply a Bonferroni correction by simply dividing the signif-
icance threshold by the number of tests performed (Dunn, 1959). In our example,
this would correspond to requiring p < 0:01  106 = 10 8. This method con-
trols the familywise error rate (FWER), which is the probability of making one
or more false discoveries. However, such a stringent threshold results in low sta-
tistical power, which is defined as the probability of correctly rejecting the null
hypothesis when the alternative hypothesis is true (1   , where  is the false
negative or type II error rate). This means that a high number of samples is
required to detect effects, especially when these effects are small.
Less conservative approaches aim to control the false discovery rate (FDR)
instead of the FWER. The FDR represents the fraction of discoveries that are
expected to be false positives. To illustrate, if we discover 500 significant associ-
ations at an FDR of 10%, we can expect that 450 of these associations are true,
while 50 are false positives. Thus, we can increase our statistical power to detect
associations by controlling the FDR, but at the cost of a larger number of false
positives. A commonly used method for controlling the FDR is the procedure of
Benjamini & Hochberg (BH, Benjamini and Hochberg, 1995). This method can
be used to calculate a BH-adjusted p-value, which represents the FDR at which
this p-value would be rejected.
However, controlling the FDR with BH’s method still limits the power to detect
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associations and does not take into account possible correlations between tests (for
example due to LD). Thus, the current best-practice method to adjust for mul-
tiple testing is to calculate empirical p-values through permutation experiments
(Churchill and Doerge, 1994). In this method, the genome-wide search is not only
performed on the real phenotype data, but also on n random permutations of the
phenotype data, where n is usually in the order of thousands. For each random
permutation, the best observed p-value (for what is almost certainly a false pos-
itive association) is recorded. The p-value obtained from the normal association
test can then be ranked in this empirical null distribution to obtain an empirical
p-value, which is corrected for multiple testing. Since this approach determines
the null distribution based on the actual phenotypes and genotypes, it automati-
cally accounts for the distribution of phenotypes (such as the possible presence of
outliers) as well as genotypes (such as correlations resulting from LD). However,
this procedure is computationally quite expensive, as the number of tests that
have to be performed are multiplied by a factor of n.
Recently, Sul and colleagues proposed a new approach for multiple-testing cor-
rection in eQTL studies, using a multivariate normal distribution to approximate
the empirical null distribution that would have been generated by permutation
experiments (Sul et al., 2015). In the future, this approach may provide a way
of achieving results comparable to permutation experiments at greatly reduced
computational complexity.
1.8. Gene expression as a quantitative trait
Despite the additional level of resolution provided by GWAS, the complex genetic
mechanisms that underlie whole-organism phenotypes have proven challenging to
understand. Exactly how loci identified in a GWAS affect the phenotype often
remains an open question, especially as many of them are not located inside
protein-coding regions (for example Easton et al., 2007).
Mutations in regulatory regions have been shown to affect a variety of phe-
notypes, including traits such as the bristle number in Drosophila (for example
Skaer and Simpson, 2000, reviewed in Wray, 2007). It thus stands to reason that
many of the loci identified in GWAS do not affect the amino acid composition
of a protein, but instead change the expression level of genes through changes in
gene regulatory regions. This change in gene expression level could then in turn
affect the phenotype. Understanding the effects of mutations on gene expression
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levels is thus an important step towards bridging the gap between genotype and
phenotype.
With the decreasing cost of microarrays and later RNA-seq (see Section 1.4),
it has now become possible to measure the expression levels of all genes of an
organism in a high-throughput manner. By considering these measurements of
gene expression levels as quantitative traits, a QTL study on gene expression can
be performed for each individual gene using a single assay. The loci identified in
such studies are called expression QTLs (eQTLs) (Schadt et al., 2003).
The multiple testing problem is even more severe in eQTL studies than in
normal GWAS, as each gene represents a separate phenotype that is being tested.
Consequently, if 10,000 genes are to be tested against 1 million variants, the total
number of tests performed will be 10000  106 = 1010 and a Bonferroni-corrected
p-value threshold would be 0:011010 = 10 12. Such a low threshold would result
in very low statistical power, which would mean that either very large sample sizes
would be required or only very large effects could be detected.
To circumvent this problem, eQTL studies often restrict the set of variants to
be tested to those in close proximity to the gene. This is based on the assumptions
that most cis regulatory regions are located near the gene and that changes to
cis-acting gene regulation have larger, more easily detectable effects than changes
to trans-acting gene regulation (Petretto et al., 2006; Wittkopp and Kalay, 2011).
By vastly decreasing the required number of tests in this way, such proximal eQTL
studies (also sometimes inaccurately called cis eQTL studies, see Section 1.8.1)
are much better powered to detect effects close to the gene, but with the limitation
of ignoring effects further away.
The first genome-wide surveys of eQTLs were carried out in the early 2000s,
based on genetic linkage analysis (Brem et al., 2002; Schadt et al., 2003). A few
years later, in 2007, the first modern eQTL studies using a GWAS approach were
conducted in humans (Stranger et al., 2007; Dixon et al., 2007). Since then, many
more eQTL studies have been performed, both in humans (Innocenti et al., 2011;
Gaffney et al., 2012; Lappalainen et al., 2013) and many other organisms (Huang
et al., 2009).
Gene regulation differs between tissues, environments, developmental stages
and cell types (The GTEx Consortium, 2013). For example, a SNP that causes a
change to a CRM may be identified as an eQTL in a study of liver cells. However,
if the transcriptional regulator that binds to this CRM is only expressed in the
liver, the SNP will have no effect in another tissue. A similar scenario could
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be imagined for different environments or developmental stages, where an eQTL
found in a given environment or a given developmental stage may not necessarily
have any effect in another.
Thus, a particular focus of eQTL studies has been the identification of eQTLs
specific to various conditions, such as cell types (Dimas et al., 2009), tissues (Nica
et al., 2011), temperature (Li et al., 2006) and differentiation state (Gerrits et al.,
2009). The relationship between eQTLs and the developmental stage of a whole
organism has only been investigated in one study so far (Francesconi and Lehner,
2014). Comparing the gene expression profiles of 200 recombinant inbred lines of
Caenorhabditis elegans, Francesconi and Lehner tested the association of genetic
markers with the expression levels of 15,855 genes. By including the estimated
developmental time point of each sample as a covariate in their test, they were
able to increase the number of proximal eQTLs that they could identify by 54%.
This led them to conclude that the developmental stage is an important factor
in gene expression dynamics and the mapping of eQTLs. However, the samples
used in this study were not staged, which meant that developmental time point
of each sample had to be estimated from its gene expression profile. In addition,
the mapping resolution of the study was quite limited, since it was performed on
individuals from recombinant inbred lines instead of a wild population.
1.8.1. cis, trans, proximal and distal
As described in Section 1.3, regulatory effects can usually be divided into those
that act in cis (on the same molecule of DNA) and those that act in trans (on a
different molecule of DNA, often through an intermediate). While eQTLs located
close to the gene are often assumed to act on gene expression in cis, a normal
eQTL study cannot provide any direct evidence of this. Thus, while it has become
common practice to describe eQTLs located close to their gene as cis eQTLs and
those further away as trans eQTLs, this terminology is not accurate.
To identify true cis and trans effects, differences in gene expression levels be-
tween two individuals can be compared to the level of allele-specific expression
observed in their F1 hybrid, similar to a classical cis-trans complementation test
(McManus et al., 2010; Goncalves et al., 2012). In this test, a real cis effect
would result in differential expression between the parents and corresponding
allele-specific expression in the offspring. On the other hand, a real trans effect
would result in no allele-specific expression in the offspring.
In this thesis, I will use the terms proximal and distal to describe genetic varia-
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tion close to and further away from the gene of interest, respectively. Only when
there is additional evidence for the mode of action of a given variant will I refer
to it as cis or trans.
1.9. The Drosophila Genetic Reference Panel
The Drosophila Genetic Reference Panel (DGRP, Mackay et al., 2012) is a col-
lection of inbred lines sampled from a natural population of D. melanogaster. It
consists of 205 lines that were generated from 205 individual flies collected at a
farmer’s market in Raleigh, North Carolina. After more than 20 generations of
inbreeding, each of these 205 lines is approximately isogenic and homozygous at
all variants.
Each inbred line provides a replenishable stock of genetically identical individu-
als on which many different kinds of experiments can be performed. At the same
time, since the lines were generated from a naturally breeding population, the
genomic variation between the lines is a good representation of the true spectrum
of allele frequencies present in the wild. The genomes of all lines in the DGRP
have been fully sequenced and genotype calls based on these sequences, including
SNPs, indels and SVs, have been made available (Huang et al., 2014). Thus,
the DGRP provides a unique resource to study the effects of genetic variation on
many different phenotypes under many different conditions.
The DGRP is particularly well suited for the fine mapping of traits in a GWAS,
as there is a very low degree of linkage disequilibrium in the population. This is
reflected in the average measure of correlation between two variants, the squared
Pearson correlation r2, decaying to less than 0.2 after only 10 bp on autosomes
(Graveley et al., 2011). This is much lower than for other organisms such as
humans, where the r2 decays to 0.2 only after approximately 30 kb (The Interna-
tional HapMap Consortium, 2007), or wild mouse populations, where the average
r2 only falls below 0.5 at a distance of 380 kb (Yalcin et al., 2010). While this high
degree of recombination would be disadvantageous for classical linkage studies, it
enables very fine-grained mapping of traits in a GWAS context, sometimes even
to individual nucleotides. Thus, the DGRP has already powered GWAS of vari-
ous phenotypes, including susceptibility to viral infection (Magwire et al., 2012),
sleep (Harbison et al., 2013), pigmentation (Dembeck et al., 2015), regulation of
growth (Vonesch et al., 2015) and life span (Ivanov et al., 2015).
The only eQTL study in the DGRP to date was published in 2012 (Massouras
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et al., 2012). In this study, Massouras and colleagues found proximal eQTLs for
2,033 out of 7,889 tested genes at an FDR of 10%. However, this study only
considered a single developmental stage, adult flies. In addition, it used data
from only 39 individuals and was thus underpowered to detect anything but the
strongest effects. I will compare the results from Massouras and colleagues to my
study in Chapter 5.
1.10. An eQTL study in Drosophila melanogaster during
embryo development
In collaboration with the Furlong group at EMBL in Heidelberg, Germany, we
designed a project to study the genetics of gene regulation during Drosophila
development. Taking advantage of the unique resource provided in the DGRP
we not only conducted an eQTL study at a single point in development, but also
compared different stages of embryogenesis. This constitutes, to my knowledge,
the first eQTL study that compares gene regulation at different stages of embryo
development.
We selected three different time points for our study that represent three major
stages of Drosophila embryogenesis:
• 2–4 h after fertilisation when the embryo transitions from the syncytium
stage into the cellularised blastoderm stage and gastrulation occurs (mor-
phological stages 5–9)
• 6–8 h after fertilisation when the germ band expands and forms visible seg-
ments (morphological stages 11–12)
• 10–12 h after fertilisation when the germ band has retracted and organ
precursor cells begin to express cell-type specific markers and differentiate
(morphological stages 13–15)
My collaborator Enrico Cannavò, a PhD student from the Furlong group, ex-
tracted RNA from whole-embryo samples of 80 different DGRP lines at each of
the three time points. By sequencing these samples using 30 Tag-Seq we were
able to both estimate gene expression levels and also generate a comprehensive,
high-resolution map of 30 UTR cleavage sites in these stages of Drosophila devel-
opment.
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In this thesis, I will describe how I processed this 30 Tag-Seq data into gene
and 30 transcript isoform expression levels (Chapter 2), how the transcriptome
differed between the developmental stages (Chapter 3), how I detected gene-
proximal eQTLs (Chapter 4), how I filtered and assessed the quality of these
eQTLs (Chapter 5), what properties these eQTLs had (Chapter 6) and finally
how I conducted a genome-wide search for eQTLs acting in trans (Chapter 7).
A paper lead by Enrico Cannavò and myself, describing parts of this project as
well as additional analysis by my collaborators, has recently been submitted for
peer review (Cannavo et al., 2015).
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2. Processing of 30 Tag-Seq data
30 Tag-Seq enables the estimation of gene expression levels as well as the iden-
tification of individual 30 transcript end sites. In this chapter, I describe how I
processed the raw 30 Tag-Seq data to locate these transcript ends and obtained
per-gene and per-transcript isoform expression levels.
2.1. Introduction
To generate the data required for our eQTL study, we sequenced the RNA of
whole embryos from 80 different DGRP lines at three different stages of embryo
development: 2–4 h, 6–8 h and 10–12 h after fertilisation. In total, this data set
comprised 254 samples, including all 240 possible combinations of the 80 DGRP
lines and the three developmental stages, as well as 14 additional replicates (see
Table A.1). All samples were sequenced on an Illumina HiSeq 2000 machine,
multiplexing ten samples per sequencing lane. Fragments from each sample were
tagged with a 6 bp barcode to allow the identification of the source sample for
each sequencing read. After demultiplexing, the number of reads in the samples
ranged between 8.0 million and 22 million (mean 13 million) for a total of 3.4
billion reads (Figure 2.1) with an effective read length of 43 bp.
An initial analysis showed that, after mapping to the genome, the 30 Tag-Seq
reads piled up in a peak shape, with their summit close to the 30 end of transcripts,
exactly as expected from the 30 Tag-Seq protocol. Figure 2.2 shows the median
30 Tag-Seq read coverage for a typical gene with a single 30 isoform, together with
the median RNA-seq coverage for comparison. A peak of reads around the 30
of the gene is clearly visible in 30 Tag-Seq, while reads are distributed across all
exons in RNA-seq.
Standard pipelines for processing and quantifying RNA-seq data such as RSEM
(Li and Dewey, 2011), Cufflinks (Trapnell et al., 2012) or HTSeq-count (Anders
et al., 2015) assume that reads are distributed along the transcript body and that
one molecule of RNA can yield multiple reads, depending on its length. Therefore,
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Figure 2.1.: Raw read counts in the 254 30 Tag-Seq samples. Most samples have between
10 million and 15 million reads, with a mean of 13 million reads.
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Figure 2.2.: 30 Tag-Seq reads and RNA-seq reads for the gene mrityu at 10–12 h after
fertilisation. Top: Median 30 Tag-Seq read coverage across all 80 lines. Bottom: Median
RNA-seq read coverage across a subset of 22 lines. Gene body shown as grey arrow, exons
shown as grey boxes.
these methods were not directly applicable to the 30 Tag-Seq data.
Estimation of expression levels of 30 Tag-Seq data can be as simple as counting
the number of reads per transcript using a reference annotation, as this number
is expected to be directly proportional to the transcript abundance (Yoon and
Brem, 2010). However, as I was also interested in discovering novel 30 transcript
ends this approach would not have been appropriate. Thus, I developed a custom
analysis pipeline to identify 30 transcript isoforms and quantify their expression
level using 30 Tag-Seq data, similar to the approach described in Smibert et al.
(2012).
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2.2. Mapping biases in eQTL studies
eQTL studies are sensitive to biases in the estimation of gene expression levels
that are correlated with genomic features. For example, the estimation of gene
expression levels from RNA-seq usually requires the reads to be mapped to a
reference genome sequence. Reads overlapping a variant will not exactly match
the reference genome if they were obtained from individuals with a non-reference
genotype, and may thus fail to be mapped to the correct location. Consequently,
one might observe a difference in the number of mapped reads between individ-
uals with the reference and the non-reference genotype. Such a bias due to a
difference in mappability may lead to the incorrect conclusion that this variant is
an eQTL, while in reality it is only affecting one’s ability to accurately measure
gene expression levels (Degner et al., 2009).
The effect of mappability bias is exacerbated by two features in my project:
Firstly, there is a large amount of indels in the D. melanogaster genome, which
can have a larger effect on read mapping than SNPs. In the variant annotation
for the DGRP (Huang et al., 2014), 657,494 indels with length greater than 4 bp
are identified, which corresponds to an average of one indel approximately every
183 bp of the genome. Thus, each of the 30 Tag-Seq peaks, which have a median
width of 226 bp (see Section 2.4), can be expected to contain at least one indel.
Secondly, because of the relatively small size of the 30 Tag-Seq peaks, a single
inconveniently placed variant can strongly affect the estimated expression level
for the entire transcript. In normal RNA-seq, these sorts of effects would be less
severe because expression levels are estimated across the whole transcript body.
−10
0
10
7,346,700 7,346,750 7,346,800 7,346,850
3'
 T
a
g−
Se
q 
co
ve
ra
ge
Figure 2.3.: Example of differential mappability in the 30 Tag-Seq peak for the gene
CTCF. 30 Tag-Seq coverage for individuals with the reference genotype shown in red
(positive values) and light red (opposite) and for individuals with the non-reference geno-
type shown in blue (negative values) and light blue (opposite). Black dashed lines show
the location of two annotated indels in the peak region.
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An example of a difference in gene expression levels associated with indels is
shown in Figure 2.3. One can clearly see that the coverage for individuals with
the reference genotype (red, positive) forms a normal peak shape as expected,
while the coverage for the non-reference genotype (blue, negative) drops to zero
in the region around the two indels (dashed vertical lines). This region of low
mappability thus results in an unusual “double-peak” shape and greatly decreased
gene expression level estimates for individuals with the non-reference genotype.
I employed two measures to minimise the chance of false positive eQTLs caused
by mapping biases. My first step was to map the 30 Tag-Seq reads to personalised
genomes instead of the reference genome, which I will expand on in the following
section. The second was to filter eQTLs by multiple criteria related to the map-
pability of the associated peak region. I will describe these steps in more detail
in Chapter 5.
2.3. Mapping of short reads to personalised genomes
To prevent variants from affecting the mappability of the genome, I mapped the
30 Tag-Seq reads to a custom personalised genome for each individual DGRP line.
For this, I developed a tool that generates a personalised genome FASTA file
for each individual listed in a variant annotation VCF file, based on a reference
genome.
My tool iterates through the variant annotation at the same time as reading the
reference genome and produces a custom reference sequence for each individual,
containing the alternate allele at each variant where the individual had a ho-
mozygous alternate genotype. For heterozygous variants, I retained the reference
sequence. This procedure is outlined in Algorithm 1.
I applied this program to the standard D. melanogaster reference genome
(BDGP5, Adams et al., 2000) and the full binned variant annotation from the
DGRP, which had been generated by the DGRP consortium based on whole-
genome DNA-sequencing data (Huang et al., 2014).
The generation of personalised genomes is complicated by structural variants
that result in indels, as the addition or deletion of parts of the genomic sequence
will shift the coordinate systems between different lines. Because of this shift, the
same gene can be located in a different location for each line, which makes com-
parisons between different lines, or in fact to the reference genome, challenging.
Nevertheless, I did want to include indels in the personalised genomes, since they
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Data: reference genome r (N), variant annotation V (I N)
Result: personalised genomes G (I N)
foreach nucleotide n 2 h1 : : : Ni do
foreach individual i 2 h1 : : : Ii do
switch type of Vi;n do
case homozygous alternate
Gi;n = Vi;n
end
case heterozygous
case homozygous reference
Gi;n = rn
end
endsw
end
end
Algorithm 1: Simplified algorithm for the generation of personalised genomes
using SNP data. N is the number of nucleotides in the genome, I is the number
of individuals.
had the largest chance of introducing mapping biases as described in Section 2.2.
To handle this shifting of coordinates, I implemented a two-step personalisation
process. First, I generated personalised genomes using only the annotated SNPs,
which by definition did not result in any changes to the coordinate system. I used
these “SNP-personalised” genomes to determine the location of all 30 Tag-Seq
peaks, which I will describe in Section 2.4. However, I only used these genomes
to find the locations of the peaks, not to quantify their expression levels. Thus,
there was no risk of introducing biases in expression levels due to indels.
Once I had determined the location of all 30 Tag-Seq peaks in my data, I gen-
erated a second set of personalised genomes that considered both the annotated
SNPs as well as annotated indels up to a size of 100 bp. When I generated these
“indel-personalised” genomes, I also generated a personalised 30 Tag-Seq peak an-
notation for each DGRP line, adjusting the coordinates of the original 30 Tag-Seq
peaks to shift with the insertions and deletions. I then mapped all reads to these
indel-personalised genomes and quantified the expression levels in each sample
using the personalised annotation, as described in Section 2.7. This approach
allowed me to account for indels, while still being able to map peaks between
DGRP lines, despite their shifted coordinate systems.
Comparing alignment statistics between mapping to the indel-personalised ge-
nomes and the reference genome, I observed that the alignments of reads to per-
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sonalised genomes tended to contain fewer gaps. On average, 2.0% of reads
mapped to the reference genome contained an insertion, compared to 1.8% of
reads mapped to the personalised genome (Figure 2.4a, Student’s t-test, p =
3:71  10 13). The same was true for deletions, with the mean percentage of
reads with a deletion dropping from 1.4% to 1.1% (Figure 2.4b, Student’s t-test,
p < 2:2  10 16).
As a result, the overall number of reads that could be mapped to the genome
increased by 0.66% on average (Figure 2.4c).
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Figure 2.4.: Comparisons between reference genome and personalised genomes. (a)
Percentage of read alignments that involved an insertion compared between reference
and personalised genomes. (b) Percentage of read alignments that involved a deletion
compared between reference and personalised genomes. (c) Increase in number of uniquely
mapped reads when mapping to personalised instead of reference genomes.
An increase of 0.66% may seem quite small, and one could argue that this
might not have been worth the effort. However, this aggregate number does not
do justice to the difference that the personalised genomes can make in preventing
false positives caused by differential mappability. Figure 2.5 shows an updated
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version of the 30 Tag-Seq peak shown in Figure 2.3. Based on the reads mapped
to the reference genome (Figure 2.5a), there seemed to be a large difference in
expression level between the reference and the non-reference allele at the given
variant. In fact, in an early version of the eQTL calls, I had listed this gene as
having an eQTL with the insertion and the deletion inside the peak as the most
strongly associated variants. However, the reads mapped to the personalised ge-
nomes (Figure 2.5b) revealed that this effect was entirely caused by a difference
in mappability introduced by these variants. Once the insertions and deletions
have been accounted for, the estimated expression level no longer significantly
differed between the genotypes. This example shows how the genome personali-
sation step allowed me to account for reference mapping biases and thus allowed
me to improve the quality of my expression level estimates.
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(a) Reads mapped to reference genome
−20
−10
0
10
20
7,346,700 7,346,750 7,346,800 7,346,850
3'
 T
a
g−
Se
q 
co
ve
ra
ge
(b) Reads mapped to personalised genome
Figure 2.5.: Example of differential mappability of the 30 Tag-Seq peak region for the
gene CTCF due to indels. 30 Tag-Seq coverage for individuals with the reference genotype
shown in red (positive values) and light red (opposite) and for individuals with the non-
reference genotype shown in blue (negative values) and light blue (opposite). Black dashed
lines show the location of two annotated indels in the peak region.
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2.4. Identification of 30 transcript end regions from 30
Tag-Seq poly(A) reads
The first step in determining gene expression levels was to determine the genomic
location of the 30 ends of transcripts in an annotation-agnostic way, from the
30 Tag-Seq data only. In theory, all regions where several 30 Tag-Seq reads map
should indicate the presence of a polyadenylated transcript’s 30 end, the 30 cleavage
site. However, a known problem with 30 Tag-Seq is that the oligo-dT primer used
during the poly(A) capture and reverse transcription step can sometimes anneal to
fragments containing a run of genomic poly(A) (Nam et al., 2002). Consequently,
simply considering every cluster of 30 Tag-Seq reads as evidence of a transcript end
would have resulted in false positives. I thus needed to find a way to differentiate
reads corresponding to real transcript ends from artefacts caused by genomic
poly(A) or other experimental noise.
Since the fragmentation step yielded fragments of varying size, our 30 Tag-Seq
data contained some reads produced from very short fragments, which started
with a few nucleotides from the 30 end of a transcript but then continued with a
long stretch of A nucleotides. This stretch of A nucleotides was generated from
the poly(A) tail itself. I called these reads polyadenylated reads (poly(A) reads).
If I could find these poly(A) reads and see where on the genome their non-poly(A)
part mapped, I would be able to identify the location of the true 30 cleavage sites.
The method I developed for this purpose is similar to the one described in Smibert
et al. (2012).
In order to identify poly(A) reads that truly came from polyadenylated tran-
script ends and not from genomic poly(A), I first mapped all reads to the SNP-
personalised genomes (see Section 2.3) in their full form using the BWA short-read
aligner (v0.6.2-r126, Li and Durbin, 2009). To account for sequencing errors and
variants that were not considered in the genome personalisation I allowed for up
to 5 mismatches and up to 10 gap extensions (parameters -n5 -e10) for the read
mapping. I also set the option -q20 to let BWA automatically trim reads if the
sequence quality fell below 20.
Any read stemming from a genomic poly(A) tract should have corresponded to
a real genomic sequence, so it should have been successfully mapped in this step.
Reads covering a poly(A) tail added during mRNA processing, however, will not
have had a corresponding genomic sequence and should have failed to map.
To obtain these reads, I extracted all reads that BWA failed to map to the
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genome in their full form and ended in at least five A-nucleotides. I trimmed all
trailing A-nucleotides off these reads and then attempted to map their remaining
parts again as described above. I considered every read that could only be mapped
in the trimmed form a true poly(A) read. A flow chart of this process is shown
in Figure 2.6.
As expected, only a small subset of reads in each sample fulfilled these criteria
(average: 0.88%). However, since we sequenced almost 3.4 billion reads in total
I was still able to obtain approximately 30 million poly(A) reads after pooling all
samples.
By determining the location of the most 30 nucleotide of each of these poly(A)
reads, I could now identify the location of putative 30 transcript ends in the D.
melanogaster genome, down to a single nucleotide. It should be noted, however,
that any A nucleotides at the 30 end of the transcript would have been trimmed
off together with the poly(A) tail, which means that I would have been unable
to detect the exact 30 end of a transcript if it ended in one or more genomic A
nucleotides.
I observed 91,345 distinct putative transcript ends (cleavage sites) supported
by at least 15 poly(A) reads each, which is more than six times as many as the
14,297 putative cleavage sites reported in a previous study of polyadenylation in
the D. melanogaster genome (Smibert et al., 2012). This is not surprising given
the large difference in sample sizes, but shows the additional degree of detail that
this study can contribute to the genome annotation, even at a relatively high
threshold of 15 reads. To simplify the downstream analysis I grouped nearby
transcript ends together into clusters, considering each region with at least 15
overlapping poly(A) reads on the same strand a 30 Tag-Seq peak region. I assume
that each such peak region corresponds to a distinct poly(A) site. The 30 end of
these peaks is defined as the most 30 cleavage site that I observed in the cluster.
Based on the expected fragment size and the observation that most non-poly(A)
30 Tag-Seq reads mapped within 200 bp of the 30 transcript end, I extended these
peak regions upstream by 200 bp to capture all associated reads. The median
summit of the 30 Tag-Seq peaks was located 90 bp upstream of the 30 end of
the peak. When two peak regions were located within 200 bp of each other, I
extended the peak only up to the 30 end of the next upstream cluster, to make
sure no overlaps occurred. In total, I identified 37,025 such 30 Tag-Seq peaks with
a median width of 226 bp. An example of the raw data used in this process is
shown in Figure 2.7 and an overview over the whole process is shown in Figure 2.8.
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Figure 2.6.: Flow chart illustrating the processing of raw 30 Tag-Seq reads for a single
sample to the mapped poly(A) reads.
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Figure 2.7.: poly(A) reads, 30 Tag-Seq reads and RNA-seq reads for the gene mrityu.
Top: Coverage of poly(A) reads from all samples. Middle: Median 30 Tag-Seq read
coverage at 10–12 h after fertilisation. Bottom: Median RNA-seq read coverage at 10–
12 h after fertilisation. 30 Tag-Seq peak region marked in red.
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Figure 2.8.: Flow chart illustrating the identification of annotated 30 Tag-Seq peak
regions from the merged set of poly(A) reads from all samples.
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2.5. Annotation of 30 Tag-Seq peaks
Once I had identified the 30 Tag-Seq peaks, I needed to assign them to genes.
This was important both for interpreting the biological meaning of the eQTLs I
would later identify as well as for estimating per-gene expression levels, which are
calculated as the sum of all peak expression levels associated with that gene (see
Section 2.7). For this process I considered all genes annotated on the standard
chromosome arms (X, 2L, 2R, 3L, 3R, 4) in FlyBase annotation version 5.47 (The
FlyBase Consortium, 2014).
Because the D. melanogaster genome is quite dense and the genome annotation
is not always accurate, finding the correct gene for each peak was often not a
straightforward task. On one hand, there were cases where the peaks I observed
did not correspond to any known 30 end of a transcript, while on the other hand
sometimes a peak could have been generated by any of several different annotated
transcripts. To decide which annotated transcript most likely produced each of
the 30 Tag-Seq peaks, I applied a hierarchical procedure. First I looked for the
annotation most likely to result in a peak — the end of an annotated transcript on
the same strand as the peak. If a peak had such an end annotated within a 500 bp
window, I assigned it to the closest one. If not, I moved on to the second-most
likely annotation and so on. These annotations were, in order:
1. Peak within 500 bp up-/downstream of annotated mRNA 30 end
2. Peak within 500 bp up-/downstream of annotated ncRNA
3. Peak within 500 bp downstream of an mRNA 50 end (TSS)
4. Peak overlapping annotated mRNA exon
5. Peak overlapping annotated mRNA intron
6. Peak within 2,000 bp downstream of annotated mRNA 30 end (extended 30
end)
7. Antisense annotation:
a) Peak within 500 bp up-/downstream of annotated mRNA 30 end
b) Peak within 500 bp downstream of an mRNA 50 end (TSS)
c) Peak overlapping annotated mRNA exon
d) Peak overlapping annotated mRNA intron
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If there were multiple possible annotations of the same rank and with equal
distance to the peak, I selected one of them at random. However, the identifiers
of all possible genes were provided as an additional annotation, which I used in
some of the downstream analysis. Any peak that did not have any transcript
annotated nearby was classified as “unannotated”.
Of the 37,025 poly(A) sites I identified, 20,939 (57%) could be assigned to a
mRNA 30 end, with the remaining 43% split between the other categories (Fig-
ure 2.9). For 6% of peaks I could not find any suitable annotation.
ncRNA
mRNA (TSS)
mRNA (extended 3' end)
unannotated transcript
mRNA (unann. end, intronic)
mRNA (unann. end, exonic)
Antisense
mRNA (3' end)
0% 20% 40%
Figure 2.9.: Transcript annotation of 30 Tag-Seq peaks.
2.6. Properties of 30 Tag-Seq peaks
To confirm that the 30 Tag-Seq peaks were representative of real transcript ends,
I performed de novo motif discovery in a stranded region of 100 bp up- and down-
stream of the 30 end of every peak. I used the software package Homer (Heinz
et al., 2010) to identify motifs of length 6 bp or 8 bp and found 20 motifs that
were significantly enriched (p < 1  10 10) around peaks. The most significantly
enriched signal (p = 1  10 537) matched the canonical polyadenylation signal
AAUAAA (Figure 2.10) and was present within the 200 bp window for 47% of
the peaks. The mean location of this motif was 15 bp upstream of the 30 end,
which is in line with prior work that has reported the location of the polyadeny-
lation signal to be approximately 10–30 bp upstream of the 30 cleavage site (see
Section 1.3.2).
Most genes had a single peak associated with them, but some had up to 75
(Figure 2.11). This is similar to the data reported by Smibert et al. (2012), who
had observed a similar long-tailed distribution of polyadenylation sites per gene.
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Figure 2.10.: AAUAAA motif found through a de novo motif search in a 200 bp window
around 30 Tag-Seq peak ends. Red dotted lines indicate 30 bp and 10 bp upstream of the
peak’s 30 end.
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Figure 2.11.: Histogram of the observed numbers of 30 Tag-Seq peaks per gene.
To determine if genes of a certain category were more likely to have many 30
Tag-Seq peaks than others, I performed a gene ontology (GO, The Gene Ontology
Consortium, 2000) enrichment analysis. However, to conduct this analysis in an
unbiased way, it was important to account for the fact that genes tended to have
more peaks the more strongly expressed they were (Figure 2.12).
This bias was most likely caused by the threshold of 15 poly(A) reads required
for the identification of a 30 Tag-Seq peak, which meant that secondary peaks of
more lowly expressed genes may not have passed this threshold while secondary
peaks of highly expressed genes did. To account for this, I stratified the genes into
ten quantiles based on the number of 30 Tag-Seq reads that had been assigned
to them. I removed the first and the last quantile to remove outliers and then
performed a GO enrichment analysis separately on each of the remaining eight
67
020
40
60
1e+01 1e+03 1e+05 1e+07
Total number of 3' Tag-Seq reads
N
um
be
r o
f a
ss
oc
ia
te
d 
pe
ak
s
Figure 2.12.: Number of 30 Tag-Seq peaks associated with each gene against the total
number of reads assigned to the gene across all samples.
quantiles. For each quantile, I classified a gene as having many peaks if it had
more peaks than 80% of all genes in the quantile. Then, using the bioconductor
package topGO (Alexa and Rahnenfuhrer, 2010), I performed a one-tailed Fisher’s
exact test to determine whether membership in any GO category was associated
with having many peaks. I tested all GO categories from the “biological process”
ontology with a minimum size of 100 annotated genes.
The GO terms “signaling” and “single organism signaling” were consistently
enriched in genes with many peaks, with a p-value of less than 0.05 after Bonfer-
roni correction in 6 out of 8 (75%) of the quantiles. Furthermore, the GO terms
“cell communication”, “regulation of biological process” and “biological regula-
tion” were enriched in 5 out of 8 (63%) quantiles using the same threshold. This
indicates that genes involved in signalling, cell communication and regulation are
particularly likely to use multiple different 30 ends regardless of expression level,
suggesting that APA may play a major role for these genes.
2.7. Quantification of expression levels
Having identified the 30 Tag-Seq peak regions, I now needed to estimate the ex-
pression level of each peak in each sample. For this, I mapped the original reads
from each sample to the genomes again, this time using the fully indel-personalised
version (see Section 2.3). Overall, 92% of successfully mapped 30 Tag-Seq reads
fell into a peak region, reflecting the good sensitivity of the peaks I had identified.
I calculated the height of each peak for each sample based on the maximum
number of overlapping reads and used this value as my measure of expression
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level. I then summed the expression levels of all sense peaks associated with each
gene, to obtain a set of total gene expression levels. While slightly different from
other approaches that simply considered the total number of reads to estimate
expression (Yoon and Brem, 2010), this approach proved to be a reliable measure
of expression levels (see Section 2.8).
To make these expression levels comparable between samples, I finally scaled
each of them by a size factor associated with each sample. Instead of using the
total sum of mapped reads as in FPKM, I estimated this size factor as the 90th
percentile of expression levels to avoid potential biases due to outliers. Once I
had divided the expression levels of each sample by this size factor, I obtained the
final, scaled expression levels. Figure 2.13 shows a flow chart of this process.
Raw 30 Tag-
Seq reads
Map to indel-
personalised genome
Find reads falling
into peak regions
30 Tag-Seq
peak regions
Calculate height
for each peak
Normalise by
90th percentile
Peak expres-
sion levels
Sum peak heights
associated with
each gene
Normalise by
90th percentile
Gene expres-
sion levels
Figure 2.13.: Flow chart illustrating the quantification of 30 Tag-Seq peak and gene
expression levels for a single sample.
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2.8. Comparison of 30 Tag-Seq to standard RNA-seq
The standard RNA-seq protocol is a widely used and reproducible method of
estimating gene expression levels (Marioni et al., 2008). In order to determine
how reliable the 30 Tag-Seq gene expression level estimates were, I thus compared
them to estimates obtained from standard RNA-seq.
For this, my collaborator Enrico Cannavò prepared a set of 22 Illumina poly(A)+
strand-specific RNA-seq libraries of samples collected at 10–12 h post-fertilisation.
The libraries were prepared from the same samples of RNA that had already
been used for the 30 Tag-Seq protocol, allowing me to treat them as technical
replicates to isolate protocol-specific effects. The fragments from 10 of the samples
were sequenced from a single end while the ones from the other 12 samples were
sequenced from both ends, yielding 10 single-end and 12 paired-end data sets.
The two groups of samples were multiplexed to 12 samples per lane and then
sequenced in two separate runs of a Illumina NextSeq 500 sequencing machine.
In total, we sequenced 360 million fragments for the single-end samples and 344
million fragments for the paired-end samples.
I demultiplexed and quality-filtered these data sets using reaper and tally (Davis
et al., 2013). After demultiplexing, the number of fragments per sample ranged
between 6.6 million and 38 million (mean 27 million).
Using STAR (Dobin et al., 2013) I then mapped the reads to theD. melanogaster
reference genome and estimated gene expression levels, measured in transcripts
per million (TPM), using Cufflinks v2.2.1 (Trapnell et al., 2012).
A scatter-plot of the expression levels estimated by RNA-seq and 30 Tag-Seq
for a sample of line 517 at 10–12 h is shown in Figure 2.14. Only genes with at
least some expression observed with both methods are shown, I will discuss genes
for which I had observed no expression at all with one of the methods below.
Spearman’s correlation coefficient between the RNA-seq and the 30 Tag-Seq
expression levels for this sample, considering all genes that showed at least some
level of expression with both methods, was 0.88 (p < 2:2  10 16). In the 22
samples I tested, this correlation coefficient ranged between 0.80 and 0.92 (mean
0.87).
To get an overview over the total degree of correlation between the methods, I
also compared the 5% trimmed mean expression levels observed in the 22 RNA-seq
libraries to the 5% trimmed mean expression levels observed in the corresponding
30 Tag-Seq libraries. A scatter plot of the mean 30 Tag-Seq expression level against
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Figure 2.14.: Scatterplot of gene expression levels estimated with standard RNA-seq
and 30 Tag-Seq for line 517 at 10–12 h. Spearman’s  = 0:88.
the mean RNA-seq expression level of each annotated gene is shown in Figure 2.15.
Spearman’s correlation coefficient for this data was  = 0:90 (p < 2:2  10 16).
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Figure 2.15.: Scatterplot of mean gene expression levels estimated with standard RNA-
seq and 30 Tag-Seq across 22 different lines at 10–12 h. Spearman’s  = 0:90.
There were, however, 1,953 genes expressed according to RNA-seq for which
I had estimated an expression level of zero in the 30 Tag-Seq data. Most of the
strongly expressed genes that I did not observe in 30 Tag-Seq were cases in which
I had in fact observed a 30 Tag-Seq peak, but where I had been unable to assign
71
this peak to a unique gene. This was the case for example for the gene sala, which
in the Flybase annotation has the exact same genomic coordinates as the gene
CG43355. As I ignored all peaks that could not be assigned to a unique gene,
it was impossible for me to observe gene expression in such a case of ambiguous
gene annotation. However, there were only 124 genes for which this was the case.
The remaining genes that I had only observed with RNA-seq were much more
lowly expressed than the genes I had observed with both methods. The median
RNA-seq expression level of the genes without ambiguous annotation but only
seen in RNA-seq was 0.16 TPM, while the median of all other genes was 20.15
TPM (Figure 2.16, Wilcoxon test, p < 2:2  10 16).
1e−01
1e+01
1e+03
Both RNA−seq only
Ex
pr
es
sio
n 
le
ve
l [T
PM
]
Figure 2.16.: Comparison of RNA-seq expression level of genes observed with both
RNA-seq and 30 Tag-Seq and those only observed with RNA-seq.
The fact that I only saw expression of such lowly expressed genes in the RNA-
seq data was not surprising, given the fact that I had obtained more than twice as
many reads per sample in the RNA-seq analysis as in the 30 Tag-Seq analysis (30
Tag-Seq reads per sample = 13 million, RNA-seq reads per sample = 27 million).
Thus, I was able to detect the levels even of very weakly expressed genes, which I
missed in the 30 Tag-Seq data. A greater sequencing depth for the 30 Tag-Seq data
would have allowed me to test these genes for eQTLs as well, but would have also
essentially doubled the cost of the sequencing for this project. Since this would
have meant that I would have been able to sequence fewer different lines, which
would have reduced my power to detect eQTLs, I believe that the omission of
some lowly expressed genes was an acceptable compromise.
In summary, the 30 Tag-Seq gene expression levels generally appeared to be
a good estimate of the true gene expression levels, as confirmed by RNA-seq.
However, there was some disagreement between the methods, which may have
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been caused by experimental variation, problems such as the assignment of a 30
Tag-Seq peak to an incorrect gene or sequencing biases inherent to one of the
protocols. I will analyse the quality and properties of these expression levels
further in Chapter 3.
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3. Analysis and normalisation of gene
expression levels
In this chapter I describe how I compared the gene expression levels I obtained
to a reference time course to remove mis-staged and low-quality samples from my
data set. I then explore differences in gene expression levels between the three
developmental stages and discuss how I normalised the expression levels to make
them suitable for eQTL testing (Chapter 4).
3.1. Introduction
The variation in gene expression levels between different individuals of Drosophila
melanogaster at the same point in development is generally low (Rifkin et al.,
2005). Within each of the three developmental stages, I should thus have obtained
similar gene expression level profiles for all samples. Hence, any sample with a
gene expression profile that was very divergent from the expected profile was
likely to be an outlier and not a reflection of genetic differences. Identifying and
removing these cases was particularly important for my eQTL study, as outliers
would decrease my statistical power to detect true genetic effects.
In addition, the samples collected for my study were staged solely by the time
since fertilisation of the egg (2–4 h, 6–8 h and 10–12 h), not by the phenotype of
the embryos. Thus, I needed to confirm that all DGRP lines did not only follow
the same developmental programme, but also developed at the same speed, with
each nominal time point reflecting the same stage of development in all samples.
3.2. The developmental transcriptome of D. melanogaster
In 2011 the modENCODE consortium performed poly(A)+ RNA-seq on embryos
from the D. melanogaster reference line at various developmental time points,
including at each 2-hour interval between 0 and 24 hours post-fertilisation (Grav-
eley et al., 2011). The gene expression levels measured in this study show that
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different genes follow different trajectories of gene expression during development,
with some of them being constitutively expressed and others switching on and off
for different developmental stages. These expression levels thus form a unique
gene expression profile at each developmental stage.
As a first step of my analysis I calculated the pairwise Spearman correlation
between the embryonic gene expression levels (measured in FPKM) provided by
the modENCODE consortium, which is shown as a heatmap in Figure 3.1.
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Figure 3.1.: Heatmap of pairwise Spearman’s correlation coefficients between all time
points in the modENCODE embryonal time course.
This heatmap shows not only that there are clear differences in gene expression
levels between the developmental time points, but also that two time points are
more similar to each other the less time has passed between them.
3.3. Staging by comparison to a developmental time
course
I thus reasoned that, as long as the 30 Tag-Seq gene expression levels correlated
reasonably well with the modENCODE gene expression levels, I should be able
to determine which developmental stage a sample came from, simply by finding
the modENCODE reference time point it was most similar to.
To test whether this method worked, I applied it to two representative sam-
ples from our 30 Tag-Seq gene expression data set, one collected at 2–4 h post-
fertilisation and one collected at 10–12 h post-fertilisation. For each sample, I cal-
culated the ranked correlation coefficient (Spearman’s ) between the 30 Tag-Seq
expression levels and the modENCODE expression levels at each of the reference
time points. I only considered genes that were observed in at least one 30 Tag-Seq
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sample and at least one modENCODE sample. I then plotted the correlation
coefficient  against the reference time points. The two examples are shown in
Figure 3.2.
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Figure 3.2.: Spearman’s  between gene expression levels of 30 Tag-Seq samples for
line 461 with each embryonic modENCODE time point. modENCODE time points that
match the collection time point highlighted in blue.
The correlation estimates followed a peak shape, indicating that the sample
correlated best with a single time point, and then became more different the
further I moved away from it. This is concordant with the assumption that
expression levels would change systematically over time. Most importantly, the
location of the peak was different for the two samples, and in fact corresponded
to one of the two reference time points closest to their collection time point. This
experiment thus showed that it was feasible to determine the developmental time
point of a sample based solely on its gene expression levels.
I now extended this approach to all 30 Tag-Seq samples to answer two ques-
tions: How well do the expression levels of each sample correlate with the ref-
erence expression levels in general and from which developmental time point is
each sample. The correlation estimate  for the original set of samples and all
embryonic modENCODE time points is shown in Figure 3.3. For each sample, I
ranked the reference time points by their , under the assumption that the most
strongly correlated time point was the most likely true time point of the sample.
If the true time point matched the collection time point, I considered the sample
validated. Additionally I also considered samples validated if the second-best cor-
relation matched the reference time point, in order to account for minor variations
in the timing of both my study as well as modENCODE.
Considering all of the embryonic modENCODE time points, the highest cor-
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Figure 3.3.: Spearman’s  between gene expression levels of each 30 Tag-Seq sample
with each embryonic modENCODE time point. modENCODE time points that match
the collection time point highlighted in blue. Vertically split by the time point the samples
were collected at, horizontally split by whether one of the two highest s was observed
for a matching time point or not.
relation coefficient  ranged between 0.78 and 0.92 (mean 0.88) for the samples.
This showed that most of our samples were of good quality and represented bi-
ological states similar to the ones from the reference time course. For almost all
of the samples the time point estimated from the modENCODE correlation was
concordant, with the collection time point matching the highest  for 238 samples
(93%) and the second-highest  for another 5 samples (2%). This showed that
the “developmental clock” seemed to run at approximately the same speed for
almost all of DGRP lines we analysed, with none of them developing noticeably
faster or slower than the reference.
However, some samples appeared to have a good correlation to one of the mod-
ENCODE time points, but not to the one as which they were labelled. For ex-
ample, the three mismatching samples from the 2–4 h time point were clearly not
correlated with the 2–4 h reference time point, but would have perfectly matched
the 10–12 h time point. In a separate analysis, Jacob Degner, a postdoctoral fellow
from the Furlong group at EMBL-Heidelberg, also observed that these samples
seemed to have been assigned to the wrong DGRP line. This was based on a com-
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parison of SNP genotypes observed in the 30 Tag-Seq data to known genotypes
from the DGRP variant annotation.
After some further investigation, it emerged that these were actually mislabelled
samples, which I could correct and assign back to their correct line and time point.
The new correlation coefficients after recovering the swapped samples are shown
in Figure 3.4. For 242 out of 254 samples (95%) the correct reference time point
now was the time point with the highest , and for an additional 5 samples (2%) it
was the second-highest. For the other seven samples, I assumed that there might
have been an error during sample preparation, sequencing or processing and thus
removed them from all further analysis. The maximum  of the remaining 247
samples ranged between 0.79 and 0.91 (mean 0.87). Thus, using this method of
developmental staging by gene expression, I was not only able to identify and
remove outliers from my study, but could also identify and correct sample swaps.
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Figure 3.4.: Spearman’s  between gene expression levels of each 30 Tag-Seq sample
with each embryonic modENCODE time point. modENCODE time points that match
the collection time point highlighted in blue. Vertically split by the time point the samples
were collected at, horizontally split by whether one of the two highest s was observed
for a matching time point or not.
Nevertheless, I could still observe some slight differences between the samples
in both the location of the best correlation and the strength of the correlation.
There are various factors that may have caused this, ranging from small differences
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in the developmental speed of different DGRP lines to technical reasons such as
sequencing problems or variation in exactly at what point in the two-hour time
range the sample was collected. However, since I could only compare our samples
to the 2 h bins from modENCODE I could not resolve this structure any further
using this method. I will discuss a possible extension of this approach for a more
fine-grained staging of samples in Chapter 8.
3.4. Differential gene expression between developmental
stages
To further investigate the differences that I could observe between developmental
stages, I conducted a differential gene expression study between all samples from
2–4 h, 6–8 h and 10–12 h after fertilisation. Since each line from the DGRP consti-
tuted an independent biological sample, I had approximately 80 replicates for the
gene expression levels at each developmental stage, allowing me to estimate both
the mean expression level and the biological variation with very high confidence.
Using DESeq2 (Love et al., 2014) on the matrix of raw summit heights (which
are comparable to the read counts usually used with DESeq2) I was able to detect
a large amount of differential gene expression between the three developmental
stages (Figure 3.5).
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Figure 3.5.: Genes differentially expressed between the three developmental stages at an
FDR threshold of 1%. (a) All differentially expressed genes. (b) Genes with an absolute
log2(fold-change) of at least 1.
Between 67% and 76% of tested genes were found to be differentially expressed
between the stages at an FDR threshold of 1%, with 8% to 24% different by more
than a factor of two. The difference was smaller between adjacent time points
(2–4 h and 6–8 h, 6–8 h and 10–12 h) than for 2–4 h and 10–12 h. These results
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are in line with the results from the modENCODE project, which had already
shown that the transcriptome undergoes massive, but systematic, changes during
embryonic development.
Genes differentially expressed with at least a two-fold change between 2–4 h and
6–8 h were enriched in 35 different GO terms in the “biological process” ontology
and depleted in another 24 (Two-tailed Fisher’s exact test, Bonferroni-corrected p-
value < 0:05). Many of the enriched terms, shown in Table 3.1 were related to the
regulation of transcription, and RNA biosynthetic processes, while the depleted
terms were related to organelle organisation, metabolic processes, translation, and
the cell cycle. Between 6–8 h and 10–12 h there were no enriched GO terms, but
a total of 73 depleted GO terms, many of them the same as between 2–4 h and
6–8 h (Table 3.2). The reason for this consistent depletion may be that genes
from these categories are important throughout the life cycle of the embryo, and
are thus constitutively expressed. The large amount of enrichment between 2–
4 h and 6–8 h may be reflective of the major changes that occur in the organism
between 2–4 h and later stages of development, including cellularisation and the
maternal-zygotic transition (see Section 1.2.1).
This large number of differences in gene expression was reflective of the scale of
change that can occur within 2 h of Drosophila embryo development. In addition,
it also showed the large statistical power that this data set provides, making it
possible to detect even low fold-changes in gene expression with high confidence.
3.4.1. Expression levels of stage-specific genes
The list of genes differentially expressed between the developmental stages in-
cluded many classic developmental genes. In this section, I will show a few ex-
amples.
twist (Figure 3.6) is a helix-loop-helix transcription factor that plays a major
role during gastrulation, when it is important for the formation of the mesoderm
(Thisse et al., 1988; Murre et al., 1989). In accordance with this function, it was
highly expressed at 2–4 h but much more lowly expressed at 6–8 h and 10–12 h.
The difference in expression level between 2–4 h and 6–8 h was highly significant
according to DESeq2 (BH adjusted p-value = 4:65  10 187), while the expression
level at 10–12 h was too low to quantify the difference.
pebbled (Figure 3.7), also known as hindsight, is a zinc finger transcription factor
involved in the retraction of the germ band, which begins during the 6–8 h time
point and completes at the beginning of the 10–12 h time point (Yip et al., 1997).
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Term Exp. Obs. Dir.  log10(p)
regulation of transcription, DNA-dep... 64.94 121 " enr. 9.08
regulation of RNA biosynthetic process 64.94 121 " enr. 9.08
regulation of transcription from RNA p... 33.35 75 " enr. 8.44
regulation of macromolecule biosynthetic... 70.99 124 " enr. 7.38
regulation of cellular macromolecule bio... 70.99 124 " enr. 7.38
transcription, DNA-dependent 70.62 122 " enr. 6.85
RNA biosynthetic process 70.81 122 " enr. 6.82
organic cyclic compound biosynthetic pr... 87.30 142 " enr. 6.60
regulation of RNA metabolic process 71.09 122 " enr. 6.60
regulation of cellular biosynthetic pr... 73.69 124 " enr. 6.30
organelle organization 94.94 42 # depl. 8.03
cellular protein metabolic process 106.49 55 # depl. 6.32
RNA processing 35.78 7 # depl. 6.22
mRNA metabolic process 28.60 6 # depl. 4.07
translation 32.24 8 # depl. 4.06
protein metabolic process 137.14 89 # depl. 3.60
mRNA processing 26.93 6 # depl. 3.44
cell cycle phase 45.09 18 # depl. 3.17
mitotic cell cycle 44.63 18 # depl. 2.89
cell cycle process 52.64 24 # depl. 2.79
Table 3.1.: GO terms in the “biological process” ontology significantly enriched (enr.)
or depleted (depl.) in genes that changed by at least two-fold between 2–4 h and 6–8 h.
p, p-value after adjustment for multiple testing. Only top 10 out of 35 enriched terms
shown. Only top 10 out of 24 depleted terms shown. Exp., expected number of genes.
Obs., observed number of genes. Dir., direction.
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Figure 3.6.: 30 Tag-Seq expression level of twist across 80 different lines from the DGRP.
Accordingly, pebbled expression was strongly increased between 2–4 h and 6–8 h
(BH adjusted p-value = 3:53 10 69) and then decreased again between 6–8 h and
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Term Exp. Obs. Dir.  log10(p)
gene expression 227.94 106 # depl. 22.82
cellular macromolecule metabolic process 346.21 210 # depl. 20.40
cellular metabolic process 455.73 318 # depl. 17.82
RNA processing 55.56 5 # depl. 16.77
cellular protein metabolic process 168.73 83 # depl. 13.52
cellular process 760.23 649 # depl. 13.17
RNA metabolic process 176.31 93 # depl. 12.00
mRNA metabolic process 44.33 5 # depl. 11.80
mRNA processing 41.71 5 # depl. 10.52
macromolecule metabolic process 408.48 303 # depl. 10.08
Table 3.2.: GO terms in the “biological process” ontology significantly enriched (enr.)
or depleted (depl.) in genes that changed by at least two-fold between 6–8 h and 10–12 h.
p, p-value after adjustment for multiple testing. Only top 10 out of 73 depleted terms
shown. Exp., expected number of genes. Obs., observed number of genes. Dir., direction.
10–12 h (BH adjusted p-value = 2:95  10 18).
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Figure 3.7.: 30 Tag-Seq expression level of pebbled across 80 different lines from the
DGRP.
The gene serpentine produces a luminal chitin binding protein, which is impor-
tant for tracheal development (Luschnig et al., 2006). serpentine has previously
been shown by in situ hybridisation to be expressed in tracheal cells starting from
morphological stage 12 (7 h 20min after fertilisation) and continuing until the
end of embryogenesis (Wang et al., 2006). The pattern that I observed was in
agreement with this, with the expression of serpentine being very low at 2–4 h
and 6–8 h and high at 10–12 h (BH adjusted p-value = 1:56 10 124 between 6–8 h
and 10–12 h).
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Figure 3.8.: 30 Tag-Seq expression level of serpentine across 80 different lines from the
DGRP.
3.5. Normalisation of 30 Tag-Seq data for eQTL discovery
For all further analyses, I only considered the first replicate that passed the staging
filter for each unique combination of line and developmental stage, resulting in
a final set of 235 samples including 76 lines for which I had data at all three
developmental stages. These gene expression levels now had to be normalised in
a way that made them suitable for an eQTL study.
In short-read sequencing there are various potential confounding factors that
can cause systematic biases in the estimated gene expression levels (Leek et al.,
2010). This can result in the expression levels of samples being closely correlated
with each other, for example because they were sequenced in the same sequencing
lane (batch effects) or because they are closely related genetically (population
structure). Large-scale correlations between samples are thus usually reflective of
confounding factors as opposed to genetic effects. In this section, I will describe
how I normalised the gene expression levels to remove any potential outliers and
then removed confounding effects using the software package PEER.
In order to estimate the level of structure in the raw (only library-size adjusted)
expression level matrix, I calculated the pairwise Spearman correlation between
each pair of samples. I then applied the hclust function in R (R Core Team,
2013) to obtain a hierarchical clustering of the samples based on the euclidean
distance between their correlation coefficient vectors.
In addition, I performed a principal component analysis (PCA) on the expres-
sion level matrix. PCA is used to transform a set of many, possibly correlated
variables (such as gene expression levels) into a set of uncorrelated (orthogonal)
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variables. These uncorrelated variables are then called the principal components
(PCs). The first principal component (PC1) always explains the largest amount of
variance in the original set, the second (PC2) explains the second-largest amount
of variance in the original set and so on. If there is large-scale structure in the
data, the first few components will explain the vast majority of the variance, while
for data with more fine-grained structure each of them will only explain a little.
Thus, we can get an idea of how structured a set of observations is by looking
at the variance explained by its first few principal components. In addition, by
projecting each sample onto the space defined by PC1 and PC2, we can get a
good overview over which samples are similar to each other. PCA is sometimes
used to correct for batch effects in sequencing data, however I will only be using
it as a diagnostic plot.
The diagnostic plots generated with these methods for the raw expression levels
of genes at 10–12 h are shown in Figure 3.9. In order to illustrate the difference
between the scaled and unscaled expression levels, I did not centre and scale
the expression level matrix for this first PCA. While the strength of the first
component was most likely caused by this lack of centring, which can inflate the
size of the first component in PCA, the size of the other components as well as
the large amount of correlation between the samples showed that there was a
substantial amount of large-scale structure in the data.
I thus applied multiple normalisation steps to our expression levels, similar to
those that had been shown to increase the number of discovered QTLs by Degner
et al. (2012). I applied these normalisations separately to each developmental
time point and to each feature type (genes and 30 Tag-Seq peaks) using custom
R scripts. I will describe them here for the example of genes at 10–12 h and show
diagnostic plots similar to Figure 3.9, using the following notation:
Let Ymethod be a N  D matrix of gene expression levels at 10–12 h, where
“method” is the normalisation method, N is the number of individuals and D
is the number of genes/peaks. I will denote operations that are applied to each
row vector i separately as Yi;::: and operations applied to each column vector j
as Y:::;j .
First, I removed all genes for which the median expression level (among all
samples) was zero, indicating that this gene was not expressed at all in more than
half of the samples. I centred and scaled the expression levels associated with each
remaining gene by subtracting the mean and dividing by the standard deviation
of the gene’s expression level. The resulting z-score describes how much above or
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Figure 3.9.: Diagnostic plots for raw, library-size adjusted gene expression level matrix
of 78 samples from the 10–12 h time point. Correlation between the samples is high (mean
 = 0:94) and the first principal component explains 92% of the variance.
below the mean expression level each individual’s expression level was, normalised
by the observed variation in the gene’s expression levels overall. This is shown in
the equation below, where mean(x) calculates the mean and sd(x) calculates the
standard deviation of a vector x.
Yz-scores:::;j = (Yraw:::;j  mean(Yraw:::;j))/sd(Yraw:::;j) (3.1)
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The diagnostic plots for the centred and scaled expression level matrix Yz-scores
are shown in Figure 3.10.
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Figure 3.10.: Diagnostic plots for centred and scaled (z-score) gene expression level
matrix of 78 samples from the 10–12 h time point. Most samples are no longer correlated
and the first principal component explains 24% of the variance, indicating that there
is less large-scale structure in the data. Expression levels are now roughly symmetric
around 0, but there are some outliers.
Since the DGRP lines used in this study were all viable and did not show
any large phenotypic differences (see Section 1.9), I further assumed that each
individual should show average expression levels for most genes, with only a few of
them being over- or underexpressed due to genetic differences. To make sure that
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all individuals conformed to this assumption, I quantile-normalised the z-scores
by transforming each individual’s z-scores into a standard normal distribution.
This is illustrated below, where qqnorm(x) is a function that takes a vector x
and returns a vector z with those values transformed into a normal distribution.
Figure 3.11 shows the diagnostic plots for this new matrix Yqq.
Yqqi;::: = qqnorm(Yz-scoresi;::: ) (3.2)
I applied these normalisation steps to both peak and gene expression levels,
and to samples from each developmental stage separately. Consequently, an in-
dividual with its expression level for a gene consistently below the mean at each
developmental stage had similar normalised values in all three stages. This be-
came important when I ran the multi-stage model to call eQTLs (see Section 4.5)
since it made it feasible to observe a common effect across all three time points
even if the mean expression level of the gene changed between the stages.
3.5.1. Correcting for batch effects and population structure using
PEER
The final step in the normalisation procedure was to apply the PEER algorithm
(Stegle et al., 2012) to the quantile-normalised z-scores in order to remove any
remaining covariance structure from the data.
PEER uses factor analysis methods to infer hidden effects from a matrix of
gene expression levels, which can then be corrected for. It assumes that there
are a relatively small number of hidden factors that affect gene expression levels
for many genes and individuals. Examples of such hidden effects in my study
could be batch affects associated with the library preparation and sequencing,
but also effects of population structure within the DGRP. Conceptually, PEER is
similar to PCA, but it does not require orthogonality of factors and automatically
determines the minimal number of factors necessary to model the structure, which
prevents over-fitting.
PEER models the observed gene expression level matrix Y (where Y = Yqq)
as follows:
Y = XU+	 (3.3)
Where X is a N  k matrix of k hidden factors, U is a kD matrix of weights
for each of the factors on each gene and 	 is the noise term (N  D), which is
88
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Figure 3.11.: Diagnostic plots for quantile-normalised expression level matrix of 78
samples from the 10–12 h time point. The first principal component now only explains
18% of the variance, indicating even less large-scale structure in the data. Expression
levels all follow exactly the same normal distribution, so they are symmetric.
assumed to follow a Gaussian distribution. PEER also allows for the specification
of an additional matrix of covariates that can be included in the model (such as
gender or age in human studies), however I did not supply any covariates in this
case. The parameters of this model, X and U are initially set to values obtained
via PCA and then iteratively refined using variational Bayesian learning (Stegle
et al., 2010).
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After applying PEER to my data, I obtained a matrix containing the residual
gene expression levels after subtracting the effect of the hidden factors. The diag-
nostic plots for these PEER-normalised expression levels are shown in Figure 3.12.
It is worth contrasting the diagnostic plots seen in Figure 3.9, where blocks of
correlated samples could be observed, with the data shown in this figure.
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Figure 3.12.: Diagnostic plots for PEER-adjusted gene expression level matrix of 78
samples from the 10–12 h time point. As expected, there is almost no remaining correla-
tion between the samples and the first principal component now explains only 4% of the
variance. The expression level distributions per sample vary slightly, but are still largely
symmetric around zero.
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With this final, fully normalised set of expression levels I could now go on to
call eQTLs, described in Chapter 4.
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4. Gene-proximal calling of eQTLs
In this chapter I describe how I used the normalised gene expression levels I
estimated in Chapter 3 to find eQTLs in a proximal window around genes and
30 Tag-Seq peaks. In the next chapter I will describe how I further filtered these
eQTLs to decrease the false positive rate and remove possible artefacts introduced
by the sequencing protocol, followed by an analysis of the properties of proximal
eQTLs in Chapter 6. Finally, I extend this approach to test for eQTLs genome-
wide in Chapter 7.
4.1. Introduction
Linear mixed models (see Section 1.7) have been shown to be a powerful tool
for modelling gene expression data (Listgarten et al., 2010) and have already
successfully been applied in genetic association studies to find eQTLs (Bennett
et al., 2010; Lippert et al., 2014; Tung et al., 2015). The mixed model framework
makes it possible to test the effect of a given variant (a fixed effect) on gene
expression, while also accounting for confounders such as the population structure
using random effects. An implementation of this framework is LIMIX (Lippert
et al., 2014), which has been developed by the Stegle group at EMBL-EBI and
allows for the rapid testing of a wide variety of univariate and multivariate linear
mixed models.
In the following sections, I will describe how I used LIMIX to model the nor-
malised expression levels as a sum of genetic and non-genetic effects and call
eQTLs in the Drosophila Genetic Reference Panel.
The genomes of all lines in the DGRP have been fully sequenced and SNPs,
indels and SVs have been annotated based on these full genome sequences (see
Section 1.9). Due to the high quality of the indels and SVs in this data set (Huang
et al., 2014), I not only considered all biallelic SNPs, but also all biallelic indels and
SVs for my study. I defined the gene-proximal area as a 50 kb window around
each gene, starting 50 kb upstream of the 50 end and ending 50 kb downstream of
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the 30 end. A window of this size would include almost all known cis-regulatory
modules associated with a known gene (1,878/1,894, 99%), as annotated in the
Redfly database of D. melanogaster regulatory elements (Gallo et al., 2011), which
suggests that most eQTLs would be located in this region. On average, this
proximal region contained 1,580 annotated variants per gene, ranging from 103
to 5,601.
For all of the following analyses I only considered the 76 lines for which at least
one replicate passed quality-control at each of the three developmental stages (see
Table A.1), for a total for 3  76 = 228 samples. Additionally, I ignored any genes
or peaks located on heterochromatic parts of chromosomes, as variants had not
been called in these regions.
4.2. Variance decomposition
A useful first step towards finding eQTLs is to determine how much of the variance
of each gene could be explained by genetic or non-genetic effects, regardless of the
exact location of the associated variant.
To perform this analysis, I used the multi-trait variance decomposition mod-
ule from LIMIX, modelling the expression levels of each gene as a sum of ran-
dom effects: the effect of the developmental stage (Dev. Stage, 2Dev), the effect
of the local genetic relatedness based on variation in a 50 kb window (proximal,
2A;proximal), the effect of global genetic relatedness based on variation further away
(distal, 2A;distal), as well as effects accounting for the interaction between the de-
velopmental stage and both types of genetic relatedness (G./Dev., 2DevA;proximal
and 2DevA;distal). I did not consider any non-additive genetic or epistatic effects,
as they would have greatly increased the complexity of the model. I assumed that
any remaining variation was either experimental or biological noise.
Since the data normalisation procedure I described in Section 3.5 was designed
to make expression levels comparable between developmental stages, I would not
have been able to estimate the developmental component if I had used this data
set. Consequently, I used the raw, library-size adjusted, expression levels instead,
which I transformed (quantile-normalised) to be normally distributed. After dis-
cussions with the authors of LIMIX I also only considered genes that were strongly
expressed in all three stages (more than 90% of samples above the 20th percentile)
for this analysis, in order to exclude genes that are only expressed in one of the de-
velopmental stages from inflating the estimates of the mean genetic/development
94
interaction effects.
This left me with a set of 6,529 genes for the variance decomposition analysis.
From this data, I calculated the relative contribution of each component to the
total variance of each gene and estimated the total narrow sense heritability (her-
itability through additive genetic effects) as the fraction of variance explained by
any of the genetic effects:
h2 = 2A;proximal + 
2
A;distal + 
2
DevA;proximal + 
2
DevA;distal (4.1)
A histogram of the total narrow sense heritability is shown in Figure 4.1.
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Figure 4.1.: Histogram of total narrow sense heritability h2 for 6,529 genes, estimated
as the fraction of variance explained by additive genetic effects.
The median heritability of gene expression levels was 29.8% and 1,130 of the
6,529 genes I analysed showed a heritability larger than 50%. I grouped the genes
into bins based on the heritability of their expression levels and then plotted the
mean size of each variance component for each group. The result is shown in
Figure 4.2.
For 2,451 genes (38%), more than half of their variance could be attributed
to the developmental stage alone. This confirmed the large difference in gene
expression levels between the three developmental stages, which I had already
observed in the differential expression analysis (Section 3.4).
In addition, this plot gave me some hints about the overall structure of genetic
effects that I might be able to observe in the eQTLs. First, the distal relatedness
matrix appeared to explain more of the variance in gene expression levels than
the proximal relatedness matrix. This suggested that there is a large number of
genetic effects acting on gene expression levels in trans. This is in line with earlier
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Figure 4.2.: Mean percentage of variance explained by each of the six variance compo-
nents in groups of genes, binned by their total narrow sense heritability.
work in Drosophila, which has shown a large amount of gene regulation occurring
in both cis and trans, with 66% of genes showing evidence of trans regulation and
51% of genes showing evidence of cis regulation (McManus et al., 2010).
The difference between distal and proximal effects was even more pronounced
in the genetic/developmental stage interaction components, where the distal re-
latedness seemed to play a much larger role than the proximal relatedness. This
suggested that developmental stage-specific regulation may largely be occurring
in trans, while cis effects are usually common amongst all developmental stages.
Nevertheless, I found 35 genes for which the proximal genetic/developmental stage
component explained more than 25% of the variance, which were likely to mani-
fest also as stage-specific eQTLs. In addition, for 323 (4.95%) of genes the pure
proximal genetic component explained more than 25% of the variance, suggesting
that I would likely be able to find a common eQTL for them.
These results confirmed that there was a genetic component to the expression
level of many genes. In addition, I could also see that the developmental stage
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did indeed play a big role in the expression levels of the genes and that there were
genetic factors whose effects were dependent on the developmental stage.
4.3. Power calculation
Before calling eQTLs I first had to answer the question whether we would actually
have enough statistical power to find eQTLs using only 228 samples.
The statistical power (see Section 1.7) in my eQTL study depends on the sample
size, the ratio between samples with the minor allele and the major allele, the size
of the effect and the desired significance level, which is the probability of a Type
I error (false positive). Since the aim of this experiment was only to determine
whether my sample size was roughly appropriate, I calculated the power of a
comparable t-test to approximate the results I could expect to obtain with the full
linear mixed model. I did not consider possible differences between developmental
stages for this experiment, but assumed that the effect had the same direction
and the same size in all three stages.
Using the R package “pwr” (Champely, 2015) I simulated the statistical power
to detect effects of different magnitudes and different MAFs, assuming a sample
size of 228 and allowing for a false positive rate of 1%. Here, the effect sizes are
defined as the standardised mean difference, that is, the difference in mean of the
two groups divided by their standard deviation. The result is shown in Figure 4.3.
This plot illustrates how my power to detect effects increases with increasing
MAF, as the sample sizes between the two genotypes become more balanced and
the estimates of mean expression level become more certain. For small effects
(0.2) I have little power even at high MAF, suggesting that we will not be able
to pick up eQTLs with small effects in this study. However, for larger effect sizes
my power looks quite promising. At a MAF of 5% I already have approximately
50% power to detect effects of size 0.8, 75% power to detect effects of size 1, 90%
power to detect effects of size 1.2 and almost 100% power for effects sizes greater
than 1.2. I decided to test only variants above this threshold of 5% in the eQTL
analysis.
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Figure 4.3.: Simulated power to detect effects of different sizes using 228 samples at
different MAFs. Dashed line indicates a MAF of 5%.
4.4. Single-stage eQTL testing
As an initial analysis, I called eQTLs in each of the three developmental stages
separately using a univariate linear mixed model similar to the ones described in
Bennett et al. (2010) and Lippert et al. (2014):
y = 1N + x+ g+ (4.2)
In which the phenotype is modelled as a sum of the intercept term 1N , a
fixed genetic effect term x, a random effect term accounting for the population
structure g and residual noise  .
I defined this model in LIMIX with the help of Francesco Paolo Casale, a PhD
student from the Stegle group and one of the co-authors of the software, using
the following variables:
• y: A vector of phenotypes (gene expression levels of the given gene) for all
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76 individuals in the given developmental stage (dimension 76).
• : The intercept parameter (scalar).
• 1N : A vector of ones (dimension N = 76).
• x: Vector of minor allele dosages for each of the 76 lines at the given vari-
ant, with 0 being a homozygous major genotype, 1 being a heterozygous
minor/major genotype and 2 being a homozygous minor genotype (dimen-
sion 76).
• : The effect size of the genotype at the given SNP in the given develop-
mental stage (scalar).
• g: A random effect term for population structure (dimension 76). Modelled
as following a multivariate normal distribution g  N (0;K), where K is
the genetic relatedness matrix calculated from the full genotype matrix.
•  : A random effect term representing residual noise (dimension 76). Mod-
elled as normally distributed, independent and identically distributed (i.i.d.)
noise:   N (0; I), where I is the identity matrix.
I could then test for association between a gene and a variant by comparing
the fit of the alternative model with  6= 0 and the fit of the no-effect model with
 = 0 using a log-likelihood ratio test in LIMIX. In this way, I tested the set of
proximal candidate variants for each gene, obtaining a p-value p and effect size 
for each variant.
To account for multiple testing within each gene-proximal region I calculated
an empirical p-value e for each uncorrected p-value p (see Section 1.7.1) as fol-
lows. I performed 10,000 permutation experiments, randomly permuting the vec-
tor of genotypes x of each variant, assigning a random set of genotypes to each
of the samples but keeping the same number of minor, heterozygous and ma-
jor genotypes. I then re-tested all variants again and determined the minimum
uncorrected p-value mi between all of them.
After performing 10,000 such random permutations for a given gene I obtained a
vector of the 10,000 minimal p-values m = hm1; : : : ;m10000i. I then counted how
many p-values in this empirical null distribution were lower than the uncorrected
p-value p and calculated the empirical p-value e as this count plus one, divided
by 10,001: e = (count(m < p) + 1)  10001 1.
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I applied this procedure to test for proximal eQTLs around each expressed gene
in each of the developmental stages separately. In total I tested 10,163 genes at
2–4 h, 10,290 genes at 6–8 h and 10,307 genes at 10–12 h.
4.4.1. Single-stage eQTL results
At an empirical p-value threshold of  = 1% I found at least one eQTL for 2,462
genes at 2–4 h, 2,404 genes at 6–8 h and 2,450 genes at 10–12 h (Table 4.1).
Stage Genes tested Genes with eQTLs
2–4 h 10163 2462
6–8 h 10290 2404
10–12 h 10307 2450
Table 4.1.: Number of eQTLs and genes with eQTLs found with the single-stage eQTL
tests.
As a first naive approach to estimate how many eQTLs were shared between all
three developmental stages, I overlapped these three sets of genes with eQTLs. I
ignored the exact location of the identified variant in this overlap to account for
some random fluctuations in the data. The resulting Venn diagram is shown in
Figure 4.4.
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Figure 4.4.: Venn diagram of genes with at least one eQTL in the three different devel-
opmental stages.
As expected, there was quite a large number of genes with an eQTL in all three
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stages (957), suggesting that the regulatory regions of many genes were being used
in all developmental stages that I analysed. In addition, the overlap between pairs
of two stages behaved as expected, with the overlap between 2–4 h and 6–8 h and
between 6–8 h and 10–12 h being almost twice as large as the overlap between
2–4 h and 10–12 h. This reflects the systematic changes in the developmental
transcriptome during embryogenesis, resulting in more similarity between 2–4 h
and 6–8 h than between 2–4 h and 10–12 h. However, the amount of genes that
only had an eQTL at one of the stages was surprisingly large. Between 25% and
34% of genes appeared only to have an eQTL at a single developmental stage.
Upon closer inspection of the data, it became clear that this did not accurately
reflect the true situation. In particular, there were many cases where there actu-
ally seemed to be an effect in all three developmental stages, but only in one of
them did the effect pass the threshold for significance, giving the impression that
this eQTL was only active in one stage. This effect was particularly common for
genes that were expressed at different levels in the three stages, with the eQTL
being much more likely to be detected in the stage with the strongest expression.
This is an expected consequence of the single-stage testing approach but makes it
challenging to derive meaningful conclusions from comparisons between the three
single-stage data sets. I thus moved on to a more rigorous approach that solves
this problem by modelling the gene expression levels from all three developmental
stages at the same time.
4.5. Multi-stage eQTL testing
Testing for eQTLs with single-stage univariate mixed models had already shown
that it was feasible to find eQTLs using our data set. However, it became clear
that it was not suitable for differentiating between eQTLs that were active in all
three developmental stages and those that were specific to one of them.
In addition to univariate mixed models, LIMIX also allows the specification
of multivariate mixed models, which enabled me to model the expression levels
at all three developmental stages simultaneously. Using a multivariate model, I
could not only test for stage-specific effects in a more accurate way, but could
also increase the statistical power by considering the data from all 228 samples
together.
When modelling a random effect in a multivariate linear mixed model, one needs
to consider the covariance both between the different traits as well as between the
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different samples. In my case, I am studying three different developmental stages
(traits) and 76 different DGRP lines (samples), which results in a 228  228
covariance matrix that can be factorised into two separate matrices: the trait
covariance matrix C (3  3), which describes the correlation of gene expression
levels in each line between the developmental stages induced by the random effect,
and the sample covariance matrix R (76 76), which describes the correlation in
gene expression levels in the same developmental stage between lines. The trait
covariance matrix and the sample covariance matrix can be combined to yield the
full covariance matrix using the Kronecker product: V = C
R.
The Kronecker product A
B represents a multiplication of the matrix A with
dimensions m n with each element of the matrix B with dimensions k  l and
then stacking the results to form a new matrix with dimensions mk  nl. For
example:
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Using this factorisation only the small trait covariance matrix needs to be es-
timated for each gene and each random effect in the model, while the sample
covariance matrix is only estimated once.
To define the multivariate models I used the same variables as described above,
with the following additions and changes:
• yf1;2;3g: Vectors of gene expression levels in each of the three developmental
stages (dimension 76 each). These are stacked to make a vector of dimension
228.
• f1;2;3g: Separate intercept parameters for each of the developmental stages
(scalar).
• c: Estimate for the effect size of the genotype at the given SNP, common
to all three stages (scalar).
• f1;2;3g: Estimate for the stage-specific effect size of the genotype at the
given SNP in addition to the common effect (scalar).
• g: A random effect term for population structure (dimension 228), the
covariance matrix of which factors into a trait and a sample covariance
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matrix as described above: g  N (0;Cg 
K), where Cg is the covariance
matrix of the developmental stages attributable to genetic factors and K is
the genetic relatedness matrix.
•  : Residual noise (dimension 228) accounting for covariance between traits
but assuming independence between samples:   N (0;Cn
 I), where Cn
is the residual covariance matrix of the developmental stages attributable
to non-genetic factors and I is the identity matrix.
Using these symbols and conventions I defined the following multivariate mod-
els, similar to the ones described in Korte et al. (2012) and Lippert et al. (2014):
• The common effect model:
264y1y2
y3
375 =
26412
3
375
 1N +
264cc
c
375
 x+ g+ (4.3)
This models the case that the expression level of the gene is explained by
a genetic effect that is the same in all three developmental stages, plus the
intercept term and random effects as described above.
• The specific effect models:
264y1y2
y3
375 =
26412
3
375
 1N +
264c + 1c
c
375
 x+ g+ (4.4)
264y1y2
y3
375 =
26412
3
375
 1N +
264 cc + 2
c
375
 x+ g+ (4.5)
264y1y2
y3
375 =
26412
3
375
 1N +
264 cc
c + 3
375
 x+ g+ (4.6)
These models can be used to test whether there is a genetic effect specific
to one of the stages in addition to the common effect.
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Similar to the single-stage model, I could now test the common-effect model
(where c 6= 0) against the no-effect model (where c = 0) to look for a variant
that had the same effect at all three developmental stages. However, in addition
to this I could then carry out three more tests, calculating the p-value for the log-
likelihood ratio test of each of the three specific models against the common-effect
model. This allowed me to determine whether there was an additional effect in
one of the stages that went beyond the common effect.
I now applied these tests to our data set as before, testing all biallelic variants
with MAF > 5% in a 50 kb region around each gene and calculating an empirical
p-value to correct for multiple testing per gene. I only tested the 10,094 genes
which were expressed in all three developmental stages, using the criteria described
in Section 3.5. An overview over the parameters of the multi-stage eQTL test is
shown in Table 4.2.
Genes Tested Variants Tests per gene
10094 1757540 1579.92
Table 4.2.: Multi-stage eQTL testing parameters: Number of unique genes tested, num-
ber of unique tested variants and mean number of tests performed per gene.
The number of tests performed per gene differed between genes, due to the
varying density of annotated variants across the genome. A histogram of the
number of tested variants per gene is shown in Figure 4.5. The minimum number
of variants I tested for a gene was 103, the maximum was 5,601.
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Figure 4.5.: Histogram of the number of variants tested with each gene in the multi-stage
eQTL testing.
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4.6. Processing of multi-stage eQTL testing results into
eQTL sets
The output of the eQTL calling step can be conceptualised as a set of V  T
matrices for each gene, where V is the number of variants and T is the number
of tests that were performed (1 common test + 3 specific tests = 4 tests). These
matrices contain all the important output for each log-likelihood test with each
variant, including the uncorrected p-value p, the empirical p-value e and the effect
size . The challenge now was to process this data in a way that allowed me to
derive biologically meaningful and interpretable results from it.
As a first step, I generated four sets of eQTLs that passed our empirical p-value
threshold of  = 1%, one for each of the four tests I performed1. The total
number of eQTLs as well as the amount of unique genes with at least one eQTL
for each of these four sets is shown in Table 4.3.
Test eQTLs Genes with eQTLs
Common effect 49649 3139
Specific effect at 2–4 h 3960 447
Specific effect at 6–8 h 906 186
Specific effect at 10–12 h 2229 335
Table 4.3.: Number of gene eQTLs and unique genes with eQTLs found with the multi-
stage eQTL tests.
From these full eQTL sets, I generated four summarised eQTL sets which con-
tained the eQTL with the lowest uncorrected p-value (the lead eQTL) for each
gene. I called these the “overview” eQTL sets.
The vast majority of the eQTLs that I found had a common effect. However,
it is important to highlight two aspects of the eQTL testing which mean that an
eQTL will be more likely to have a common effect than a specific effect:
First, if the effect sizes associated with a variant differ between the three de-
velopmental stages, the common effect size c will essentially be an average of
the three true effect sizes. Thus, if the effect is strong in one of the stages and
weak but not opposite in the other stages, the common effect test may still find
an association, but with a decreased effect size. Second, for a specific effect to
be identified, the model with the specific effect has to fit the data significantly
1This threshold corresponds to a false-discovery rate (FDR) of approximately 10% across all
tested genes and models.
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better than the common effect model, which is a stringent criterion.
Together, these two aspects of the test design may result in cases where a
specific effect is “split up” into a weak common effect, which underestimates the
effect size, and a weak specific effect, which corrects this underestimation. Either
or both of these effects may fail to pass the significance threshold, which can
result in me either classifying a specific effect as a common effect or missing the
association completely.
Interestingly, I also found much fewer eQTLs specific to 6–8 h than to the other
two time points. A possible explanation for this may be that there are some
regulatory mechanisms that are most active around the first time point in this
study and then become less used over time, while the usage of other mechanisms is
low at first but then increases over time. This would be in line with the fact that
2–4 h covers both the syncytium stage as well as the maternal-zygotic transition
(MZT), which are associated with direct regulation through protein gradients and
miRNAs, while at 10–12 h gene regulation occurs more often through indirect
signalling pathways.
Consequently, 2–4 h and 10–12 h could be expected to be quite different from
each other, while 6–8 h as the midpoint would share some features with 2–4 h and
some features with 10–12 h and would thus have fewer unique eQTLs. However, it
is also possible that this difference is caused, at least in part, by the experimental
design, in which most of the samples from 6–8 h were sequenced before the other
samples. This may have increased the technical variance of the 6–8 h samples,
which would have resulted in a lower statistical power to detect effects at 6–
8 h and thus fewer stage-specific eQTLs. I will comment on this aspect of the
experimental design in Chapter 8.
4.6.1. eQTL clouds
As described in Section 1.9, there is a very low degree of linkage disequilibrium
(LD) in the DGRP. In theory, this low LD, coupled with the fact that the DGRP
lines have been fully sequenced, may allow for the identification of the exact causal
locus for many genes. However, while the genome-wide LD is low, there are still
some regions in the genome where variants are in high LD with each other. If
any one of these variants has an effect on a gene’s expression level, all the other
variants in LD will be associated with the expression level as well. This effect can
lead to large numbers of variants being associated with a single gene. Figure 4.6
shows that, while the number of associated variants per gene was generally low,
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there are some genes that had more than a hundred different variants associated
with their expression level.
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Figure 4.6.: Boxplot of the number of associated variants per gene found with each of
the four tests. Genes without any significant associations not shown.
In order to determine whether these associations were caused by LD or represent
separate genetic effects I could have performed a conditional analysis: For each
gene with more than one significant association, I could compare a model with
only the lead variant as a fixed effect to a model with the lead variant plus a
second variant as fixed effects. If the secondary variants were merely in LD with
the lead variant, the log-likelihood ratio test of the two-variant model against the
single-variant model should not result in a significant p-value. If, however, there
were actually multiple effects acting independently, the model with two variants
should fit the data better than the single-variant model, resulting in a significant
p-value. This procedure could then be continued with a possible third variant,
and so on, until there are no more significant associations. However, due to the
relatively low sample size in our study, I did not attempt to perform this analysis,
since I would have been unlikely to have enough statistical power to test for the
second variant in almost all of the cases.
Even in cases of high LD the causal variant should be the one most strongly as-
sociated with the expression levels and thus be listed as the lead variant. However,
due to the stochasticity involved in gene expression level measurement and eQTL
testing, sometimes another variant may randomly have been more strongly asso-
ciated, resulting in that variant being listed as the lead variant in the “overview”
set.
In order to account for this uncertainty, I generated four more sets of eQTLs that
did not just contain the lead variant for each gene, but also all other associated
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variants with an uncorrected p-value that was within one order of magnitude,
similar to the approach used in Ding et al. (2014). This resulted in a set of “eQTL
clouds” containing one or more likely causal variants for each gene (Table 4.4).
Test Genes with eQTLs Variants per cloud
Common effect 3139 4.17
Specific effect at 2–4 h 447 4.35
Specific effect at 6–8 h 186 3.32
Specific effect at 10–12 h 335 3.94
Table 4.4.: Number of variants in gene eQTL clouds for each of the multi-stage tests.
A boxplot of the number of variants in the eQTL clouds of the different genes
is shown in Figure 4.7. While there were still some cases of close to 100 variants
associated with a single gene, the numbers decreased across almost all of the cases.
The size of the region encompassed by the variants in the clouds (measured
from the leftmost to the rightmost variant) is shown in Figure 4.8. Again, most
eQTL clouds only covered a small region, indicating that they may only contain
the causal variant and a few variants close-by that were in LD with it. However,
there are cases where the region covered by the variants is much larger. The fact
that eQTLs are so far away from each other could either be caused by very large
regions of LD, or indicate the presence of multiple uncorrelated eQTLs acting
independently on gene expression.
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Figure 4.7.: Boxplot of the number of variants per gene within the eQTL cloud found
with each of the four tests. Genes without any associated variants not shown.
108
1e+01
1e+03
1e+05
com
mon
spec
ific, 2
−4 h
spec
ific, 6
−8 h
spec
ific, 1
0−12
 h
e
QT
L 
clo
ud
 w
idt
h 
[bp
]
Figure 4.8.: Boxplot of the width of eQTL clouds found with each of the four tests in
bp. Genes without any associated variants not shown.
4.6.2. Interpreting stage-specific effects
One of the big advantages of the multi-stage eQTL testing over the single-stage
eQTL testing was that it would allow me to determine which eQTLs were actually
active in all three developmental stages and which ones were stage-specific in a
statistically rigorous way. However, due to the way I tested for common and
specific effects, I could not easily deduce this information from the eQTL calls. In
particular, I noticed that there were quite a few cases where there was a common
effect in one direction, which was then counteracted by a specific effect in the
opposite direction. This meant that, while the eQTL had been called as specific
in a given stage X, the eQTL was actually active in the other two stages Y and
Z and specifically not active in X.
In order to handle these cases appropriately and extract a set of eQTLs that
were truly active at only a single stage, I devised a classification procedure, which
I applied to all variants that showed a significant association in at least one of four
multi-stage tests. This classification procedure made use of the results from the
single-stage eQTL testing, and, in particular, the effect sizes I had calculated for
each variant/gene pair. I extracted the corresponding effect sizes from the three
single-stage tests for each multi-stage eQTL, which gave me an indication of how
much of an effect each of the multi-stage eQTLs had in each of the three stages.
For every eQTL, I first checked whether it had a significant common effect. If it
did, I immediately classified it as a common eQTL, regardless of the other tests.
This merged the eQTLs active in two stages with the eQTLs active in three stages,
but greatly simplified the classification. Most eQTLs were common, indicating
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that most effects were indeed shared across at least two stages. An example of
the single-stage effect sizes of a common eQTL in the three stages is shown in
Figure 4.9a.
If an eQTL did not have any common effect, but had more than one specific
effect, I classified the eQTL as “complex”. These are cases where the eQTL may
not just be active in one stage and inactive in the other, but may actually have
an opposite effect in two different stages. An example of such a case is shown in
Figure 4.9b.
Finally, for all eQTLs that only had a single significant specific effect, I com-
pared the effect sizes that had been estimated for this eQTL in the single-stage
eQTL test for the three stages. If the effect size was largest for the stage in which
the specific effect was called, I classified it as a single-stage eQTL. This is the
group of eQTLs for which I could be confident that they had an effect in only one
stage. Figure 4.9c shows the effect sizes of an eQTL that was specific to 2–4 h.
If the effect sizes were not consistent with this being a single-stage eQTL (e.g.
the eQTL was called specific to stage X, but its effect size was actually larger in
stage Y ) I classified this as a weak complex eQTL. An example of this pattern is
shown in Figure 4.9d. Manual inspection of some of these weak eQTLs revealed
that they were most likely eQTLs that were acting at two of the stages, but fell
just below the significance threshold to be called a common effect.
A flow chart of this procedure is shown in Figure 4.10.
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Figure 4.9.: Examples of effect sizes obtained from the single-stage eQTL testing for
multi-stage eQTLs from different specificity classes. Gene names shown in parenthesis.
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Figure 4.10.: Flow chart illustrating the classification of an eQTL into common, com-
plex, weak complex or single-stage eQTLs.
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4.7. Comparison between single-stage and multi-stage
eQTL tests
I now compared the results from the single-stage eQTL testing to the results from
the multi-stage eQTL testing. Since the multi-stage testing was in theory better
powered to detect effects common to all three stages, I first overlapped the set of
genes with common multi-stage eQTLs with the set of genes with eQTLs in all
three single-stage tests (Figure 4.11).
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single−stage,
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Figure 4.11.: Venn diagram of genes with at least one eQTL common to the three
single-stage tests (red) and common in the multi-stage eQTL testing (blue).
Reassuringly, almost all of the common single-stage eQTLs (944/957) were also
found with the multi-stage test, confirming that the common-effect test worked as
expected. In addition, the multi-stage testing found a large number of additional
common eQTLs (2,195), which I had not been able to detect or classify correctly
with the single-stage tests. Finally, 13 common eQTLs were found with the single-
stage testing but not with the multi-stage testing. This discrepancy may have
been caused by random variation in the model fitting and calculation of empirical
p-values. In fact, for seven of these eQTLs I found a common association in the
multi-stage testing that was close to passing the significance thresholds as well,
with an empirical p-value below 0:05. In addition, complex specific effects, with
an eQTL having a positive effect in one stage and a negative effect in the other,
may have been misclassified as common in the single-stage testing but not in the
multi-stage testing.
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To compare how many of the single-stage effects were also found with the multi-
stage testing, I overlapped the three sets of single-stage eQTLs that were specific
to a single time point with the set of all multi-stage eQTLs (Figure 4.12).
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Figure 4.12.: Venn diagram of genes with at least one eQTL specific to the given develop-
mental stage from the single-stage eQTL testing (red) and all eQTLs from the multi-stage
eQTL testing (blue).
At 2–4 h, 446/826 (54%) single-stage eQTLs were also found in the multi-stage
testing. Most (345) of these were found to have a common effect in the multi-
stage set, indicating that they had previously been misclassified as specific. The
remaining 101 eQTLs were in one of the stage-specific eQTL sets. Surprisingly,
the remaining 380 single-stage eQTLs from 2–4 h were not found in the multi-stage
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eQTL testing at all. Closer inspection of the data for these revealed that almost
all of them had been classified as a small common effect plus a small specific
effect in the multi-stage eQTL testing, however with neither of them reaching the
significance threshold. I observed a similar overlap at the two other developmental
stages as well, with many formerly stage-specific effects now being classified as
common, but some no longer being found.
This effect, which I described in Section 4.6, is an unfortunate consequence of
the test design that appears to have decreased the number of stage-specific eQTLs
that I was able to call. However, the multi-stage testing allowed me to identify
many more common eQTLs than the single-stage tests. A full four-way overlap
of the genes with eQTLs in each of the three single-stage tests as well as in the
multi-stage test is shown in Figure 4.13.
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Figure 4.13.: Venn diagram of genes with at least one eQTL in the single-stage eQTL
testing (red, blue, green) and at least one eQTL in the multi-stage eQTL testing (purple).
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4.8. Comparison to variance decomposition
In Section 4.2 I decomposed the variance of the expression levels of 6,529 genes
into different components, assigning them to either additive genetic effects (prox-
imal and distal), interaction effects between genetics and the developmental stage
(proximal and distal), the developmental stage itself and noise. My expectation
was that I would be more likely to find eQTLs for genes for which the proximal
genetic and genetic/development components accounted for a large percentage
of the total variance and less likely to find eQTLs when these components were
small. In addition, I expected that genes with a large pure genetic component
were likely to be common eQTLs, while genes with a large genetic/development
interaction component were more likely to be stage-specific eQTLs.
I could now test these assumptions by determining whether I had found at least
one proximal eQTL for each of the 6,529 genes. Figure 4.14 shows the percentage
of variance explained by the sum of the two proximal genetic components, grouped
by whether the gene had an eQTL. As expected, the genes with eQTLs had much
larger fractions of their variance explained by genetic effects (Wilcoxon rank sum
test, p = 2:83  10 232).
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Figure 4.14.: Boxplots of the percentage of variance in gene expression levels explained
by proximal genetic components, grouped by whether I found a proximal eQTL for the
gene.
To compare the difference between pure genetic effects and genetic/development
interaction effects, I further split up the genes by whether they had no eQTL, an
eQTL with a common effect, an eQTL with a specific effect or both (Figure 4.15).
Genes with common eQTLs had a significantly larger pure genetic component than
genes without any eQTL (Wilcoxon rank sum test, p = 1:26  10 271) and genes
with specific eQTLs had a significantly larger genetics/development interaction
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component than genes with a common eQTL (Wilcoxon rank sum test, p =
1:23  10 42).
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Figure 4.15.: Boxplots of the percentage of variance in gene expression levels explained
by pure proximal genetic effects (a) and interaction between proximal genetic and devel-
opmental effects (b), grouped by eQTL specificity.
This analysis showed that the results from the variance decomposition agreed
with the results from the eQTL testing, despite the different normalisation meth-
ods used in the two data sets. However, the agreement was not perfect and there
were some genes with large genetic components for which I did not find an eQTL.
For example, I was unable to find any eQTL for 40 (12%) of the 323 genes for
which I had estimated that more than 25% of the variance could be attributed
to the proximal genetic component.
It is likely that this difference is because I estimated the variance explained
by all proximal variants as a group in the variance decomposition, while in the
eQTL testing I tested each variant individually for association. This means that
if the expression level of a gene was influenced by several weak proximal genetic
effects, I may have been able to detect the sum of these effects in the variance
decomposition, but may not have had enough statistical power to detect an effect
of any single variant.
4.9. 30 isoform eQTLs
As described in Chapter 2, I initially calculated the expression levels of individual
30 end peaks, which I then summed up to form the gene expression levels. While
this gene expression level is the trait in which changes are more likely to have
an effect on the organism, I was also curious about what eQTLs for individual
117
peaks could tell me about the mechanism and regulation of alternative 30 isoform
usage. Thus, in addition to calling eQTLs on the total gene expression level, I
also looked for eQTLs that affected only a single 30 end peak.
For this, I applied the multi-variate eQTL testing procedure described in Sec-
tions 4.5 and 4.6 to the set of 30 Tag-Seq peak expression levels. I tested a
total of 31,913 peaks for association with variants in a 50 kb region upstream and
downstream of the peak, for an average of approximately 1,392 variants per peak
(Table 4.5).
Peaks Tested Variants Tests per peak
31913 1762906 1392.12
Table 4.5.: Multi-stage eQTL testing parameters: Number of unique peaks tested, num-
ber of unique tested variants and mean number of tests performed per peak.
As before, I called four different sets of eQTLs, testing for both common effects
and effects specific to one of the time points. The resulting total number of 30
isoform eQTLs is shown in Table 4.6.
Test Peaks with eQTLs Variants per cloud
Common effect 10387 4.02
Specific effect at 2–4 h 822 3.63
Specific effect at 6–8 h 380 2.84
Specific effect at 10–12 h 669 3.32
Table 4.6.: Number of variants in peak eQTL clouds for each of the multi-stage tests.
I will return to this set of 30 isoform eQTLs in Chapter 6 to study cases of 30
isoform-specific eQTLs and alternative polyadenylation.
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5. Quality-control of eQTLs
In this chapter I begin to explore the sets of eQTLs I found in Chapter 4, particu-
larly with regard to technical confounders. In order to identify false positives that
may have been caused by the 30 Tag-Seq protocol, I estimate the concordance be-
tween eQTLs and gene expression levels measured with standard RNA-seq. Based
on the differences I observe, I add additional filtering steps which aim to remove
many of these false positives. Finally, I show examples of eQTLs, including two
associated with the classic Drosophila genes white and Dichaete, and describe how
I validated the set of eQTLs using in situ hybridisation and previously published
data.
5.1. Validation of 30 Tag-Seq eQTLs with RNA-seq
In Section 2.8, I described how I compared the gene expression levels obtained
from 30 Tag-Seq with the ones obtained from RNA-seq. I observed that, in gen-
eral, the mean gene expression levels were correlated well across samples, with
Spearman’s  = 0:90. However, I also observed that for some genes the expres-
sion levels differed between RNA-seq and 30 Tag-Seq, suggesting that one of the
measurements was incorrect. Thus, I wanted to ensure that the eQTLs found
with 30 Tag-Seq were not caused by protocol-specific biases, and would replicate
when gene expression levels were measured with other methods.
Since the promoter region at the 50 end of genes is essential for the regulation
of transcription (see Section 1.3.1), an enrichment of eQTLs around the 50 end of
their gene would be expected. To check for such an enrichment, I calculated the
location of each lead gene eQTL with a common effect relative to its associated
gene. Locations within each gene body were scaled by the gene length to allow
for comparison between them. The resulting plot is shown in Figure 5.1.
As expected, there was an enrichment of eQTLs at the 50 end of genes. However,
the largest aggregation of eQTLs was observed at the 30 end. While such an
enrichment of eQTLs around the 30 end of genes had also been shown before in
119
050
100
150
200
250
−1000 bp gene 5' end gene 3' end +1000 bp
Location of eQTL relative to gene
G
en
es
Figure 5.1.: Position of lead gene eQTLs (common effect) relative to their associated
gene. Locations inside the gene body in fractions of gene length, locations outside of the
gene body in raw bp. Red lines denote location of the 50 and 30 end of the gene.
the DGRP (Massouras et al., 2012) as well as other eQTL studies (Tung et al.,
2015), the strength of the signal in my data was larger than expected.
In fact, a similar enrichment of eQTLs around the 30 end of genes had previously
been found in humans (Veyrieras et al., 2008). However, in a follow-up study using
RNA-seq instead of microarrays, the authors found that this enrichment was no
longer present (Veyrieras et al., 2012). This lead them to conclude that the 30
enrichment was almost entirely an artefact caused by their use of microarrays
with probes at the 30 end of transcripts, which meant that any eQTL affecting
the usage of the last exon of a gene would look like an eQTL for the whole gene.
In theory, 30 Tag-Seq should not exhibit this problem since I called 30 end peaks
de novo without any prior expectation of where the 30 end of a transcript would
be (see Chapter 2). When calculating the total gene expression level, I considered
peaks at annotated transcript ends as well as inside the gene body, which meant
that a mere shift in the location of a 30 end should not have resulted in a change
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in the estimated gene expression level. However, if a 30 end was located more
than 2 kb away from the annotated end I may have assigned it to another gene,
which would have led to false positives.
In addition, false positive eQTLs caused by variants associated with differential
mappability (as described in Section 2.2) are likely to be located inside or very
close to the 30 Tag-Seq peaks, resulting in an enrichment at the 30 end of the gene. I
thus needed to convince myself of the validity of the eQTLs, and in particular show
that the eQTLs could be reproduced using RNA-seq as an alternative method of
estimating gene expression levels.
To this end, I checked the effect sizes predicted by my eQTLs for concordance
with the effects I could observe in our RNA-seq data. As described in Section 2.8,
this data set consisted of 22 libraries of standard Illumina stranded poly(A)+
RNA-seq, which were obtained from the same samples of RNA that had been
used for the 30 Tag-Seq measurements at 10–12 h. It is important to stress that
these samples, while well suited to account for differences in sequencing protocols,
did not represent independent biological replicates. Thus, this analysis did not
allow me to identify false positives caused by other sources of errors, such as issues
with the quality of the genotype data, population structure, or problems during
sample preparation or collection.
To remove any unwanted population structure and batch effects due to the
different sequencing runs, I applied similar normalisation steps to the RNA-seq
expression levels as I had applied to the 30 Tag-Seq data (centring and scaling,
quantile-normalisation, PEER with 5 hidden factors).
A heatmap of the final data set and a plot of the samples projected onto the
first two principal components from a PCA are shown in Figure 5.2. As for the 30
Tag-Seq data, the normalisation had successfully removed large-scale experimental
batch and population structure effects, resulting in a data set with little structure,
well suited for eQTL testing. The two different sequencing methods used (paired-
end/PE and single-end/SE) did not form any strong clusters, confirming that
they could be combined without further adjustments.
Using this normalised set of RNA-seq expression levels I now attempted to
replicate the effects predicted by my 30 Tag-Seq eQTLs, using the set of lead gene
eQTLs with a common effect as my test set. For this, I calculated the difference in
RNA-seq expression levels between samples with the homozygous major and the
homozygous minor genotype for each eQTL. Based on this difference, I could then
classify each eQTL by whether the direction of the change in RNA-seq medians
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Figure 5.2.: Diagnostic plots of RNA-seq samples from the 10–12 h time point.
was concordant with the direction predicted by the 30 Tag-Seq effect size. I only
applied this test to eQTLs where I had obtained RNA-seq expression levels for
at least two lines homozygous for each the major and the minor allele, to avoid
incorrect calls caused by single outliers.
I observed a concordance rate of 76% for the eQTLs overall, which was sig-
nificantly better than the rate of 50% I would have expected at random (exact
binomial test, p = 2:36  10 156). This indicated that the eQTLs were gener-
ally predictive of the gene expression level, even when measured with a different
method. The fact that not all of the eQTLs were concordant could at least par-
tially be explained by experimental variation and the fact that the number of
samples in the RNA-seq data was lower, leading to higher noise.
However, I also observed that the concordance of eQTLs differed based on their
location relative to the gene, with a concordance rate of 86% for eQTLs at the 50
end of genes but only 69% for eQTLs at the 30 end of genes (Figure 5.3).
Furthermore, Figure 5.4 shows the relative location of a high-confidence set of
542 eQTLs where the eQTL could be validated in the RNA-seq data. I defined this
set as all eQTLs where the RNA-seq expression level was significantly different
using a Wilcoxon test between the major and minor allele (unadjusted p < 0:05)
and the sign of the difference in medians was concordant with the eQTL effect
direction. Comparing this to the locations of all eQTLs (Figure 5.1) reinforces
the notion that the eQTLs around the 50 end were much more likely to be valid
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Figure 5.3.: Fraction of concordant and discordant eQTLs grouped by their location
relative to their associated gene.
than the ones around the 30 end. While the peak at the 30 end was much larger
before, the height is now almost exactly equal between the 30 and 50 end.
This difference in quality between the 30 and the 50 end suggested that there was
still an effect resulting in more false positives around the 30 end of the gene, despite
my efforts to account for the mappability of peak regions. Thus, I explored criteria
by which I could filter my eQTLs to improve their quality, using the concordance
as an estimate of their true positive rate.
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Figure 5.4.: Position of high-confidence lead gene eQTLs (common effect) relative to
their associated gene. Locations inside the gene body in fractions of gene length, locations
outside of the gene body in raw bp. Red lines denote location of the 50 and 30 end of the
gene.
5.2. Filtering of eQTL sets
5.2.1. Estimating the mappability of the genome
Since mappability was still the most likely culprit for possible false positive eQTLs,
I looked for a way to identify regions of low mappability in the genome. Jacob
Degner, a post-doctoral fellow from the Furlong group at EMBL-Heidelberg, had
encountered a similar question in a project of his and kindly shared his data with
me. For each nucleotide of the D. melanogaster genome, Jacob had estimated
whether this nucleotide was mappable in each individual DGRP line, based on a
mapping of the genome DNA-seq data provided by the DGRP back to the ref-
erence genome. Using this data set, I calculated aggregate mappability statistics
for each 30 Tag-Seq peak, including the minimum and mean mappability in the
peak region.
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In addition, for each DGRP line, I calculated the fraction of mappable bases
in all 30 Tag-Seq peaks associated with each gene separately. For each eQTL,
I could then test for a significant difference in mappability between the major
and the minor alleles using a Wilcoxon rank sum test. I also tested whether the
mappability of a line was associated with the estimated 30 Tag-Seq gene expression
level of that line at each developmental stage, by calculating Spearman’s  between
the mappability and the expression level estimates.
5.2.2. Selection of filtering parameters
Using the RNA-seq concordance data described in Section 5.1 as a quality measure
I now tested the effect of the mappability parameters as well as additional filtering
criteria on the quality of the eQTLs. My aim was to find a set of eQTLs that
had a good concordance rate, while retaining as many eQTLs as possible. I used
the set of lead eQTLs from the common effect test on gene expression levels to
optimise these parameters, but then extended them to all other eQTL sets as well.
The parameters I tested for their effect on concordance were:
• Properties affecting mappability of a gene’s 30 Tag-Seq peaks:
– How large was the fraction of heterozygous variants in the peaks? Het-
erozygous variants, which were still present in the lines despite their
inbreeding, were not accounted for during genome personalisation.
– How many variants were there in these peaks in total? Highly variable
regions were more likely to contain unidentified and rare variants, which
were not accounted for during genome personalisation.
– How long were the variants in these peaks on average? Long indels
were more likely to cause mappability problems than short indels or
SNPs.
– What was the estimated minimum level of mappability in the peaks?
– What was the estimated mean level of mappability in the peaks?
– What was the p-value of the association test between mappability and
genotype in the peaks? The genotype at the eQTL should have been
independent of the mappability of the peak.
– What was the minimum p-value of the association test between map-
pability and expression level in the peaks? The expression level should
have been independent of the mappability of the peak.
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• The presence of certain genomic sequences close to the variant, which may
have been indicative of problems during the 30 Tag-Seq protocol that may
have led to artefacts.
– A run of 8, 10, or 12 A nucleotides, which may have been associated
with oligo-dT mispriming.
– Parts of the adaptors and PCR primers used in the 30 Tag-Seq protocol.
• Properties of the lead variant:
– Was the variant an indel? Indels may have had larger effects on genes
and their regulatory regions, but may also have caused bigger problems
in mappability.
– Was the variant located in, or close to, a 30 Tag-Seq peak? Variants
inside the 30 Tag-Seq peak were more likely to be associated with map-
pability than variants further away.
– What was the MAF of the variant? A larger MAF meant I had higher
statistical power.
• Properties of the gene:
– Did the gene only have a single 30 Tag-Seq peak or more? A com-
plex 30 isoform structure may have introduced artefacts into the gene
expression level estimates.
– How long was the gene?
– How highly expressed was the gene? The variance of expression levels
caused by technical factors decreases the more highly expressed a gene
is, increasing power.
• Properties of the eQTL:
– How many other associated variants did the gene have in the eQTL
cloud? A large number here may have been related to residual popu-
lation structure or long-range LD.
– How strong was the effect size and the log2(fold-change)? A stronger
effect should have been easier to detect in the RNA-seq data.
– How strong was the uncorrected p-value? A more significant eQTL
should have been more reproducible.
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For each dichotomous (boolean) variable, I counted the number of concordant
cases for each of the groups. I tested how significantly different these numbers
were using a two-tailed Fisher’s exact test. Two examples of the fractions of
concordant cases for different variables are shown in Figure 5.5.
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Figure 5.5.: Fractions of concordant lead gene eQTLs for two example boolean variables.
The first variable (Figure 5.5a) shows whether the associated variant was an
indel or not. This variable did not seem to have any influence on the concordance
rate, as shown by the uniform plot and the resulting p-value of 1. In contrast, the
variable indicating whether the variant was within 25 bp of the peak (Figure 5.5b)
did seem to have a large effect on the concordance rate, with p = 1:90  10 8.
Similarly, for each continuous variable, I calculated the difference in value be-
tween concordant and discordant cases using a Wilcoxon rank sum test. Two
examples of such variables are shown in Figure 5.6.
The first variable, the minor allele frequency of the variant (Figure 5.6a), did
not appear to be associated with the concordance rate, with p = 0:72. However,
the variable that reflected the maximum heterozygosity rate of variants in the
peak regions (Figure 5.6b) showed a clear association with the concordance rate
(p = 1:97  10 8), with higher values being associated with lower concordance.
From the set of continuous variables, I selected two variables for further optimi-
sation, which were strongly associated with the concordance rate. These were the
maximum heterozygosity rate (p = 1:90  10 8) and the p-value of the correlation
between the genotypes and the mappability of the peak regions (p = 1:84  10 3).
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Figure 5.6.: Fractions of concordant lead eQTLs for two example continuous variables.
The fact that both of these correlated with the concordance rate again agreed with
the expectation that a large fraction of the discordant eQTL calls might have been
false positives caused by mappability problems, especially in heterozygous regions.
For each of them, I chose several possible threshold values and then calculated
the concordance rate as well as the fraction of eQTLs passing the filters. The
resulting data points are shown in Figure 5.7.
Based on these results I set the thresholds for maximum heterozygosity to 40%
and the threshold for the p-value of the mappability correlation to 10 6 as these
appeared to represent a good compromise between increase in concordance and
loss of eQTLs. The data point showing the expected results of these thresholds is
highlighted as a triangle in Figure 5.7. For the common gene eQTLs, this resulted
in a set of 2,095 genes with eQTLs, down from 3,139 genes in the unfiltered set
(67%).
Additionally, I noted that the boolean variable indicating whether the variant
was close to a peak or not appeared to have a large effect on the concordance
rate (p = 1:90  10 8). This suggested that there were additional problems with
variants close to 30 Tag-Seq regions, which were not detected by the mappability
filters. I thus removed all genes with their lead variant within 25 bp of the 30
Tag-Seq peak, which resulted in a further reduction to 1,596 cases 51%.
This filter, by definition, removed almost all signal close to the 30 end of genes.
However, my analysis of high-confidence eQTLs had shown that there seemed to
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Figure 5.7.: Percentage of concordant eQTLs plotted against the percentage of eQTLs
passing the filters. Coloured points show eight different combinations of filtering thresh-
olds on the p-value of the correlation between the genotypes and the mappability of the
peak regions and the maximum heterozygosity rate. Chosen thresholds shown as triangle.
Dotted line shows the results that could be obtained with an optimal filter, under the
conservative assumption that the RNA-seq estimates always describe the true expression
level.
be an enrichment of real eQTLs at the 30 end even in the RNA-seq data, which
suggested that this filter might have removed a substantial amount of real signal
as well. Thus, to account for this highly conservative filter, I also generated a
second set of eQTLs without this filter, which I used to study specifically cases of
eQTLs at the 30 end of genes.
Finally, I also removed all genes for which I had found a very large number
of associated variants, or variants very far apart from each other, i.e. where the
eQTL cloud was large. This was because these were likely to be regions of strong
LD where it would be unlikely that I had identified the real causal variant as my
lead eQTL. I thus removed all genes where the gene had more than 10 variants in
its eQTL cloud or where the variants in the eQTL cloud spanned more than 10 kb.
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For the common gene eQTLs this resulted in the removal of a further 372/1,596
of genes and a final eQTL set of 1,224 genes (39% of the unfiltered set).
It should be noted that this filter will also have removed cases where there are
actually two independent genetic effects acting on the gene. However, due to
the relatively low sample size I would have been underpowered to systematically
detect cases like these, as discussed in Section 4.6.1. Visual inspection of some of
the genes removed by the cloud filter also did not indicate the presence of a large
amount of such cases.
After applying all of these filters, I observed a final concordance rate of 83% in
the set of lead gene eQTLs with a common effect (Figure 5.8).
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Figure 5.8.: Difference in normalised medians for expression levels measured with stan-
dard RNA-seq at 10–12 h plotted against effect size at 10–12 h of 30 Tag-Seq eQTLs.
Concordant eQTLs shown in blue, discordant eQTLs shown in red.
Having found this set of filters to be appropriate for decreasing the false positive
rate caused by protocol-specific effects, I applied them to all eQTL sets. This
included both the set of stage-specific lead eQTLs, as well as the four sets of
eQTL clouds, where I removed the entire eQTL cloud if the lead variant did not
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pass the filters and also removed individual variants from eQTL clouds if they did
not pass the filters themselves.
Finally, I applied all but the close-to-peak filter to all peak eQTL sets as well.
Out of 10,387 common peak lead eQTLs, I was left with 7,296 eQTLs after the
mappability filters and 5,883 eQTLs after the cloud filter (57%).
5.3. Examples of eQTLs
Before I analysed these filtered sets of eQTLs in aggregate (see Chapter 6) I
inspected a few individual genes to get an impression of what these eQTLs look
like in detail.
An example for an common eQTL associated with the gene nicotinic Acetyl-
choline Receptor 2 (nAChR2) is shown in Figure 5.9. nAChR2 is a subunit
of the nicotinic Acetylcholine receptor, which is involved in the central nervous
system of Drosophila (Gundelfinger and Hess, 1992). I observed a single 30 Tag-
Seq peak for this gene, consistent with the single 30 end isoform that has been
observed previously (The FlyBase Consortium, 2014). The lead eQTL, a T to
C SNP, was located 37 bp upstream of the 50 end of nAChR2 and had a MAF
of 46% in the DGRP. This nucleotide change was negatively associated with the
gene’s expression level, with individuals homozygous for the major allele showing
almost twice the level of expression as individuals homozygous for the minor allele
at 6–8 h.
The top of the first panel (Figure 5.9a) shows the body of the gene (in black),
with the boxes indicating exons and the arrow indicating the orientation of the
gene, as well as all tested variants around it (circles). For each tested variant, its
Y-position shows the strength of association of that variant with the expression
level of the gene, as expressed by the  log10(p) value of the common-effect test.
This manner of depicting the association of variants by their genomic location is
called a Manhattan plot. The lead variant is shown as a yellow circle, and all
other variants are coloured by their r2 to this variant, indicating the strength of
LD between them.
Below the variants and the gene body, the 30 Tag-Seq coverage associated with
this gene at the three developmental stages is shown. This shows the median read
coverage of all lines with the major allele (red, above 0) and the minor allele (blue,
below 0) at the lead eQTL. For ease of comparison, the coverage is reflected on
the X-axis in a lighter colour. For readability only the read coverage inside the 30
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Figure 5.9.: eQTL for the gene nAChR2. (a) Top: Manhattan plot of variants around
the gene body (black). Below: Median 30 Tag-Seq coverage at 2–4 h, 6–8 h and 10–12 h,
grouped by major/minor allele at the lead eQTL. Only reads associated with nAChR2
shown. Bottom: Boxplots of 30 Tag-Seq (b) and RNA-seq (c) expression levels. Samples
with heterozygous genotype at the lead eQTL omitted.
Tag-Seq peaks associated with this gene is shown.
The bottom left panel (Figure 5.9b) shows a comparison of the gene expression
levels at each of the three developmental stages between the major (red) and
the minor (blue) allele, as estimated from scaled 30 Tag-Seq read counts. The
boxplots indicate the overall distribution of the expression levels, while the points
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show each individual line’s expression level. The same comparison is repeated
based on the RNA-seq data for 10–12 h in the bottom right panel (Figure 5.9c).
I also found eQTLs for two classic Drosophila genes described in Section 1.1:
white and Dichaete (see Section 1.1.2). The eQTL plots for these genes are shown
in Figures 5.10 and 5.11.
The lead eQTL for white was located it its first intron, approximately 1 kb
downstream from the gene’s 50 end. It had a MAF of 23% and resulted in a
change from an A to a T nucleotide, which was associated with a weak negative
effect on the expression level. As before, I only observed a single 30 Tag-Seq peak
for this gene, consistent with the existing annotation.
For Dichaete, I observed two separate 30 Tag-Seq peaks, matching the location of
the two alternate poly(A) sites that are known for this gene. The lead eQTL was
located very close to the secondary, less highly expressed, 30 Tag-Seq peak, 15 bp
downstream of the annotated cleavage site. This would have normally resulted in
a removal of this gene by the filters, but I retained the eQTL for this analysis after
closer inspection did not reveal any likely mappability problems and the RNA-seq
data was concordant. The lead variant was an A to C SNP with a MAF of 9%.
It was associated with a decreased expression level of the secondary 30 isoform,
which consequently decreased the overall expression level of the gene.
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Figure 5.10.: eQTL for the gene white. (a) Top: Manhattan plot of variants around
the gene body (black). Below: Median 30 Tag-Seq coverage at 2–4 h, 6–8 h and 10–12 h,
grouped by major/minor allele at the lead eQTL. Only reads associated with white shown.
Bottom: Boxplots of 30 Tag-Seq (b) and RNA-seq (c) expression levels. Samples with
heterozygous genotype at the lead eQTL omitted.
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Figure 5.11.: eQTL for the gene Dichaete. (a) Top: Manhattan plot of variants around
the gene body (black). Below: Median 30 Tag-Seq coverage at 2–4 h, 6–8 h and 10–12 h,
grouped by major/minor allele at the lead eQTL. Only reads associated with Dichaete
shown. Bottom: Boxplots of 30 Tag-Seq (b) and RNA-seq (c) expression levels. Samples
with heterozygous genotype at the lead eQTL omitted.
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5.4. Validation of eQTLs by in situ hybridisation
As a final quality control step for my eQTLs, I also wanted to validate the impact
of some of the eQTLs I had found using an in vivo experiment. To this end, my
collaborator Enrico Cannavò (a PhD student from the Furlong group in EMBL-
Heidelberg) and I selected a set of genes with eQTLs, on which Enrico then
performed RNA in situ hybridisation (Levsky and Singer, 2003). By comparing
the in situ hybridisation results from flies between the major and minor allele,
we could test whether the eQTL did in fact result in a change in the amount of
RNA present in the embryo. Using this method, we could successfully validate
the eQTL for the gene GstD1, for which I had observed a very large change in
gene expression between the two alleles. As predicted by the eQTL, expression of
GstD1 was only observed in the fly with the major allele and was also consistent
between 6–8 h and 10–12 h, as shown in Figure 5.12). An eQTL plot for this gene
is shown in Figure 5.13.
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Figure 5.12.: In situ hybridisation of GstD1 (red) in embryos homozygous for the ma-
jor (top) and minor (bottom) allele. Collected at 6–8 h (left) and 10–12 h (right) after
fertilisation. White arrows indicate the midgut, which shows high levels of GstD1 only
in the major allele. Microscopy and figure by Enrico Cannavò.
The in situ hybridisation experiment showed that variants that I found to be as-
sociated with the 30 Tag-Seq expression levels indeed resulted in molecular changes
in the organism and could be validated even with this completely different technol-
ogy. In addition, Enrico Cannavò also performed a further set of experiments on
another three genes with a single, promoter-proximal, strongly associated SNP as
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Figure 5.13.: eQTL for the gene GstD1. (a) Top: Manhattan plot of variants around
the gene body (black). Below: Median 30 Tag-Seq coverage at 2–4 h, 6–8 h and 10–
12 h, grouped by major/minor allele at the lead eQTL. Only reads associated with GstD1
shown. Bottom: Boxplots of 30 Tag-Seq (b) and RNA-seq (c) expression levels. Samples
with heterozygous genotype at the lead eQTL omitted.
their eQTL. For each eQTL, he determined the DNA sequence around that SNP,
both for strains with the major allele and for strains with the minor allele. Using
an in vitro Luciferase reporter assay, he could then test whether these stretches
of DNA resulted in a change in expression of the adjacent gene. In all three cases,
he was able to recapitulate the change predicted by the eQTL. These results will
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be reported in more detail in our joint paper (Cannavo et al., 2015).
5.5. Comparison of eQTLs with a previously published
study
In 2012, Massouras and colleagues published the first eQTL study in the DGRP
(Massouras et al., 2012). Their study differed from our study in multiple ways,
namely:
• They tested samples from a single stage (adult flies), not from multiple
developmental stages.
• They obtained gene expression levels for 39 lines, resulting in low statistical
power.
• They estimated gene expression levels from microarrays instead of from a
sequencing-based method.
• They did not perform any mappability filtering.
Due to these major differences, a large amount of overlap between my sets of
eQTLs and the Massouras set was not likely. In particular, the lack of mappability
filtering and their reliance on less accurate expression level estimates (microarrays)
may have led to an increased amount of false positives in their study. Nevertheless,
I would expect that genes with an eQTL in my study would have an increased
chance of also having an eQTL in the Massouras study.
To test this assumption, I overlapped the set of genes for which I had found a
significant eQTL in my study with the set of genes with eQTLs from Massouras
and colleagues. Out of the 1,224 genes that had a significant common eQTL after
filtering, 295 (24%) also had an eQTL in the older study. Out of the 8,870 genes
that I had tested but that did not have an eQTL in my study, 1,333 (15%) had
an eQTL in theirs. This difference constitutes a significant enrichment (Fisher’s
exact test, p = 1:12  10 14).
In fact, I identified exactly the same variant as the eQTL for 73 out of the 295
genes with overlaps. For 69 of these (98%) the direction of the predicted effect
was also the same in both studies.
This shows that, while there are clear differences between the eQTL sets, there
is still considerable overlap, which speaks to the true signal present in both of
these completely independently obtained eQTL sets.
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6. Analysis of gene-proximal eQTLs
In Chapter 4, I described how I used a multivariate linear mixed model to jointly
call eQTLs in the three developmental stages in this study: 2–4 h, 6–8 h and 10–
12 h after fertilisation. I tested each gene and each 30 isoform for association with
variants in a 50 kb window around the gene. After applying a set of filters to
remove possible false positives in Chapter 5, I obtained four sets of eQTLs each
for genes and 30 isoforms: a set of eQTLs common to all three developmental
stages, and three sets of eQTLs with specific effects in one of the developmental
stages. In this chapter, I describe the properties of these eQTL sets.
6.1. Properties of common gene eQTLs
For the first part of my analysis, I concentrated on the set of 1,224 lead gene
eQTLs with a common effect, since they made up the largest part of the eQTLs
and thus provided me with the greatest power to detect interesting patterns.
6.1.1. Enriched and depleted gene categories
A naive view of development would be that any changes to the timing or level of
the expression of developmental genes would result in abnormal development or
death of the embryo before it reaches adulthood. On the other hand, genes that
are not important for development would not be under such strong constraints
and should thus be more likely to tolerate changes in expression level. In line with
this, earlier studies of gene expression level variation in Drosophila have shown
that the expression levels of genes important in development are more constrained
than those of other genes (Rifkin et al., 2003; Rifkin et al., 2005; Kalinka et al.,
2010).
Consequently, I would expect that I would be less likely to find eQTLs for genes
associated with development. In order to test this hypothesis, I performed a GO
enrichment/depletion analysis comparing the set of genes with an eQTL to the
full set of genes that I had tested.
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In order to account for possible confounding effects of the filters I applied to
the eQTLs (see Chapter 5), I applied the same filters to the background set of
tested genes whenever possible. In particular, I removed all tested genes where
the most strongly associated (not necessarily significant) variant was close to a 30
Tag-Seq peak or was associated with mappability or where there was a variant
with high heterozygosity in one of the gene’s peaks.
After accounting for these factors, I found 6 GO categories that were signifi-
cantly enriched and 69 that were significantly depleted for genes with common
eQTLs, using a two-tailed Fisher’s exact test with topGO. I only tested GO cat-
egories with a minimum size of 100 annotated genes and used the BH method
to control the FDR. A selection of significantly depleted and enriched GO terms
in the “biological process” (BP) and “molecular function” (MF) gene ontologies
at an FDR of 5% are shown in Tables 6.1 and 6.2. There were no enriched or
depleted terms in the “cellular component” (CC) ontology at this significance
threshold.
Term Exp. Obs. Dir. FDR
carboxylic acid metabolic process 33.00 49 " enr. 0.02
organic acid metabolic process 34.66 50 " enr. 0.03
oxoacid metabolic process 34.66 50 " enr. 0.03
cellular amino acid metabolic process 24.34 37 " enr. 0.04
single-organism metabolic process 136.62 162 " enr. 0.05
organ development 117.81 70 # depl. 0.00
single-organism developmental process 201.70 151 # depl. 0.00
organ morphogenesis 59.18 33 # depl. 0.00
single-organism process 513.83 460 # depl. 0.00
regulation of multicellular organismal p... 45.54 23 # depl. 0.00
anatomical structure development 254.61 208 # depl. 0.00
regulation of cellular process 243.37 197 # depl. 0.00
regulation of biological process 262.17 216 # depl. 0.01
imaginal disc development 53.28 30 # depl. 0.01
regulation of developmental process 42.22 22 # depl. 0.01
Table 6.1.: Terms in the “biological process” ontology significantly enriched (enr.) or
depleted (depl.) for eQTLs at an FDR threshold of 5%. Only top 10 out of 62 depleted
terms shown. Exp., expected number of genes. Obs., observed number of genes. Dir.,
direction.
As expected, there was a strong depletion of genes with eQTLs in many devel-
opmentally important categories, such as “regulation of developmental process”,
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Term Exp. Obs. Dir. FDR
catalytic activity 382.63 426 " enr. 0.02
sequence-specific DNA binding 31.03 13 # depl. 0.01
nucleic acid binding transcription facto... 46.27 27 # depl. 0.02
DNA binding 76.75 53 # depl. 0.02
sequence-specific DNA binding transcript... 46.27 27 # depl. 0.02
binding 492.09 450 # depl. 0.02
protein binding 136.96 108 # depl. 0.03
structural molecule activity 50.18 33 # depl. 0.04
Table 6.2.: Terms in the “molecular function” ontology significantly enriched (enr.) or
depleted (depl.) for eQTLs at an FDR threshold of 5%. Exp., expected number of genes.
Obs., observed number of genes. Dir., direction.
“organ development”, and “imaginal disc development”. Similarly, the molecular
functions depleted in eQTLs included terms such as “DNA binding” and “protein
binding” and “structural molecule activity”.
On the other hand, I observed an enrichment of GO categories related to
metabolic processes and catalytic activity. This agrees with earlier work which
had suggested that the developmental expression levels of metabolic genes are
under less selection and are thus more free to vary between individuals (Kalinka
et al., 2010).
6.1.2. eQTLs in developmentally important genes
While there was a general depletion in developmental genes among those with
eQTLs, there were some exceptions — for example, I had found eQTLs for 32
genes annotated with the GO term “embryo development”. These eQTLs were of
particular interest, as they provided a set of developmental genes for which gene
expression levels appeared to diverge between individuals due to genetic variation.
The variants associated with these loci reached minor allele frequencies of up to
49%, suggesting that their change in expression level was not under negative
selection.
One possible reason for this would be that these genes were not actually impor-
tant in the developmental stage in which they were affected by the eQTLs. One
could thus argue that these eQTLs just represented fluctuations of no biological
consequence and that the genes were much more tightly regulated in the stages
where they were actually important. To account for this concern, I looked for
embryo development genes that were strongly expressed during one of our devel-
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opmental stages, suggesting that they had a function in that stage. Using the
modENCODE developmental time course data (see Chapter 3), I calculated the
maximum expression level during embryo development for each gene and then
compared the expression level at each of my three developmental stages to this
maximum. I considered each gene that was expressed to at least 70% of its max-
imum expression level at one of the three developmental stages to be strongly
expressed. For each of the strongly expressed genes, I also checked whether I had
observed a concordant significant difference in the RNA-seq data, as described in
Chapter 5.
I found 22 genes with common gene eQTLs that were annotated with “embryo
development” and strongly expressed in at least one of the time points in my
study. A list of these 22 genes and the properties of their eQTLs is shown in
Table 6.3.
For three of these 22 genes I had also observed a significant effect in the RNA-
seq data (Wilcoxon test, unadjusted p < 0:05), suggesting that their eQTLs were
particularly strong and reliable. These were brn (brainiac), ecd (ecdysoneless)
and Orct2 (Organic cation transporter 2). Further literature review revealed that
these genes indeed have known functions during embryo development:
• brainiac: Most highly expressed at 2–4 h, log2(fold-change) =  0:18 at this
stage (decrease). Multiple associated variants in the only exon.
This gene is a Glycolipid-specific 1,3N-Acetylglucosaminyltransferase (Mül-
ler et al., 2002), which is known to be important for epithelial morphogenesis
during D. melanogaster oogenesis (Goode et al., 1996).
• ecdysoneless: Most highly expressed at 6–8 h, log2(fold-change) = 0:71 at
this stage (increase). Multiple associated variants in the second (and last)
exon. While this gene was most strongly expressed at 6–8 h in individuals
with the reference allele, its expression was actually higher at 2–4 h for
individuals with the alternate allele.
This gene is associated with the production of the steroid hormone ecdysone
which is important for the coordination of many developmental processes,
including embryogenesis (Gaziova et al., 2004). Disruption of ecdysone pro-
duction by a mutation in this gene has been associated with a variety of
developmental defects.
• Organic cation transporter 2 (also known as calderón): Most highly ex-
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2–4 h 6–8 h 10–12 h
Gene Lead variant MAF Exp. log2(fc) Exp. log2(fc) Exp. log2(fc)
aub 2L:11033738 0.04 0.87 1.62 0.42 1.35 0.24 1.55
ecd * 3L:2264533 0.06 0.57 1.13 0.57 0.71 0.37 0.72
jeb 2R:7949532 0.06 0.14 0.93 0.28 0.31 0.16 0.15
eIF4AIII 3R:4112706 0.04 5.01 0.89 3.30 0.47 2.03 0.26
phm X:18580422 0.09 0.84 -0.84 0.06 -0.87 0.07 -0.68
Sec61 2L:6496440 0.04 2.40 0.84 6.85 0.55 7.93 0.25
htl 3R:13922002 0.04 0.71 -0.39 0.68 -0.75 0.77 -0.54
csul 2R:12122214 0.05 1.08 -0.72 0.57 -0.26 0.30 -0.08
faf 3R:27611336 0.26 2.37 0.70 1.36 0.40 1.85 0.22
Orct2 * 3R:20098687 0.30 0.36 0.55 1.85 0.34 0.37 0.38
Rop 3L:4136262 0.49 0.90 0.28 1.19 0.48 1.93 0.34
aPKC 2R:10834039 0.24 2.09 -0.48 1.92 -0.24 1.29 -0.23
nst 3L:12526237 0.46 1.46 0.46 1.11 0.31 1.63 0.30
stumps 3R:10423593 0.34 2.03 -0.41 2.65 -0.19 2.13 -0.05
dia 2L:20726434 0.13 0.83 -0.35 0.84 -0.36 0.69 -0.34
Nc 3L:9964959 0.33 2.18 0.12 1.47 0.32 1.37 0.19
brn * X:3999298 0.31 0.26 -0.18 0.20 -0.10 0.13 -0.31
numb 2L:9448470 0.07 1.97 -0.11 1.94 -0.26 1.85 -0.30
inx2 X:6943533 0.18 21.76 0.30 35.85 0.19 24.93 0.17
Hakai 2L:19598306 0.09 1.23 -0.28 1.08 -0.07 0.59 -0.25
Mad 2L:3147509 0.09 1.83 0.27 1.90 0.18 1.66 0.26
sqh X:6121036 0.19 9.53 0.20 11.83 0.07 10.11 0.11
Table 6.3.: Lead common eQTLs associated with strongly expressed genes that were
annotated with the GO term “embryo development” (GO:0009790) or its children. Exp.,
mean expression level. log2(fc), log2 of fold-change between the minor and major allele.
*, significant effect also observed in RNA-seq data. Sorted by absolute log2(fold-change).
pressed at 6–8 h, log2(fold-change) = 0:34 at this stage (increase). Single
strong lead variant in the promoter region.
Loss of this gene has been associated with an inability of embryos to retract
the germ band during embryogenesis, a delay in developmental speed and a
decrease in the body size of adult flies (Herranz et al., 2006).
Manhattan plots for the three genes, together with the median 30 Tag-Seq cov-
erage and the boxplots of 30 Tag-Seq and RNA-seq expression levels compared
between the two genotypes are shown in Figures 6.1 to 6.3.
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Figure 6.1.: eQTL for the gene brn. (a) Top: Manhattan plot of variants around the
gene body (black). Below: Median 30 Tag-Seq coverage at 2–4 h, 6–8 h and 10–12 h,
grouped by major/minor allele at the lead eQTL. Only reads associated with brn shown.
Bottom: Boxplots of 30 Tag-Seq (b) and RNA-seq (c) expression levels. Samples with
heterozygous genotype at the lead eQTL omitted.
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Figure 6.2.: eQTL for the gene ecd. (a) Top: Manhattan plot of variants around the
gene body (black). Below: Median 30 Tag-Seq coverage at 2–4 h, 6–8 h and 10–12 h,
grouped by major/minor allele at the lead eQTL. Only reads associated with ecd shown.
Bottom: Boxplots of 30 Tag-Seq (b) and RNA-seq (c) expression levels. Samples with
heterozygous genotype at the lead eQTL omitted.
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Figure 6.3.: eQTL for the gene Orct2. (a) Top: Manhattan plot of variants around
the gene body (black). Below: Median 30 Tag-Seq coverage at 2–4 h, 6–8 h and 10–
12 h, grouped by major/minor allele at the lead eQTL. Only reads associated with Orct2
shown. Bottom: Boxplots of 30 Tag-Seq (b) and RNA-seq (c) expression levels. Samples
with heterozygous genotype at the lead eQTL omitted.
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Since a loss of Orct2 had previously been associated with a decrease in the
body size of flies, I tested whether there was an association between its eQTL
and a recently published set of adult body size phenotypes (Vonesch et al., 2015).
In their study, Vonesch and colleagues phenotyped adults from 149 DGRP lines
for a measure of size based on their wing imaginal disc (the centroid size) and
one based on their eye imaginal disc (interocular distance). Interestingly, the
centroid size of male adult flies was indeed slightly increased for flies with the
minor genotype at the SNP (one-sided Wilcoxon rank-sum test, p = 0:09), in
line with my observation that expression of Orct2 was higher for flies with the
minor genotype. However, accounting for the fact that I tested four phenotypes
for association (male/female centroid size, male/female interocular distance) the
Bonferroni-corrected p-value accounting for multiple testing would have only been
0.36.
To explore this further, I plotted the male centroid size against the expression
level of Orct2 and then coloured each line by its genotype at the eQTL. Using this
approach, I could test whether there was a correlation between Orct2 expression
and size even without the eQTL or whether the correlation was entirely driven by
the genotype. If the former were the case, there would be a correlation between
expression level and size within each genotype as well, while if the latter were the
case there would be no clear correlation. The result of this analysis is shown in
Figure 6.4.
As expected, given my small sample size and the complexity of this whole-body
phenotype, I did not have enough data to reach any confident conclusions about
the association between gene expression levels and body size. Nevertheless, the
data seems to suggest that while the size estimate is overall positively associated
with the gene expression level (black line, Spearman’s  = 0:16), this is mainly
driven by a strong positive association in flies homozygous for the minor allele
(blue line, Spearman’s  = 0:43). For flies homozygous for the major allele, there
actually seems to be a weak negative correlation (red line, Spearman’s  =  0:11).
This interaction is suggestive of a complex relationship between this SNP, the
gene expression of Orct2 and body size. While not statistically significant, this is
certainly an interesting case which might warrant further study, as I will discuss
in Chapter 8.
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Figure 6.4.: Rank of centroid size of male adult flies plotted against the rank of gene
expression level of the gene Orct2 at 6–8 h post-fertilisation. Points coloured by whether
lines were homozygous for the major or minor allele. Coloured lines show linear fits for
the respective alleles, black line shows fit through all points. Samples with heterozygous
genotype omitted for simplicity.
6.1.3. Location of eQTLs with respect to gene
Analysing the location of eQTLs relative to their associated gene has already
proven helpful for quality control of the eQTL sets (see Chapter 5). However,
where eQTLs are located with respect to their gene is also interesting biologically,
in particular because of the detailed fine mapping that the LD structure in the
DGRP allows me to do. Figure 6.5 shows the relative location of eQTLs as in
Chapter 5 (Figure 5.1), but this time only considering the fully filtered set. This
plot now shows the expected strong enrichment of eQTLs around the promoter
region (50 end) of their associated gene.
Since I tested variants up to a distance of 50 kb for eQTLs, I also found eQTLs
further than 1,000 bp away from their gene, which are not shown in this plot. To
summarise these, I categorised each lead eQTL by the type of its location:
1. More than 200 bp upstream of the gene
2. Within 200 bp of the gene’s 50 end
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Figure 6.5.: Position of lead gene eQTLs (common effect) relative to their associated
gene. Locations inside the gene body in fractions of gene length, locations outside of the
gene body in raw base pairs. Red lines denote location of the 50 and 30 ends of the gene.
3. In gene body, overlapping an exon
4. In gene body, not overlapping an exon (intronic)
5. Within 200 bp of the gene’s 30 end
6. More than 200 bp downstream of the gene
Figure 6.6 shows the count of lead gene eQTLs with a common effect in each
category, compared to a random sample of 100,000 tested variants.
These results show that, while significantly more eQTLs were located close
to the 50 end of genes than would be expected by chance (Fisher’s exact test,
p = 1:33  10 225), most eQTLs were actually located further away from the
gene, both in the upstream and in the downstream regions. Figure 6.7 shows the
absolute distance of the lead gene eQTLs from their associated gene’s 50 end, the
putative transcription start site (TSS).
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Figure 6.6.: Number of lead gene eQTLs (common effect) in different features of their
associated gene, compared to a random sample of 100,000 tested variants. Gene 30 and
50 ends include all eQTLs within 200 bp of the respective end.
Again, an enrichment of eQTLs close to the TSS was clearly visible. 415 lead
eQTLs (34%) were located within 1 kb of their gene, 72% were found within
10 kb. However, I did find eQTLs in the entire gene-proximal 50 kb window I
searched, with the furthest being 49,940 bp away. This strongly suggests that
there would have been further eQTLs beyond this threshold. I describe my work
towards finding these distal eQTLs in Chapter 7.
Genes with their lead eQTL located more than 10 kb away from their TSS were
strongly enriched in the GO categories “response to stimulus”, “cell proliferation”,
“single-organism developmental process” and “cell surface receptor signaling path-
way” when compared to the genes with closer lead eQTLs (Fisher’s test, minimum
category size 10, Bonferroni-adjusted p-value < 0:05). This suggests that such
genes are more likely to have eQTLs in distal regulatory regions — possibly either
because they tend to have more distal regulatory regions in general, or because
their promoter-proximal regulatory regions are under stronger evolutionary con-
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Figure 6.7.: Histogram and cumulative density of the absolute distance of lead gene
eQTLs (common effect) from the transcription start site (TSS) of their associated genes.
Only the region 50 kb is shown.
straints. An example of one such gene, visgun, is shown in Figure 6.8. The eQTL
for this gene is an A to G polymorphism, located more than 37 kb upstream of
the TSS.
There were seven other genes in the region between this variant and the TSS of
visgun, six of which I had tested for eQTLs as well. However, none of their expres-
sion levels were significantly associated with the genotype at the variant (common
effect test, best uncorrected p = 0:10), suggesting that this eQTL only has an ef-
fect on visgun. How this long-range interaction is achieved mechanistically and
why the other genes are not affected is not clear, making this a potentially inter-
esting area for further study.
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Figure 6.8.: eQTL for the gene vsg. (a) Top: Manhattan plot of variants around the
gene body (black). Surrounding genes shown as grey arrows. 30 Tag-Seq coverage not
shown. Bottom: Boxplots of 30 Tag-Seq (b) and RNA-seq (c) expression levels. Samples
with heterozygous genotype at the lead eQTL omitted.
6.1.4. eQTLs at the 30 end of genes
As described in Section 5.2, I applied a filter to all eQTLs that removed any
eQTL within 25 bp of a 30 Tag-Seq peak. This filter did successfully decrease my
false positive rate and thus helped me generate a set of high-confidence eQTLs.
However, since most 30 Tag-Seq peaks were located close to the 30 end of genes, it
also led to the removal of almost all eQTLs in that region. It is thus important
to note that the low amount of eQTLs at the 30 end of genes, seen in Figure 6.5,
does not tell the whole story. Figure 6.9 shows what Figure 6.5 would look like
considering the same mappability filters but omitting the close-to-peak filter.
Without this filter, eQTLs were not only enriched in the 50 promoter region of
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Figure 6.9.: Position of lead gene eQTLs (common effect) relative to their associated
gene, not filtered by close-to-peak filter. Locations inside the gene body in fractions of
gene length, locations outside of the gene body in raw bp. Red lines denote location of
the 50 and 30 end of the gene.
genes, but even more strongly enriched around the 30 end of the gene they were
associated with. While some of these eQTLs at the 30 end were likely to be false
positives (see Figure 5.3) some of them were likely to be real eQTLs, affecting
processes such as 30 polyadenylation or post-transcriptional regulation by ncRNAs
(see Sections 1.3.2 and 1.3.3) through disruption or creation of sequence motifs.
In particular, I observed a strong enrichment of genes with lead eQTLs located
within 100 bp of the 30 end of 30 Tag-Seq peaks, the putative site of cleavage
and addition of the poly(A) tail. These genes were enriched in GO categories
including “cellular component organization” and “sequence-specific DNA binding
RNA polymerase II transcription factor activity” compared to all other genes
with eQTLs (Fisher’s test, minimum category size 10, Bonferroni-adjusted p-
value < 0:05). I explore eQTLs that may be associated with polyadenylation in
more detail in Section 6.3.
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6.1.5. eQTLs in DNase I hypersensitive sites and CRMs
Gene expression and gene regulation are associated with increased DNA accessi-
bility (see Section 1.3.1), which can be estimated using DNase I assays (Gross and
Garrard, 1988). In this assay, chromatin is digested by the enzyme DNase I and
the digested fragments are sequenced using high-throughput DNA sequencing. As
DNase I is much more likely to digest DNA in open chromatin, in particular if
that region of the DNA is stressed, the accessibility of a region of DNA can be
estimated by the number of sequencing reads obtained from this assay. Regions
that are particularly accessible are called DNase I hypersensitive sites (DHSs).
DHSs are known to be markers for regulatory elements such as promoters,
enhancers and silencers (Boyle et al., 2008). Thus, eQTLs should be more likely
to be located in DHSs than expected by chance. To test whether my eQTLs
supported this hypothesis, I overlapped the set of common gene eQTLs with a
set of D. melanogaster DHSs generated by David Garfield (a post-doctoral fellow
from the Furlong group, EMBL-Heidelberg) based on data provided in Thomas et
al. (2011). In this test, I only considered the 556 eQTLs that were located further
than 1,000 bp from their associated gene, to concentrate my search on putative
enhancers and silencers away from the core promoter. Of these 556 eQTLs, 24%
overlapped a DHS, compared to 19% in a null distribution of randomly chosen
variants (one variant per tested gene). This is a significant increase, suggesting
that my eQTLs are indeed enriched in DHSs (Fisher’s exact test, p = 0:02).
In addition, I also overlapped my set of eQTLs with a set of known CRMs from
the Redfly database of Drosophila regulatory elements (Gallo et al., 2011). As of
June 2015, this database contains a collection of 5,557 experimentally validated
CRMs. For 1,894 of these, the CRM was also associated with a target gene. While
I did not observe a significant enrichment of eQTLs in CRMs in general, I did
find 46 genes for which the top eQTL was inside an annotated CRM. For 4 of
these the CRM was also assigned to the correct gene, for 36 the CRM was not
assigned to any specific gene and for 6 the gene did not match. This mismatch
is however not surprising, as CRMs have been shown to have effects on multiple
genes at the same time (Link et al., 2013). In fact, these results suggest that my
eQTL data set may be useful to annotate these known CRMs further with novel
target genes.
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6.1.6. Kmer enrichment of eQTLs
The low degree of LD in the DGRP (see Section 1.9) often allowed me to not only
determine whether a gene had an eQTL, but also narrow the association down to
one or a few likely causal variants. While I would of course still miss ungenotyped
variants, the fact that the genotype data that I used had been generated from full
genome sequences meant that I was highly likely to have tested the true causal
variant, as long as it was biallelic and present in the population with a MAF of
at least 5%.
In particular, the eQTLs where the “eQTL cloud” had a size of one (i.e. where
there was no second-best variant within an order of magnitude of the top vari-
ant) constituted a set of very likely causal eQTLs. I took the subset of these
eQTLs where that single variant was also a SNP to obtain a set of 527 expression
quantitative trait nucleotides (eQTNs).
For each eQTN, I extracted the two bases upstream and two bases downstream
of the nucleotide from the correct strand of the reference genome, to form kmers
of length 5 bp. Using the information whether the eQTN had a positive or a
negative effect size I then generated two sets of 527 kmers, one that contained the
eQTN with the more highly expressed allele and one that contained the one with
the more lowly expressed allele.
I counted how often I observed each kmer in the higher and in the lower set and
tested for a significant difference in direction using a binomial test. I opted to use
this approach instead of a de novo motif enrichment analysis in regions flanking
the eQTN (Ettwiller et al., 2007; Bailey et al., 2009; Heinz et al., 2010) for two
reasons. First, this approach would not have taken advantage of the fact that I
actually know the exact nucleotide that has been mutated, rather than just the
general region. Second, motif enrichment tools are usually optimised for ChIP-seq
experiments and thus assume that there are few canonical motifs that can explain
a large fraction of the signal. This is very unlikely to be the case here, since I did
not limit my analysis to a single transcription factor with a single binding site
motif.
I observed the strongest difference for the kmer TTCTT which was associated
with decreased gene expression levels for five genes but never associated with
increased gene expression levels (unadjusted p = 0:0625). I further noticed that
in the group of the four related kmers TTATT, TTCTT, TTGTT and TTTTT
a G or C base ([GC]) in this location was always associated with a decrease in
expression (8 decreasing versus 0 increasing cases) while an A or T base ([AT])
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was almost always associated with an increase (1 versus 9 cases). The eQTNs for
the 8 genes where the change between a TT[CG]TT kmer and a TT[AT]TT kmer
resulted in an increase of expression are shown in Table 6.4.
Gene eQTN MAF Location Low High
Atf6 2R:1011634 0.13 upstream C T *
CG15369 X:9094032 0.11 upstream C * T
CG15544 3R:26637326 0.06 upstream G * T
PI31 2R:7881876 0.08 upstream C * T
Prp38 2R:5018473 0.05 upstream C T *
CG13133 2L:10061227 0.08 downstream G * A
CG42342 3R:12350405 0.27 internal intron C * T
Cpsf73 3R:14489189 0.16 internal exon C T *
Table 6.4.: eQTNs disrupting the TT[CG]TT motif with a corresponding increase in
expression. Low, nucleotide in the more lowly expressed allele. High, nucleotide in the
more highly expressed allele. Major allele marked with an asterisk (*).
For 5 out of 8 genes, the variant was located a considerable distance (10–25 kb)
upstream of the TSS. For the sixth case, CG13133, the eQTN was 30 kb down-
stream of the 30 end. The eQTN for the seventh gene, CG42342, was located
in the middle of the annotated gene region. However, this gene is almost 70 kb
long and has many exons, suggesting that the kmer may actually still have been
located several kb upstream of an unannotated promoter for a shorter isoform.
Finally, for Cpsf73, the kmer was located directly in the promoter region, 61 bp
inside the gene body. The fact that at least six of the kmers were located so far
away from the TSS, with a strong bias to the upstream region, suggests that these
kmers may be an important part of a distal CRM.
Intriguingly, TTGTT or its reverse complement AACAA is known to be part
of the consensus binding site sequence of transcription factors containing a SOX
domain, including Dichaete in Drosophila (Ma et al., 1998; Noyes et al., 2008)
and Sox5 in mouse (Denny et al., 1992). While it is important to stress that
this analysis is based on very few observations, these eQTNs may thus prove an
interesting target for further study.
6.1.7. Negative selection and the Winner’s Curse
In theory, I would expect that eQTLs leading to a large change in gene expression
would be selected against, since a big difference in the expression level of a gene is
likely to be detrimental. Thus, strong eQTLs should generally be under negative
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selection, leading to a low frequency of the allele in the population. In order to
determine whether I could see such an effect in my data, I plotted the absolute
effect size of each lead gene eQTL (common effect) against the MAF of the as-
sociated variant (Figure 6.10). If negative selection was acting on the eQTLs, I
expected to see a depletion of strong effect sizes at high MAF and an enrichment
of strong effect sizes at low MAF.
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Figure 6.10.: Absolute effect size of lead gene eQTLs (common effect) plotted against
the MAF of their associated variant. Red line shows a LOESS fit.
Indeed, this plot seemed to show evidence of negative selection, with most strong
eQTLs having a low MAF, and no high-frequency variant exhibiting strong effects.
If the eQTLs were not under selection, I would have expected the effect sizes to
be randomly distributed across the allele frequencies.
However, it soon emerged that this effect was almost certainly a manifestation
of the Winner’s Curse (Button et al., 2013; Halsey et al., 2015). In short, this
describes the phenomenon that studies identifying new effects almost always over-
estimate the size of that effect, in particular when they are lowly powered. The
power to detect eQTLs is correlated with the MAF of the tested variant as I have
157
shown when I calculated the statistical power of this study (Section 4.3). Thus,
it was possible that, due to the Winner’s Curse, I not only overestimated effect
sizes for some eQTLs but was also more likely to do so for variants with a low
MAF.
To illustrate this problem, I simulated this effect for an example eQTL. I gen-
erated data reflecting a change in expression level with a constant effect size of
0.25, to which I added noise from a standard normal distribution ( = 0,  = 1)
to reflect experimental and biological variation. I generated 100,000 variants with
exponentially decreasing MAF and tested each of them for association with the
effect. Figure 6.11 shows the effect size estimates for each of the 100,000 variants.
For high MAF, the estimated effect size was close to the true value of 0.25 (blue
dashed line), with little variation around it. However, for lower MAF, the spread
around the real effect size was much larger, with estimates reaching values of more
than 3.
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Figure 6.11.: Estimated effect size of simulated eQTLs plotted against the MAF of the
variant. Blue dashed line shows the true effect size of  = 0:25, red dashed line shows
the MAF cutoff of 5%.
158
I adjusted the p-values for multiple testing using BH’s method and extracted
the 2,399 variants with MAF > 5% that passed a strict threshold of 1% FDR.
The resulting distribution of absolute effect sizes is shown in Figure 6.12. Only
the variants for which the effect size happened to be larger than the real effect
passed the p-value threshold. The lower the MAF was, the more pronounced this
overestimation of the effect size became, due to the larger error of the estimates.
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Figure 6.12.: Absolute effect size of simulated eQTLs plotted against the MAF of the
variant. Only variants with FDR < 1% and MAF > 5% are shown. Blue dashed line
shows the true effect size of  = 0:25, red line shows a LOESS fit.
The clear resemblance between the simulated (Figure 6.12) and the real data
(Figure 6.10) suggests that this supposed negative selection effect is indeed likely
to be a result of the Winner’s Curse. It is still possible that my observations may
have been caused by a combination of this artefact and true biological effects, but
I was unable to disentangle these effects based on this data.
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6.2. Common and stage-specific gene eQTLs
One of the main novel aspects of my study is the measurement of gene expression
levels at three different developmental stages rather than just one. The expec-
tation was that this would allow me to find not only eQTLs that had an effect
whenever the gene was expressed, but also eQTLs that only had an effect during
specific stages of development. Mechanistically, these eQTLs might, for example,
be located in CRMs that are bound by a transcriptional regulator that is only
active during a single stage in development.
Based on the classification procedure described in Section 4.6.2, I found common
eQTLs for 1,224 genes, eQTLs specific to 2–4 h for 136 genes, eQTLs specific to
6–8 h for 79 genes, eQTLs specific to 10–12 h for 113 genes, 20 complex cases
and 177 weak two-stage eQTLs. A heatmap of the absolute effect sizes of specific
eQTLs compared between the three developmental stages is shown in Figure 6.13.
The effect sizes shown here were obtained from the single-stage eQTL testing, as
described in Section 4.6.2.
This plot illustrates the complex interaction between development and gene
regulation, with all possible combinations of stage-specific effects being observed.
6.2.1. Assigning each eQTL to a developmental stage
In addition to looking for eQTLs that were specific to a single developmental stage,
I also classified each eQTL by the stage in which the effect was most pronounced.
For this classification, I fitted an additional multivariate model in LIMIX, which
allowed for a different effect size coefficient i to be assigned to each developmental
stage: 264y1y2
y3
375 =
26412
3
375
 1N +
26412
3
375
 x+ g+ (6.1)
With yi; i;1N ;x;g and  as defined in Section 4.5. For each variant that was
found to be significantly associated with the common or specific effect tests, I
extracted the values 1, 2 and 3 from this model and assigned the eQTL to the
developmental stage i where i was largest. I found 661 genes with their strongest
eQTL at 2–4 h, 515 genes with their strongest eQTL at 6–8 h and 573 genes with
their strongest eQTL at 10–12 h after fertilisation.
Using this annotation, I compared the relative location of each eQTL to the
160
Single
2−4h
Two stages
Complex
Single
6−8h
Single
10−12h
2−4h 6−8h 10−12h
0.0
0.4
0.8
1.2
1.6
Absolute
Effect Size
Figure 6.13.: Single-stage effect sizes of the 525 lead eQTLs with different specificity
(y-axis) in the three developmental stages (x-axis). Sorted by absolute effect size within
each group.
associated gene between the different developmental stages. As shown in Fig-
ure 6.14, the eQTL locations were largely similar between developmental stages.
Interestingly, there did seem to be an increase in the amount of eQTLs inside of
the gene body at 2–4 h. In particular exonic eQTLs were almost twice as common
at 2–4 h as at 6–8 h and 10–12 h (122 versus 47 + 60 cases, Fisher’s exact test,
p = 3:92  10 7). Among the genes with an exonic eQTL strongest at 2–4 h was
the developmental gene ecd, which I had identified earlier.
One possible way mutations in the exon of a gene can affect its expression
level is through changes to miRNA binding sites (see Section 1.3.3). 2–4 h is
the developmental time point during which the maternal-to-zygotic transition
(MZT) occurs, which has previously been associated with regulation by miRNAs
in Drosophila as well as other organisms (see Sections 1.2.1 and 1.3.3).
To gain a better understanding of this phenomenon, I performed a second kmer
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Figure 6.14.: Percentage of lead gene eQTLs (both common and specific effect) in
different features, coloured by the developmental stage (Dev. stage) in which the strongest
effect was observed. Gene 30 and 50 ends include all eQTLs within 200 bp of the respective
end.
enrichment analysis (as described in Section 6.1.6) on the 55 exonic eQTNs that
were associated with a single SNP and had their strongest effect at 2–4 h. Search-
ing for a kmer of length 5 bp within 2 bp of the eQTN I found that the kmers
GC[AT]GG appeared to be associated with a decrease in gene expression, with
10 negative and 2 positive associations. I performed the same analysis on the 61
exonic eQTNs that had their strongest effect in 6–8 h or 10–12 h and did not find
a single instance of this kmer in these stages.
This hints at the presence of a gene regulatory mechanism associated with the
kmer GC[AT]GG that is more active in early stages of development than in later
ones. A possible explanation for this would be that there is a miRNA that targets
this sequence, which is only expressed at 2–4 h, potentially because it is involved in
the MZT. Exonic mutations have also been observed to affect splicing (Cartegni
et al., 2002), and sequences associated with this phenomenon in humans have
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indeed been observed to contain the reverse complement sequences of the kmer,
CCTGC and CCAGC (Cavaloc et al., 1999). However, due to the low number of
cases I had observed, I was unable to investigate this further.
6.3. 30 isoform eQTLs and alternative polyadenylation
QTLs
So far, I have only described eQTLs that affected the total expression level of
genes. However, as I described in Chapter 4, I also tested each 30 Tag-Seq peak
individually for association with proximal variants. This allowed me to find a set
of eQTLs that affected the usage of individual 30 isoforms of a given gene, which
I called 30i-eQTLs.
Several mechanisms have been suggested that may result in alternative polyade-
nylation (APA) through changes to different regions association with the polyade-
nylation procedure (see Section 1.3.2). This includes the canonical poly(A) motif
itself (AAUAAA) as well as the USE and DSE. Changes to the motifs located in
these regions may increase or decrease the rate of cleavage, polyadenylation and
subsequent termination at a 30 cleavage site. If these processes are changed at
the first poly(A) site, this may then have the opposite effect on downstream 30
ends as transcription continues to the next poly(A) site. Depending on how this
change in poly(A) site usage affects the mRNA stability and degradation rate,
this change may or may not lead to a change in the overall gene expression level,
reflected in the steady-state level of mRNA.
As I described in Chapter 5, I applied the same set of filters to the 30i-eQTLs as
for the gene eQTLs, except for the close-to-peak filter which would have removed
almost all of the data. This difference results in one important caveat with the
analysis of 30i-eQTLs: the potential for mappability artefacts as described in
Section 2.2 is larger than for gene eQTLs. I applied the same stage-specificity
classification as described in Section 6.2 to the 30i-eQTLs, resulting in a set of
5,883 common 30i-eQTLs and 1,241 stage-specific 30i-eQTLs. However, in the
following sections, I will only discuss the 5,883 common 30i-eQTLs.
For genes with only a single 30 Tag-Seq peak, the 30i-eQTLs were almost equiv-
alent to the associated gene eQTLs. This was expected, as the gene expression
level is calculated as the sum of all 30 Tag-Seq peak expression levels. However,
for genes with more than one observed 30 end, the 30i-eQTLs could exhibit more
interesting behaviours.
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6.3.1. Isoform-specific eQTLs
Particularly interesting were the cases where a variant was associated with the
expression level of an individual 30 isoform, but not of the whole gene. Such
eQTLs could be specifically affecting the usage of a single poly(A) site and might
thus allow me to observe the effects of a variant on 30 polyadenylation. As a first
step, I thus removed all 30i-eQTLs where the associated gene also had a common
eQTL, to obtain sets of 30i-eQTLs where the eQTL was not associated with the
overall gene expression level. Of the 5,883 peaks with at least one common 30i-
eQTL, 2,682 did not have any significant common effect eQTL for their associated
gene. I called these 2,682 30i-eQTLs, associated with 1,689 different genes, isoform-
specific eQTLs (is-eQTLs). Many of these is-eQTLs were located closely upstream
or downstream of the 30 end of their associated peak, with a median distance of
22.5 bp upstream (Figure 6.15).
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Figure 6.15.: Distance of is-eQTLs to the 30 end of the associated 30 Tag-Seq peak. (a)
Full histogram. (b) Histogram of all is-eQTLs within 500 bp of the 30 end.
As the 30 end of the 30 Tag-Seq peak is approximately equivalent to the cleavage
site, this would be consistent with the hypothesis that many of these is-eQTLs
are affecting 30 APA signals, such as the canonical poly(A) motif AAUAAA or
the USE and DSE upstream and downstream of it. However, this location could
also be a sign of artefacts caused by mappability problems, with variants inside
the peak region affecting how many reads could be mapped back to the peak
in different individuals. While I did attempt to account for these problems (see
Sections 2.2 and 5.2) it was still difficult to confidently state whether or not these
is-eQTLs were the consequence of real gene regulatory mechanisms.
In an attempt to shed more light on this, I determined the location of the
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summit of each peak, calculated as the median among the summit locations in
each individual sample. Since the read length we used for 30 Tag-Seq was 43 bp
and I only considered the height of the summit to estimate the expression level of
the peak, any variant further than 43 bp away from the summit should not result
in changes to the estimated expression level. After removing all is-eQTLs within
43 bp (the read length) of the peak summit there was still a visible enrichment
of is-eQTLs around the 30 end of the peak. The median distance of is-eQTLs to
their associated 30 end was now 11 bp upstream, as shown in Figure 6.16.
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Figure 6.16.: Distance of is-eQTLs further than 43 bp away from their 30 Tag-Seq peak’s
summit to its 30 end. (a) Full histogram. (b) Histogram of all is-eQTLs within 500 bp of
the 30 end.
In theory, we could imagine that each is-eQTL switches the 30 end usage of a
given transcript between two alternative 30 isoforms. In one allele, the poly(A)
machinery recognises the first set of poly(A) motifs and begins the process of
polyadenylation, resulting in the first 30 isoform being used. In the other allele,
a variant decreases the efficiency of polyadenylation of the first motif and tran-
scription continues to the next poly(A) site, where a new 30 end is generated. The
result would be that the usage of the first poly(A) site is decreased or entirely
abolished, with a corresponding increase in usage of the second poly(A) site.
Thus, every peak with an is-eQTL around its poly(A) motif should be followed
by another 30 end peak. I tested this assumption for the set of 620 is-eQTLs
that were located within 100 bp of the 30 end of their associated peak, but at
least 43 bp from its summit, suggesting that they affected cleavage at the given
30 end. For each of these is-eQTLs, I determined whether there was a second 30
Tag-Seq peak associated with the same gene located further downstream. 512
(83%) is-eQTLs had a second 30 Tag-Seq peak further downstream. Overall, only
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18,993 (71%) of tested 30 Tag-Seq peaks associated with multi-peak genes had a
second peak further downstream, which is significantly fewer (Fisher’s exact test,
p = 1:28  10 10). These results are consistent with the assumption that these is-
eQTLs are affecting the efficiency of cleavage and polyadenylation of the 30 end,
resulting in a shift in the 30 end usage to other sites further downstream.
As in Section 6.1.6, I searched for 5-mers affected by is-eQTLs with an excess of
positive or negative effects on the expression level. I tested the 453 is-eQTLs that
were located within 100 bp of the 30 end of their peak, at least 43 bp away from
their peak’s summit and with another peak further downstream. From these, I
again considered only the 319 is-eQTLs that were associated with only a single
SNP, which meant that I was likely to have identified the causal is-eQTN.
The most strongly enriched kmers were ATAAA and AAAGA, which were both
observed nine times on the more highly expressed allele and never on the more
lowly expressed allele. In both cases, an A-nucleotide in the more highly expressed
allele had been replaced by another nucleotide in the more lowly expressed allele
(AT[CGT]AA and AA[CGT]GA). Both of these kmers are similar to the canonical
poly(A) motif AATAAA, with the first kmer actually being a substring of it.
Thus, these may be cases where changes to the canonical poly(A) motif have led
to APA, with the binding affinity of the poly(A) machinery differing between the
two alleles. Overall, is-eQTLs seemed to be heavily enriched in A-rich regions.
6.3.2. Alternative polyadenylation QTLs
The previous analysis had already shown that peaks with is-eQTLs at their 30 end
tended to be followed by another peak, in line with their expected involvement
in APA. In fact, each such pair of peaks should result in two is-eQTLs, as any
variant associated with a decrease in the usage of the first peak should also be
associated with an increase in the usage of the second peak. An example of such
30 isoform switching, which I observed for the gene YL-1, is shown in Figure 6.17.
The difference in transcript length between the major and minor allele due to
this is-eQTL is clearly visible, both in the 30 Tag-Seq and in the RNA-seq data.
The SNP associated with this switch is located inside the first 30 Tag-Seq peak,
22 bp upstream of the putative cleavage site, in the region expected to contain
the canonical poly(A) motif (see Section 1.3.2). While individuals with the major
allele have the sequence GAATAAAA at this location, individuals with the minor
allele have the sequence GAATAATA instead. Thus, the is-eQTL disrupts the
canonical AATAAA motif at the first poly(A) site, decreasing its usage. The
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Figure 6.17.: 30 isoform switching of the gene YL-1. Top: Manhattan plot of variants
around the gene body (black). Middle: Median 30 Tag-Seq coverage at 2–4 h, 6–8 h and
10–12 h, grouped by major/minor allele at the lead eQTL. Only reads associated with
YL-1 shown. Bottom: Median RNA-seq coverage at 10–12 h, grouped by major/minor
allele at the lead eQTL. Only reads associated with YL-1 shown.
location of the 30 end consequently shifts to the second poly(A) site, approximate
350 bp downstream.
In practice, several factors made the comprehensive identification of these cases
more complicated. First, the rate of mRNA degradation can differ between 30
isoforms, for example through the inclusion of different miRNA binding sites (see
Section 1.3.3). Consequently, the steady-state expression levels may have differed
if alternative 30 polyadenylation sites were used, even if the transcription rate
itself stayed the same. Second, if a gene had more than two 30 isoforms, the signal
became challenging to detect: When one of these 30 isoforms was decreased by
an is-eQTL, the corresponding increase could become split up among the other
isoforms, resulting only in small changes to their expression levels. Finally, any
random variation in the testing or problems with the mappability of one of the
peak regions may have led to one of the is-eQTLs not being called. Hence, while
I did find at least two is-eQTLs with opposite signs for 356 out of 1,689 genes
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with is-eQTLs, only 43 of them involved the same lead variant. I thus searched for
cases of 30 isoform switching in a more systematic way, without relying exclusively
on the is-eQTLs.
For this purpose, I returned to the full set of significant common 30i-eQTLs and
identified those cases where the associated gene had at least two 30 Tag-Seq peaks.
For each time point, I determined the most strongly expressed 30 isoform of each
gene in each line based on the raw 30 Tag-Seq expression level. Counting how
often each peak was the most highly expressed peak for each of the genotypes,
I then built a N  G contingency table for each gene, where N is the number
of peaks and G is the number of genotypes. I tested for differences in 30 peak
usage patterns between the genotypes using a two-sided Fisher’s exact test and
calculated the FDR (across tested variants, developmental stages and genes) using
the BH method.
I applied a stringent threshold of FDR < 1% and removed all cases where one
of the peaks would have failed the mappability filters described in Section 5.2. In
addition, I removed all cases in which the most commonly used 30 isoform was
the same in both the major in the minor allele. This resulted in a final set of
405 loci associated with alternative polyadenylation of 186 genes, which I called
apaQTLs. For each gene, I selected the apaQTL with the best p-value for a final
set of 186 lead apaQTLs. A plot of the distances between the most used 30 ends
at the major and the minor allele for 127 apaQTLs is shown in Figure 6.18. There
were 59 genes with an apaQTL that led to a change of more than 1,000 bp, which
I have omitted from this plot.
Interestingly, for 73 genes with an apaQTL, the variant was only significantly
associated with a change in poly(A) site, but not with a change in expression
level. This suggests that the steady-state expression level for this gene stayed
relatively constant, regardless of the poly(A) site that was being used. While
these different 30 isoforms thus did not appear to be differentially degraded, they
may have had different translation rates because of differences in their 30 UTR or
yielded different proteins through alternative splicing coupled with APA resulting
in the omission or addition of exons.
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Figure 6.18.: Distance between the most used 30 ends at the major and the minor allele
for 127 apaQTLs. Genes with a distance of more than 1,000 bp omitted.
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7. Distal and trans eQTLs
In Chapters 4 and 5 I described how I searched for gene-proximal eQTLs, located
within 50 kb of the gene or 30 transcript end that they were associated with. In
this chapter I describe how I extended this approach to search for eQTLs genome-
wide, and investigate some properties of distal and trans eQTLs.
7.1. Introduction
I had based my choice of window size for the gene-proximal eQTL search on the
observation that over 99% of annotated D. melanogaster cis-regulatory modules
(CRMs) are located closer than 50 kb to their gene, as described in Chapter 4.
By focusing on this region close to the gene, I concentrated on variants that were
most likely to be eQTLs, while ignoring the vast majority of other variants that
were unlikely to be associated. This decreased the computational complexity of
the testing and increased the power to detect effects, since I only needed to test an
average of 1,392 variants per gene instead of all 1,772,891 variants genome-wide.
The analysis of the proximal eQTLs (see Chapter 6) suggested that this was a
valid assumption, with more than 80% of the proximal eQTLs located within 15 kb
of the gene. However, I also observed eQTLs further away from their associated
gene, throughout the entire search window of up to 50 kb.
This showed that, while the vast majority of eQTLs could indeed be found prox-
imal to the gene, I was potentially missing some interesting eQTLs further away.
These distal eQTLs may represent long-range cis effects as well as trans effects. In
addition, I was also interested in finding eQTLs on different chromosomes, which
would be likely to be true trans effects.
In this chapter, I describe the process and the results of mapping eQTLs
genome-wide, with the aim of finding distal cis and trans eQTLs. For the purpose
of these analyses, I consider an eQTL to be in trans if it is located on a different
chromosome arm from its associated gene.
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7.2. Genome-wide calling of eQTLs
As for the gene-proximal eQTLs (Chapter 4), I tested for common effects using
a multi-stage linear mixed model and processed the results into a set of genome-
wide common eQTLs. I did not attempt to call stage-specific eQTLs as I did not
expect the statistical power to be sufficient to find such effects.
Conducting such a GWAS on 10,094 phenotypes (the expression levels of each
gene) posed some major computational challenges.
For proximal eQTLs, I had calculated empirical p-values to account for multiple
testing and local LD structure of each gene, using 10,000 permutation experiments
per gene (see Section 4.5). It was possible to calculate this in less than an hour per
gene, as each permutation took less than a second to calculate. However, for the
genome-wide eQTLs, this number would have increased to approximately 10 CPU
minutes per permutation and 60 CPU days per gene, for a total of approximately
1,658 CPU years.
Thus, for the genome-wide eQTL testing, I opted to control the FDR across all
tested variants and genes at the same time using the BH method instead. This had
the advantage that I did not need to perform any permutation experiments, vastly
increasing the speed of my computations but at the cost of decreased statistical
power. As early trials indicated that the BH method was much more sensitive
to outliers caused by non-normally distributed phenotypes than my previous ap-
proach, I adjusted the gene expression level normalisation procedure described
in Section 3.5 as follows to make the data more suitable for genome-wide eQTL
calling.
Instead of simply centring and scaling the gene expression levels within each
gene, I quantile-normalised them by transforming them into a standard normal
distribution (inverse normal transformation). I used PEER (see Section 3.5.1) on
these normally distributed expression levels to capture residual variation while
correcting for up to k = 25 hidden confounding factors (Section 7.2.1 describes
how this number was chosen). Finally, I performed a second inverse normal trans-
formation on these residuals to obtain the final, normally distributed phenotypes.
This procedure likely further decreased the statistical power by omitting some
of the true structure in the data, but also removed outliers from the data which
would have otherwise increased the false positive rate.
However, even the BH method could not be applied directly to this data, due to
the amount of tests I had performed. I had tested V = 1,772,891 variants for asso-
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ciation with N = 10,094 genes, which resulted in a total of V N = 17,895,561,754
(17.9 billion) p-values to be corrected. Simply holding these numbers in memory
would already have required at least 143 gigabytes of RAM (64 bits per p-value).
To handle this amount of data in an efficient way, I developed a custom approach
that allowed me to apply the BH method to my data set by parallelising parts of
the computation and avoiding unnecessary calculations.
This approach took advantage of the fact that BH is a step-up procedure,
meaning that it involves analysing p-values in increasing order (starting from
the most significant) until a suitable threshold is reached. After this threshold
has been found, all p-values greater than it are guaranteed to not pass the FDR
threshold. Thus, I was able to decrease the number of p-values I had to test
vastly by only considering p-values likely to be significant. I chose p = 10 5 as a
conservative threshold and extracted eQTLs with p-values smaller than this in a
parallelised fashion.
This resulted in a much more tractable set of 415,775 p-values. I sorted these
p-values in order of increasing value and calculated the critical p-value for each
of them using the formula ci = FDR  in with FDR = 10%. However, instead of
setting n to the length of the p-value vector as in the normal BH procedure, I
set it to the original number of p-values V N . I then found the largest i = imax
such that pi  ci and classified all p-values with rank i  imax as passing the
FDR threshold. This procedure is mathematically equivalent to applying the BH
procedure to the entire vector of p-values but could be calculated within seconds
using a standard amount of RAM.
7.2.1. Optimising the number of hidden factors
A fundamental problem in searching for trans effects while also accounting for
experimental batch effects is that it is not necessarily possible to distinguish be-
tween the two. When I corrected for batch effects using PEER, I assumed that
eQTLs should only affect few genes, meaning that any systematic difference be-
tween samples that affected many genes at once was likely to be a batch effect.
This assumption is not necessarily valid for trans eQTLs, since a change in the
protein structure or the expression level of, for example, a transcription factor
may affect the expression of many downstream genes.
The number of different effects that PEER tries to remove from the data is given
by the number of hidden factors k. The larger k is, the more structure may be
removed from the data. Experimental noise, which I expect to be stronger than
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the effects of trans-acting factors, will be removed first. Consequently, k needs to
be large enough to capture most of the possible experimental batch effects, but
small enough such that trans effects are not yet removed from the signal.
I normalised the data as described above, using different values of k between 1
and 50. For each k, I called eQTLs genome-wide and applied the FDR correction
using the BH procedure. I then counted how many unique genes had at least
one eQTL, as well as how many genes had at least one trans eQTL. The result is
shown in Table 7.1.
k eQTL genes, total eQTL genes, trans
2 764 64
5 1027 94
10 1154 107
15 1176 111
20 1173 108
25 1184 114
30 1177 112
50 1173 107
Table 7.1.: Total number of genes with eQTLs and number of genes with eQTLs in trans
for different numbers of hidden PEER factors k.
Between k = 2 and k = 10, the number of eQTLs quickly increased with an
increasing number of hidden factors, suggesting that there were indeed some ma-
jor experimental batch effects that PEER was effectively correcting for. Beyond
k = 10 this positive effect seemed to weaken until the number of eQTLs started
decreasing again after k = 25. As k = 25 seemed to result in the highest number
both of overall eQTLs as well as trans eQTLs, I chose this value for all further
analyses. This set contained 11,022 eQTLs for 1,184 unique genes, 203 of which
(114 unique genes) were located on a chromosome arm different from their asso-
ciated gene.
7.2.2. eQTLs associated with inversions
Chromosomal inversions are large-scale structural changes to chromosomes that
are known to result in large regions of strong LD in the genome (see Section 1.5).
Thus, if a variant associated with an inversion is an eQTL, other variants associ-
ated with the inversion will also look like they are eQTLs. This could potentially
complicate the interpretation of my results, as a gene with a proximal eQTL may
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have other variants in LD much further away, giving the impression that there is
a distal eQTL.
There are 16 inversions that have been identified among the DGRP lines (Huang
et al., 2014). I obtained the inversion genotypes for each of the DGRP lines used
in my study and encoded them as minor allele dosages, with numbers from 0 to
2 indicating the number of minor alleles present in the line. For each inversion,
I calculated the squared Pearson’s correlation coefficient r2 between the dosage
of each inversion and each of the 1,772,891 tested variants in the genome. The
distribution of the strongest r2 per variant is shown in Figure 7.1.
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Figure 7.1.: Histogram of the strongest r2 to an inversion for all 1,772,891 tested variants.
While most of the tested variants were not associated with any inversion, there
were some that showed evidence of linkage to the inversion. As a conservative
filter, I removed all eQTLs with r2 > 0:1 from the analysis. After this filter, I was
left with 10,301 eQTLs for 1,101 unique genes (157 eQTLs, 92 genes in trans).
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7.3. Comparison between genome-wide and gene-proximal
eQTLs
I compared this unfiltered set of 10,301 common, genome-wide eQTLs to the
unfiltered set of 49,649 common, gene-proximal eQTLs described in Section 4.6.
There were 2,111 genes that only had an eQTL in the proximal eQTL set, 73
genes with eQTLs only in the genome-wide eQTL set and 1,028 genes for which
I found at least one eQTL with both approaches (Figure 7.2a). In fact, for 986
(96%) of the latter genes I found exactly the same variant as an eQTL with both
approaches. This overlap further increased when I only considered those variants
that were tested in both analyses, namely those within 50 kb of the gene. In this
case, I found 2,152 genes with eQTLs only in the proximal search, 3 genes with
eQTLs only in the genome-wide search and 987 genes with both proximal and
genome-wide eQTLs (Figure 7.2b).
2111
73
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Proximal
Genome−wide, all
(a) All eQTLs
2152
3
987
Proximal
Genome−wide, within 50kb
(b) Only eQTLs within 50 kb
Figure 7.2.: Overlap between genes with proximal eQTLs (red) and genome-wide eQTLs
(blue) with a common effect.
Of course, this large agreement between proximal and genome-wide eQTL calls
did not come as a surprise as I had applied the same model to the same data.
Nevertheless, this shows that there is no large disagreement between the two
different normalisation and p-value adjustment methods used. There were three
genes for which I found proximal eQTLs with the genome-wide but not with
the proximal test: CG15213, CG31102, and CadN2. In theory, I should have
found these associations also during the proximal eQTL testing, since I tested the
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same genes with the same variants. However, given the differences between the
approaches (including running PEER with a different number of hidden factors
and correcting for multiple testing in different ways) a small discrepancy like this
would be expected.
The results from this overlap also allowed me to get an impression of how much
larger the power to detect eQTLs was when I only tested variants in a small
window around the gene instead of genome-wide. Based on the number of genes
for which I found eQTLs with the two different approaches, I achieved at least a
threefold increase in power by restricting the analysis to variants proximal to the
gene and thus decreasing the multiple-testing burden.
7.4. Filtering and RNA-seq validation of genome-wide
eQTLs
To account for mappability, I applied the same set of filtering criteria that I had
applied to the proximal eQTLs (see Chapter 5) to all the genome-wide eQTLs that
were not located in trans. If the most strongly associated variant of a gene failed
these filters, I removed all other variants associated with that gene as well. After
removing all eQTLs involving a region with heterozygosity > 40%, eQTLs corre-
lated with the mappability of the 30 Tag-Seq peaks and variants closer than 25 bp
to an associated 30 Tag-Seq peak, the final set of genome-wide eQTLs contained
3,553 eQTLs for 436 genes (142 eQTLs, 86 genes in trans).
Next, I performed RNA-seq validation of this set of filtered genome-wide eQTLs,
using the same approach as described in Section 5.1. I only tested the strongest
eQTL for each gene, but giving priority to eQTLs on different chromosome arms.
The concordance rate I observed in this set of 436 lead genome-wide eQTLs was
85% (Figure 7.3). The concordance was slightly lower for those eQTLs on a
different chromosome arm from their gene, but still clearly above the random
expectation of 50% (Figure 7.4).
These results confirmed that the genome-wide 30 Tag-Seq eQTLs were unlikely
to have been caused by protocol-specific biases. Again, this was not unexpected
as false positives caused by mappability problems would have to be located close
to the gene, so there was no reason to expect that whole-genome eQTLs would
be more likely to be artefacts than proximal eQTLs. For 146 lead genome-wide
eQTLs I could also see a significant difference in RNA-seq expression levels be-
tween the major and minor allele that had been predicted by the eQTL (Wilcoxon
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Figure 7.3.: Difference in normalised medians for expression levels measured with stan-
dard RNA-seq at 10–12 h plotted against effect size at 10–12 h of genome-wide 30 Tag-Seq
eQTLs. Concordant eQTLs shown in blue, discordant eQTLs shown in red.
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Figure 7.4.: Fraction of concordant and discordant eQTLs grouped by their location
relative to their associated gene.
test, p < 0:05). Six of these eQTLs were located in trans and are shown in Ta-
ble 7.2, annotated with the gene located closest to the variant and the effect of
the variant based on its location and gene annotation, as predicted by the tool
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snpEff (Cingolani et al., 2012). A Manhattan plot of all tested variants for the
gene CG13827, which is a component of the peroxisome membrane (Faust et al.,
2012), is shown in Figure 7.5.
Chr. Gene Lead variant MAF  Variant effect Closest gene
X Traf-like 3R:14089716 0.07 -1.70 intergenic region CG18599
3R Spn85F 3L:13294092 0.06 1.65 upstream Acp70A
3R Acf1 2L:16008623 0.28 1.00 intronic beat-Ic
3R CG13827 2R:17778487 0.13 1.44 intronic Fili
3R lig3 2R:18052757 0.06 1.63 upstream a
2L zf30C 3R:25519022 0.11 1.70 intronic dmrt99B
Table 7.2.: Trans eQTLs validated using RNA-seq expression levels. Chr., chromosome
of gene with expression level change. , effect size. Closest gene, gene located closest to
the eQTL.
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Figure 7.5.: Genome-wide Manhattan plot for the gene CG13827.  log10(p) value
of all tested variants plotted against the rank of their location, coloured by chromosome
arm. Only variants with  log10(p) > 2 are shown as individual points, most strongly
associated variant is plotted with increased size. Arrow: Location of CG13827.
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7.5. Location of genome-wide eQTLs with respect to their
genes
In Chapter 4, I made the assumption that most eQTLs strong enough to be de-
tected would be located within 50 kb of the gene. This new genome-wide analysis
now gave me the chance to test this assumption. I calculated the genomic dis-
tance of each eQTL from its associated gene, assigning an infinite distance to any
eQTL on a different chromosome arm. Figure 7.6 shows the distribution of these
values, truncated at 200 kb.
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Figure 7.6.: Histogram of genome-wide eQTLs distances from their associated genes.
Red line shows the 50 kb threshold used for the proximal eQTL calling, blue line an-
other possible threshold at 70 kb. eQTLs further than 200 kb or located on a different
chromosome arm from their associated gene are displayed as 200 kb.
While this distance distribution shows that eQTLs can be located many hun-
dreds of kb away from their associated gene, the vast majority (84%) of them
were located within 50 kb (red line). This shows that 50 kb was a good choice
of threshold, which allowed me to achieve good statistical power while still being
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able to identify most eQTLs. However, in hindsight it might have been better to
slightly extend the cut-off to 70 kb (blue line), which might have allowed me to
find a few more eQTLs (87%).
As in Section 6.1.3, I performed a GO enrichment analysis on the 115 genes that
were located further than 10 kb from the TSS of their associated gene but on the
same chromosome arm. I observed similar enrichments as I had already observed
for the gene-proximal set of eQTLs, including the terms “single-organism devel-
opmental process”, “organ development”, and “response to stimulus”. However,
due to the lower number of genes available for this analysis in the genome-wide
eQTL set, these terms no longer passed a Bonferroni-adjusted p-value threshold
of 0.05, with adjusted p-values of 0.06, 0.07 and 0.08 respectively. This demon-
strates that, while the genome-wide eQTL search was able to identify some distal
eQTLs that were not tested in the proximal eQTL search, the increased num-
ber of eQTLs in the proximal analysis provided me with greater power to detect
patterns, even at intermediate distances.
In addition, I also performed a GO enrichment analysis of the set of 106 genes
that had at least one eQTL located further than 1Mb away from the gene or
on a different chromosome arm. These genes were weakly enriched in the GO
terms “cell-cell signaling” and “regulation of RNA metabolic process”, but the
sample size was too small to be able to consider this enrichment significant after
Bonferroni correction. Comparing the p-value of these terms to an empirical null
from 1,000 random permutation experiments resulted in empirical p-values of 0.17
and 0.70, respectively. A list of the eight genes in the category “cell-cell signaling”
with a distal eQTL is shown in Table 7.3 and a genome-wide Manhattan plot for
the gene Sra-1, which plays a role in the development of axons (Bogdan et al.,
2004), is shown in Figure 7.7. While the power to detect features of such distal
eQTLs was clearly very limited, this shows that interesting associations might be
uncovered in a more highly powered study.
Figure 7.8 shows the position of the 3,553 filtered genome-wide eQTLs against
the position of the gene that they were associated with.
This plot confirms that most eQTLs appeared to be located very close to their
associated gene but also shows a number of eQTLs further away from their gene or
in trans. However, there did not appear to be any eQTLs affecting the expression
of many different genes in trans at the same time. Such an eQTL would appear
as a vertical line of dots in this plot, indicating that many genes are associated
with the same eQTL hotspot (Albert and Kruglyak, 2015).
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Chr. Gene Lead variant MAF  Variant effect Closest gene
3R CG13827 2R:17778487 0.13 1.44 intronic Fili
3R CG31122 3R:11593798 0.20 1.02 upstream CG5623
3L Cip4 2R:7061368 0.25 -1.07 50 UTR variant shn
2L Pde11 X:17581143 0.31 -0.97 intronic chas
3R Snap24 2R:18721687 0.07 -2.01 synonymous CG30265
2R Sply X:22220978 0.29 -0.88 intergenic region
3R Sra-1 X:2375360 0.24 -0.94 splice region trol
3L dlt 3L:16565368 0.14 -1.84 splice region Mipp1
Table 7.3.: Genes annotated with the GO term “cell-cell signaling” and a distal eQTL
at least 1Mb away or on a different chromosome arm. Chr., chromosome of gene with
expression level change. , effect size. Closest gene, gene located closest to the eQTL.
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Figure 7.7.: Genome-wide Manhattan plot for the gene Sra-1.  log10(p) value of all
tested variants plotted against the rank of their location, coloured by chromosome arm.
Only variants with  log10(p) > 2 are shown as individual points, most strongly associated
variant is plotted with increased size. Arrow: Location of Sra-1.
Finally, I searched for trans eQTLs that were predicted to affect the protein
coding region of a gene. These cases were particularly interesting, as they could
have involved polymorphisms causing a structural change to a transcriptional
regulator, which then resulted in the decreased binding of that regulator to a
binding site. There were two such eQTLs, shown in table Table 7.4.
The first eQTL had a negative effect on the expression level of the gene CG-
12096, which is annotated with the GO terms “cellular response to DNA damage
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Figure 7.8.: Location of genes (Y-axis) plotted against the location of their association
variant (X-axis) for all 3,553 filtered genome-wide eQTLs. Chromosome arms shaded in
alternating grey/white pattern.
stimulus” (Ravi et al., 2009) and “proteasome assembly” (Cho-Park and Steller,
2013). The protein affected by the variant itself was Or83c, which is a Odorant
receptor (Ronderos et al., 2014). Its 31st amino acid, Serine, is changed to Alanine
due to a T to G polymorphism at the variant. The second eQTL decreased the
expression of CG10289. This gene is not annotated with any GO terms, but
has been associated with the PpV phosphatase (Yin et al., 2014). The variant
changes the 38th amino acid in the gene CG30087, which has been annotated
with “serine-type endopeptidase activity”, from Threonine to Proline through an
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Chr. Gene Lead variant MAF  Variant effect Closest gene
X CG12096 3R:1903915 0.12 -1.33 missense variant Or83c
3L CG10289 2R:11580064 0.30 -1.07 missense variant CG30087
Table 7.4.: eQTLs that are predicted to have a non-synonymous effect on a gene in
trans. Chr., chromosome of gene with expression level change. , effect size.
A to C polymorphism. Neither of these cases thus appeared to have an obvious
mechanistic explanation, which may mean that they were false positives but could
also make them interesting targets for further study.
The Manhattan plot for CG12096 is shown in Figure 7.9; the Manhattan plot
for CG10289 is shown in Figure 7.10.
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Figure 7.9.: Genome-wide Manhattan plot for the gene CG12096.  log10(p) value
of all tested variants plotted against the rank of their location, coloured by chromosome
arm. Only variants with  log10(p) > 2 are shown as individual points, most strongly
associated variant is plotted with increased size. Arrow: Location of CG12096.
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Figure 7.10.: Genome-wide Manhattan plot for the gene CG10289.  log10(p) value
of all tested variants plotted against the rank of their location, coloured by chromosome
arm. Only variants with  log10(p) > 2 are shown as individual points, most strongly
associated variant is plotted with increased size. Arrow: Location of CG10289.
7.6. Comparison to variance decomposition
The results from the variance decomposition analysis (see Section 4.2) suggested
that trans regulation was prevalent in the D. melanogaster genome, with 15% of
genes having more than 25% of their total variance in expression level explained
by distal genetic relatedness (putative trans effects). The reason that I was nev-
ertheless unable to identify trans eQTLs with an effect on many genes is thus
unlikely to be reflective of a lack of real trans regulation, and may instead have
been caused by some or all of the following factors:
1. Low power: Correcting for multiple testing across all variants in the genome
vastly decreased the statistical power. Additionally, trans effects tend to
have low effect sizes, which makes them hard to detect (Petretto et al.,
2006). Since I only used 228 samples from 76 different lines for my analysis,
I was unlikely to detect any such weak effects.
2. Selection: A mutation changing the expression level of many genes at the
same time in trans is likely to have a more extreme effect than a single
cis regulatory mutation, and may thus be under stronger selection (Wray,
2007). It is possible that such effects would not be present in the population
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at my MAF threshold of 5%.
3. Polygenic effects: The trans effects that I observed in the variance decom-
position may have actually been the sum of many small effects, all acting
in trans. I would have been able to detect such effects in the variance de-
composition since I was considering all distal variants at the same time, but
the effects of the individual variants may have been below the threshold of
detectable effects in this study.
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8. Concluding remarks
In this work, I have described an eQTL study in the Drosophila Genetic Reference
Panel, which has yielded interesting new insights into gene regulation. Thanks
to the high degree of fine mapping possible in this population, I was often able
to identify the location of individual nucleotides associated with gene expression
and study their exact location with respect to the gene. I found eQTLs proximal
to the promoter, but also many around the 30 end of the gene or in more distal
regions. In addition, the nucleotide-level accuracy of this study allowed me to
find eQTLs affecting potential novel binding sites involved in gene regulation.
Using the 30 isoform expression data generated by 30 Tag-Seq, I could not only
annotate new 30 polyadenylation sites genome-wide, but also identify a new type
of QTL affecting alternative polyadenylation. These apaQTLs were associated
with a switch in 30 polyadenylation site usage, both with and without a change
in the total gene expression level.
The multi-stage experimental design further enhanced this study, allowing me
to search for gene regulatory differences between different stages of embryo de-
velopment. This revealed some interesting stage-specific effects that illustrate the
plasticity of gene regulation throughout development. My observation that eQTLs
with a strong effect at 2–4 h after fertilisation tended to be enriched in exons sug-
gests that post-transcriptional regulatory mechanisms may be more prevalent at
early stages of development.
In addition, I have shown how eQTL and gene expression data can be employed
in the study of organismal phenotypes, using the example of Orct2. Such an ap-
proach could be used to help our understanding of the causal relationships between
a phenotype and the expression levels of associated genes in a process similar to
Mendelian randomisation, which has been used to identify causal associations in
human health (Lawlor et al., 2008).
Finally, I have developed a large collection of data sets in the course of this
project, which I hope will prove useful for the entire Drosophila community. Using
the data sets that we have submitted for publication (Cannavo et al., 2015),
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other researchers will be able to find alternative polyadenylation sites, compare
expression levels, and identify regulatory regions for thousands of genes in D.
melanogaster.
8.1. Possible improvements to this study
In hindsight, there were of course some aspects of this study that could have been
improved. First and foremost, an increase in the sample size would not only have
increased my power to find more proximal eQTLs, but would also have allowed
me to conduct a full study of trans-acting eQTLs, which was underpowered at
the current sample size. Samples from additional developmental stages would
have also been very helpful in disentangling common from stage-specific effects.
Similarly, a fully randomised sample preparation and sequencing design would
have made it easier to limit batch effects, requiring fewer normalisation steps.
The data generated by 30 Tag-Seq also proved to be challenging to process and
analyse, as most of the commonly used tools had been designed for standard
RNA-seq. The poly(A)+ RNA-seq protocol may have thus been a better choice
to estimate gene expression levels, and may have also been less susceptible to
mappability artefacts. However, this would have meant that I would not have
been able to identify apaQTLs or study 30 transcript end locations in this amount
of detail.
In addition to these changes to the experimental design, there are also some
improvements that I could have made to the way I analysed the data. If I had
filtered the variants to be tested more aggressively and removed variants of low
quality or in strong LD to another variant, I could have potentially decreased the
number of tests I needed to perform, without missing any positive associations.
This could have increased my power, particularly in the genome-wide eQTL anal-
ysis. A more carefully chosen mappability filter might have also allowed me to
remove more false positives while keeping more true positives.
8.2. Future steps
I believe that there are many interesting analyses that could be performed to
extend and build upon this work.
On the computational side, the data I generated represents a treasure trove
of information that could be very useful for studies of gene expression and gene
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regulation in Drosophila. For example, in 2009, Ayroles and colleagues studied
the systems genetics of gene expression in 40 Drosophila Genetic Reference Panel
lines using microarray data from adult individuals (Ayroles et al., 2009). Using
the data from my project, this study could now be repeated with a doubled
sample size, a more accurate method of determining gene expression levels and
the additional dimension of multiple developmental time points.
In addition, my approach to the developmental staging of Drosophila by gene
expression levels could be extended much further. Using machine learning tech-
niques it may even be possible to predict the exact developmental time point of
each individual. This would allow one to consider the developmental time point
as a covariate in the eQTL study, which could yield very interesting results. The
concept of determining the developmental stage of an organism from its gene
expression levels could also be expanded to other organisms.
It would also be very interesting to conduct additional in vitro and in vivo
assays to follow up on the phenomena that I observed, to help confirm some of
my results and study their impact on the organism. For example, it remains to
be seen what effects an experimental disruption of the novel binding site motifs
that I found would have on the expression level of genes. In addition, the effect
of eQTLs on organismal phenotypes could be studied further, as I have shown
with the example of Orct2. This could involve both the collection of additional
phenotyping data as well as the targeted modification of the DNA at a given
eQTL, using a technique such as the CRISPR/Cas9 system (Bassett et al., 2013;
Hsu et al., 2014).
A heterozygous F1 cross of different lines from the DGRP could also be an
interesting resource for further study. For example, these offspring could be tested
for allele-specific expression, which would make it possible to not only validate
the effect of some of the eQTLs that I have identified, but also distinguish cis and
trans regulatory effects in a much more accurate manner. Conducting multiple
such crosses between different lines and analysing gene expression at multiple
stages of development might yield completely new insights into the heredity and
plasticity of gene regulation.
Recently, single-cell RNA-seq has also become available, enabling the measure-
ment of gene expression levels in individual cells (Tang et al., 2009). While this
technology is still being developed, recent improvements now allow for the anal-
ysis of gene expression levels of thousands of individual cells at the same time
(Macosko et al., 2015). This may make it possible to study the transcriptome
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of different cell types in the developing Drosophila embryo to a level that is not
feasible with the current whole-embryo RNA-seq data. Obtaining this data from
multiple individuals could even allow for an eQTL study based on single-cell se-
quencing data, although the cost of this would most likely be prohibitive at the
current time.
8.3. Genetics on the fly
Since Morgan started his work with Drosophila melanogaster more than a cen-
tury ago, the fruit fly has played a major (and arguably the most important) role
in the study of genetics and development. Yet in spite of these decades of close
examination, there are still many questions left unanswered and new experimen-
tal methods continuously open up new avenues of study. In this thesis, I have
contributed to our understanding of gene regulation by using genetic association
techniques in this model organism. There are many other molecular and organis-
mal phenotypes in Drosophila to which this technique could be applied. Thus, I
believe that the study of Drosophila melanogaster will continue to bring exciting
new discoveries in the decades and centuries to come.
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A. Supplementary Table
A.1. Samples used in this study
Time Line Repl. Run Lane Barcode Reads QC eQTLs
2–4 h 21 1 22 C1RHM TTGCGG 11781844
6–8 h 21 1 7 D18BD TCCGTC 12443917
10–12 h 21 1 12 C1FY9 AAGTGC 11765316
2–4 h 26 1 18 C1J9A GATGCT 16020124
6–8 h 26 1 10 C1CKM GATGCT 15509549
10–12 h 26 1 17 C1J9A GATGCT 16928923
2–4 h 28 1 22 C1RHM CGTACG 15305686
2–4 h 28 2 24 C1TAU CCGTAT 11231565 –
6–8 h 28 1 10 C1CKM CCACTC 15783639
6–8 h 28 2 24 C1TAU TTGCGG 11361119 – –
10–12 h 28 1 17 C1J9A CCGTAT 13711981 – –
10–12 h 28 2 23 C1TAU GATGCT 12888337
2–4 h 40 1 22 C1RHM TACAAG 13173984
2–4 h 40 2 24 C1TAU CGTACG 10826737 –
6–8 h 40 1 24 C1TAU TACAAG 11817078
10–12 h 40 1 24 C1TAU TCCGTC 11280581
2–4 h 41 1 21 C1J9A GATGCT 21951300
6–8 h 41 1 10 C1CKM AAGTGC 15306165
10–12 h 41 1 25 C258F GATGCT 15466033
2–4 h 42 1 18 C1J9A CCGTAT 12453968
6–8 h 42 1 8 C1CKM GATGCT 15649897
10–12 h 42 1 14 C1FY9 GATGCT 14773016
2–4 h 57 1 20 C1J9A GATGCT 14301333
6–8 h 57 1 8 C1CKM CCGTAT 12824090
10–12 h 57 1 13 C1FY9 TACAAG 15722406
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2–4 h 75 1 22 C1RHM TCCGTC 13256971
6–8 h 75 1 10 C1CKM ATTATA 14548749
10–12 h 75 1 17 C1J9A TTGCGG 11993024
2–4 h 83 1 24 C1TAU CCACTC 13005031
6–8 h 83 1 23 C1TAU CCGTAT 11664281
10–12 h 83 1 23 C1TAU TTGCGG 12447528
2–4 h 93 1 22 C1RHM GATGCT 16337643
6–8 h 93 1 10 C1CKM GGAGAA 16053679
10–12 h 93 1 14 C1FY9 CCGTAT 14606457
2–4 h 129 1 21 C1J9A CCGTAT 12186219
6–8 h 129 1 10 C1CKM CCGTAT 13862381
10–12 h 129 1 17 C1J9A CGTACG 13762668
2–4 h 176 1 22 C1RHM CCGTAT 11394736
6–8 h 176 1 8 C1CKM TTGCGG 16844815
10–12 h 176 1 13 C1FY9 TTGCGG 13057662
2–4 h 177 1 20 C1J9A CCGTAT 13912216
6–8 h 177 1 7 D18BD CCACTC 11817487
6–8 h 177 2 8 C1CKM CGTACG 14263778 –
10–12 h 177 1 25 C258F CCGTAT 13881302
2–4 h 181 1 20 C1J9A TTGCGG 11653877
6–8 h 181 1 8 C1CKM TACAAG 11989556
10–12 h 181 1 12 C1FY9 ATTATA 11893302
2–4 h 208 1 16 D1MWE CCGTAT 11889102
6–8 h 208 1 5 C0PPA TCCGTC 13926767
10–12 h 208 1 11 C1CKM GATGCT 14101030
2–4 h 227 1 22 C1RHM CCACTC 11872220
6–8 h 227 1 7 D18BD AAGTGC 11644217
10–12 h 227 1 12 C1FY9 TACAAG 12941098
2–4 h 239 1 25 C258F TTGCGG 12388091
6–8 h 239 1 12 C1FY9 GATGCT 13683224
10–12 h 239 1 17 C1J9A TACAAG 15586529
2–4 h 280 1 21 C1J9A TTGCGG 9480810
6–8 h 280 1 12 C1FY9 TTGCGG 10695199
10–12 h 280 1 17 C1J9A CCACTC 14553632
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2–4 h 301 1 15 C1J9A CGTACG 15816037
6–8 h 301 1 2 D150P TCCGTC 10914175
10–12 h 301 1 3 D150P TCCGTC 12733925
2–4 h 303 1 15 C1J9A TACAAG 13372145
6–8 h 303 1 4 D150P GATGCT 14978759
10–12 h 303 1 6 D18BD GATGCT 11812297
2–4 h 304 1 16 D1MWE GATGCT 13513702
6–8 h 304 1 2 D150P CCACTC 12806480
10–12 h 304 1 6 D18BD CCGTAT 10571228
2–4 h 307 1 19 C1J9A TCCGTC 13646698
6–8 h 307 1 3 D150P GATGCT 13654237
10–12 h 307 1 9 C1CKM GATGCT 13173636
2–4 h 313 1 15 C1J9A CCGTAT 14048595
6–8 h 313 1 2 D150P GATGCT 12001999 – –
6–8 h 313 2 5 C0PPA CCACTC 11060246
10–12 h 313 1 6 D18BD TTGCGG 8361208
2–4 h 318 1 18 C1J9A TTGCGG 14207627
6–8 h 318 1 10 C1CKM TTGCGG 14145307
10–12 h 318 1 19 C1J9A GATGCT 13681324
2–4 h 320 1 18 C1J9A CGTACG 14116237
6–8 h 320 1 11 C1CKM CCACTC 13723436
10–12 h 320 1 13 C1FY9 CCGTAT 13209356
2–4 h 324 1 16 D1MWE TTGCGG 10853915
6–8 h 324 1 5 C0PPA GGAGAA 13775191
10–12 h 324 1 11 C1CKM CCGTAT 14837755
2–4 h 335 1 25 C258F ATTATA 12638023
6–8 h 335 1 25 C258F GGAGAA 11933184
10–12 h 335 1 26 C258F AAGTGC 13070336
2–4 h 357 1 19 C1J9A CCACTC 14660601
6–8 h 357 1 3 D150P CCGTAT 13852505
10–12 h 357 1 9 C1CKM CCGTAT 14690063
2–4 h 358 1 16 D1MWE CGTACG 12369969
6–8 h 358 1 5 C0PPA CGTACG 11668578
10–12 h 358 1 9 C1CKM TTGCGG 10810663
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2–4 h 360 1 16 D1MWE TACAAG 13654383
6–8 h 360 1 5 C0PPA TACAAG 17035971
10–12 h 360 1 11 C1CKM TTGCGG 13398508
2–4 h 362 1 16 D1MWE TCCGTC 12907513
6–8 h 362 1 5 C0PPA ATTATA 10011283
10–12 h 362 1 9 C1CKM TCCGTC 14754377
2–4 h 365 1 15 C1J9A GGAGAA 13465344
6–8 h 365 1 2 D150P TACAAG 10684547
10–12 h 365 1 6 D18BD TACAAG 12400547
2–4 h 370 1 20 C1J9A TACAAG 11915348
6–8 h 370 1 11 C1CKM AAGTGC 14704146
10–12 h 370 1 12 C1FY9 TCCGTC 12646054
2–4 h 374 1 18 C1J9A TACAAG 13922196
2–4 h 374 2 23 C1TAU CGTACG 11705149 –
6–8 h 374 1 24 C1TAU AAGTGC 11902037
10–12 h 374 1 19 C1J9A CCGTAT 11983094
10–12 h 374 2 23 C1TAU TACAAG 13172663 –
2–4 h 375 1 14 C1FY9 CCACTC 13132406
6–8 h 375 1 1 C0R6L TTGCGG 8039426
6–8 h 375 2 1 C0R6L CGTACG 10016269 –
6–8 h 375 3 1 C0R6L TACAAG 7930105 –
6–8 h 375 4 1 C0R6L AAGTGC 13628433 –
6–8 h 375 5 1 C0R6L TCCGTC 12677795 –
10–12 h 375 1 3 D150P TTGCGG 11771741
2–4 h 379 1 15 C1J9A TTGCGG 13021221
6–8 h 379 1 5 C0PPA TTGCGG 12754934
10–12 h 379 1 11 C1CKM CGTACG 14690477
2–4 h 380 1 16 D1MWE AAGTGC 12756991
6–8 h 380 1 4 D150P TACAAG 16415155
10–12 h 380 1 6 D18BD TCCGTC 12284806
2–4 h 391 1 19 C1J9A AAGTGC 14965944 –
10–12 h 391 1 9 C1CKM CCACTC 14910779 –
2–4 h 399 1 15 C1J9A TCCGTC 11556094
6–8 h 399 1 5 C0PPA GATGCT 13796695
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10–12 h 399 1 9 C1CKM AAGTGC 15003665
2–4 h 406 1 18 C1J9A TCCGTC 14880631
6–8 h 406 1 7 D18BD GATGCT 11352918
10–12 h 406 1 24 C1TAU GATGCT 14456415
2–4 h 427 1 16 D1MWE ATTATA 13701215
6–8 h 427 1 1 C0R6L CCACTC 9019205
10–12 h 427 1 6 D18BD CCACTC 12115891
2–4 h 437 1 15 C1J9A CCACTC 14630484
6–8 h 437 1 2 D150P CCGTAT 10915500
10–12 h 437 1 6 D18BD AAGTGC 11596118
2–4 h 441 1 21 C1J9A CGTACG 8826935
6–8 h 441 1 11 C1CKM ATTATA 14731230
10–12 h 441 1 17 C1J9A AAGTGC 15687845
2–4 h 461 1 20 C1J9A CCACTC 13338891
6–8 h 461 1 7 D18BD CCGTAT 10883516
10–12 h 461 1 13 C1FY9 GATGCT 14248775
2–4 h 486 1 19 C1J9A ATTATA 14320964
6–8 h 486 1 4 D150P CCACTC 15438102
6–8 h 486 2 4 D150P TCCGTC 14131598 –
10–12 h 486 1 9 C1CKM ATTATA 19097360
2–4 h 491 1 20 C1J9A TCCGTC 11168114
6–8 h 491 1 7 D18BD ATTATA 10113031
10–12 h 491 1 24 C1TAU ATTATA 11615487
2–4 h 508 1 23 C1TAU TCCGTC 11745552
6–8 h 508 1 23 C1TAU CCACTC 13030804
10–12 h 508 1 24 C1TAU GGAGAA 10275782
2–4 h 509 1 25 C258F TCCGTC 13000929 – –
6–8 h 509 1 26 C258F TTGCGG 10915133 –
10–12 h 509 1 25 C258F TACAAG 11894923 – –
2–4 h 517 1 14 C1FY9 GGAGAA 13865949
6–8 h 517 1 4 D150P CCGTAT 14657885
10–12 h 517 1 3 D150P AAGTGC 13564087
2–4 h 531 1 26 C258F TCCGTC 13241308
6–8 h 531 1 26 C258F CCGTAT 12386145
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10–12 h 531 1 25 C258F CCACTC 11289089
2–4 h 535 1 20 C1J9A AAGTGC 16087068
6–8 h 535 1 7 D18BD GGAGAA 10541169
10–12 h 535 1 25 C258F CGTACG 14911611
2–4 h 555 1 20 C1J9A ATTATA 13533782
6–8 h 555 1 4 D150P AAGTGC 16109231
10–12 h 555 1 11 C1CKM TCCGTC 17341619
2–4 h 639 1 16 D1MWE CCACTC 11461026
6–8 h 639 1 5 C0PPA AAGTGC 8638928
10–12 h 639 1 9 C1CKM GGAGAA 15659478
2–4 h 642 1 18 C1J9A CCACTC 14837681
6–8 h 642 1 10 C1CKM CGTACG 16326137
10–12 h 642 1 19 C1J9A TTGCGG 12721184
2–4 h 703 1 18 C1J9A AAGTGC 15900554
6–8 h 703 1 8 C1CKM CCACTC 10102112
10–12 h 703 1 13 C1FY9 TCCGTC 17182039
2–4 h 705 1 20 C1J9A GGAGAA 12548270
6–8 h 705 1 4 D150P ATTATA 15518714
10–12 h 705 1 9 C1CKM TACAAG 17101670
2–4 h 707 1 19 C1J9A GGAGAA 14488320
6–8 h 707 1 3 D150P CGTACG 14620265
10–12 h 707 1 9 C1CKM CGTACG 12746206
2–4 h 712 1 16 D1MWE GGAGAA 14068272
6–8 h 712 1 5 C0PPA CCGTAT 11123448
10–12 h 712 1 11 C1CKM TACAAG 14793132
2–4 h 714 1 14 C1FY9 TCCGTC 12198641
6–8 h 714 1 4 D150P CGTACG 16010824
10–12 h 714 1 4 D150P GGAGAA 12633038
2–4 h 716 1 21 C1J9A TACAAG 10372292
6–8 h 716 1 10 C1CKM TACAAG 20292861
10–12 h 716 1 17 C1J9A GGAGAA 15202525
2–4 h 721 1 21 C1J9A TCCGTC 20211499
6–8 h 721 1 10 C1CKM TCCGTC 14115601
10–12 h 721 1 19 C1J9A CGTACG 14517882
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2–4 h 730 1 26 C258F CCACTC 12242783
6–8 h 730 1 26 C258F GATGCT 14280745
10–12 h 730 1 26 C258F TACAAG 13722762
2–4 h 732 1 14 C1FY9 AAGTGC 13261726
6–8 h 732 1 2 D150P TTGCGG 9845147
10–12 h 732 1 6 D18BD ATTATA 12075591
2–4 h 765 1 14 C1FY9 TTGCGG 13934616
6–8 h 765 1 4 D150P TTGCGG 16308325
10–12 h 765 1 3 D150P ATTATA 14285231
2–4 h 774 1 15 C1J9A AAGTGC 13948525
6–8 h 774 1 2 D150P ATTATA 14267311
10–12 h 774 1 3 D150P GGAGAA 14355524
2–4 h 786 1 14 C1FY9 ATTATA 14215097
6–8 h 786 1 2 D150P CGTACG 13145134
10–12 h 786 1 6 D18BD GGAGAA 11896970
2–4 h 790 1 21 C1J9A CCACTC 9956160
6–8 h 790 1 7 D18BD TTGCGG 11497242
10–12 h 790 1 13 C1FY9 CCACTC 16668866
2–4 h 799 1 14 C1FY9 CGTACG 14924156 –
6–8 h 799 1 1 C0R6L GGAGAA 9429397 – –
10–12 h 799 1 3 D150P TACAAG 13781951 –
2–4 h 804 1 18 C1J9A ATTATA 13361712
6–8 h 804 1 12 C1FY9 CCGTAT 13495211
10–12 h 804 1 17 C1J9A ATTATA 14678740
2–4 h 805 1 20 C1J9A CGTACG 12253214
6–8 h 805 1 8 C1CKM TCCGTC 14397449
10–12 h 805 1 13 C1FY9 CGTACG 14867230
2–4 h 810 1 23 C1TAU AAGTGC 14121610
6–8 h 810 1 23 C1TAU ATTATA 12849453
10–12 h 810 1 25 C258F AAGTGC 10454738
2–4 h 820 1 15 C1J9A ATTATA 12111362
6–8 h 820 1 2 D150P GGAGAA 11568504
6–8 h 820 2 1 C0R6L ATTATA 10667592 –
10–12 h 820 1 6 D18BD CGTACG 12491873
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2–4 h 852 1 14 C1FY9 TACAAG 15121258 –
6–8 h 852 1 1 C0R6L GATGCT 20274449 –
6–8 h 852 2 1 C0R6L CCGTAT 15143335 –
10–12 h 852 1 26 C258F CGTACG 12514736 – –
2–4 h 859 1 22 C1RHM AAGTGC 15732503
6–8 h 859 1 7 D18BD CGTACG 11693671
10–12 h 859 1 13 C1FY9 AAGTGC 14677842
2–4 h 879 1 21 C1J9A AAGTGC 9999969
6–8 h 879 1 12 C1FY9 CCACTC 13593490
10–12 h 879 1 19 C1J9A TACAAG 14409397
2–4 h 887 1 23 C1TAU GGAGAA 12170735
6–8 h 887 1 11 C1CKM GGAGAA 19557175
10–12 h 887 1 17 C1J9A TCCGTC 14103103
2–4 h 890 1 18 C1J9A GGAGAA 13352966
6–8 h 890 1 7 D18BD TACAAG 13129505
10–12 h 890 1 12 C1FY9 CGTACG 13292262
2–4 h 892 1 21 C1J9A ATTATA 11652415
6–8 h 892 1 8 C1CKM AAGTGC 12842089
10–12 h 892 1 13 C1FY9 ATTATA 14072234
2–4 h 897 1 21 C1J9A GGAGAA 9453103
6–8 h 897 1 8 C1CKM ATTATA 12298790
10–12 h 897 1 13 C1FY9 GGAGAA 14633849
2–4 h 908 1 22 C1RHM ATTATA 15158181
6–8 h 908 1 8 C1CKM GGAGAA 12822587
10–12 h 908 1 12 C1FY9 GGAGAA 11892591
Table A.1.: List of all samples sequenced for this study. Repl., replicate. Run, sequencing
run. Lane, sequencing lane used. Reads, number of sequenced reads. QC, did this sample
pass quality control by comparison to modENCODE time course? eQTLs, was this sample
used for the multi-stage eQTL study?
198
Bibliography
Abrams, John M, Kristin White, Liselotte I Fessler, and Hermann Steller (1993).
“Programmed cell death during Drosophila embryogenesis.”Development (Cam-
bridge, England) 117.1, pp. 29–43.
Adams, Mark D, Susan E Celniker, Robert A Holt, Cheryl A Evans, Jeannine
D Gocayne, Peter G Amanatides, Steven E Scherer, Peter W Li, Roger A
Hoskins, et al. (2000). “The genome sequence of Drosophila melanogaster”.
Science 287.March, pp. 2185–95.
Albert, Frank W and Leonid Kruglyak (2015). “The role of regulatory variation
in complex traits and disease”. Nature Reviews Genetics 16.4, pp. 197–212.
Alexa, Adrian and Jorg Rahnenfuhrer (2010). topGO: Enrichment analysis for
Gene Ontology. R package version 2.12.0.
Allison, David B, Xiangqin Cui, Grier P Page, and Mahyar Sabripour (2006).
“Microarray data analysis: from disarray to consolidation and consensus.”
Nature Reviews Genetics 7.1, pp. 55–65.
Altenburg, Edgar and Hermann J Muller (1920). “The Genetic Basis of Truncate
Wing,-an Inconstant and Modifiable Character in Drosophila.” Genetics 5.1,
pp. 1–59.
Altshuler, David, Mark J Daly, and Eric S Lander (2008). “Genetic Mapping in
Human Disease”. Science 322.5903, pp. 881–888.
Alwine, James C, David J Kemp, and George R Stark (1977). “Method for detec-
tion of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-
paper and hybridization with DNA probes.” Proceedings of the National
Academy of Sciences of the United States of America 74.12, pp. 5350–4.
199
Anders, Simon, Paul Theodor Pyl, andWolfgang Huber (2015). “HTSeq–a Python
framework to work with high-throughput sequencing data”. Bioinformatics
31.2, pp. 166–169.
Anderson, John S Jacobs and Roy Parker (1998). “The 3’ to 5’ degradation of
yeast mRNAs is a general mechanism for mRNA turnover that requires the
SK12 DEVH box protein and 3’ to 5’ exonucleases of the exosome complex”.
EMBO Journal 17.5, pp. 1497–1506.
Anderson, Kathryn V, Gerd Jürgens, and Christiane Nüsslein-Volhard (1985).
“Establishment of dorsal-ventral polarity in the Drosophila embryo: Genetic
studies on the role of the Toll gene product”. Cell 42.3, pp. 779–789.
Atwell, Susanna, Yu S Huang, Bjarni J Vilhjálmsson, Glenda Willems, Matthew
Horton, Yan Li, Dazhe Meng, Alexander Platt, Aaron M Tarone, et al. (2010).
“Genome-wide association study of 107 phenotypes in Arabidopsis thaliana
inbred lines.” Nature 465.7298, pp. 627–631.
Ayroles, Julien F, Mary Anna Carbone, Eric a Stone, Katherine W Jordan,
Richard F Lyman, Michael M Magwire, Stephanie M Rollmann, Laura H
Duncan, Faye Lawrence, et al. (2009). “Systems genetics of complex traits in
Drosophila melanogaster.” Nature genetics 41.3, pp. 299–307.
Bailey, Timothy L, Mikael Boden, Fabian A Buske, Martin Frith, Charles E Grant,
Luca Clementi, Jingyuan Ren, Wilfred W Li, and William S Noble (2009).
“MEME SUITE: tools for motif discovery and searching.” Nucleic acids re-
search 37.Web Server issue, W202–8.
Banerji, Julian, Sandro Rusconi, and Walter Schaffner (1981). “Expression of a -
globin gene is enhanced by remote SV40 DNA sequences”. Cell 27.2, pp. 299–
308.
Bannister, Andrew J and Tony Kouzarides (2011). “Regulation of chromatin by
histone modifications.” Cell research 21.3, pp. 381–395.
Barski, Artem, Suresh Cuddapah, Kairong Cui, Tae Young Roh, Dustin E. Scho-
nes, Zhibin Wang, Gang Wei, Iouri Chepelev, and Keji Zhao (2007). “High-
Resolution Profiling of Histone Methylations in the Human Genome”. Cell
129.4, pp. 823–837.
200
Bartel, David P. (2009). “MicroRNAs: Target Recognition and Regulatory Func-
tions”. Cell 136.2, pp. 215–233.
Bassett, Andrew R, Charlotte Tibbit, Chris P Ponting, and Ji Long Liu (2013).
“Highly Efficient Targeted Mutagenesis of Drosophila with the CRISPR/Cas9
System”. Cell Reports 4.1, pp. 220–228.
Benjamini, Yoav and Yosef Hochberg (1995). “Controlling the False Discovery
Rate: A Practical and Powerful Approach to Multiple Testing”. Journal of
the Royal Statistical Society. Series B (Methodological) 57.1, pp. 289 –300.
Bennett, Brian J, Charles R Farber, Luz Orozco, Hyun Min Kang, Anatole Ghaz-
alpour, Nathan Siemers, Michael Neubauer, Isaac Neuhaus, Roumyana Yor-
danova, et al. (2010). “A high-resolution association mapping panel for the
dissection of complex traits in mice.” Genome research 20.2, pp. 281–90.
Benoit, Beatrice, Chun Hua He, Fan Zhang, Sarah M Votruba, Wael Tadros,
J Timothy Westwood, Craig a Smibert, Howard D Lipshitz, and William E
Theurkauf (2009). “An essential role for the RNA-binding protein Smaug dur-
ing the Drosophila maternal-to-zygotic transition.” Development (Cambridge,
England) 136.6, pp. 923–932.
Bogdan, Sven, Oliver Grewe, Mareike Strunk, Alexandra Mertens, and Christian
Klämbt (2004). “Sra-1 interacts with Kette and Wasp and is required for
neuronal and bristle development in Drosophila.” Development (Cambridge,
England) 131.16, pp. 3981–3989.
Botstein, David, Raymond L White, Mark Skolnick, and Ronald W Davis (1980).
“Construction of a genetic linkage map in man using restriction fragment
length polymorphisms.” American journal of human genetics 32.3, pp. 314–
31.
Boyle, Alan P, Sean Davis, Hennady P Shulha, Paul Meltzer, Elliott H Mar-
gulies, Zhiping Weng, Terrence S Furey, and Gregory E Crawford (2008).
“High-resolution mapping and characterization of open chromatin across the
genome.” Cell 132.2, pp. 311–22.
201
Brem, Rachel B., Gael Yvert, Rebecca Clinton, and Leonid Kruglyak (2002).
“Genetic Dissection of Transcriptional Regulation in Budding Yeast”. Science
296.5568, pp. 752–755.
Brennecke, Julius, David R. Hipfner, Alexander Stark, Robert B. Russell, and
Stephen M. Cohen (2003). “bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the proapoptotic gene
hid in Drosophila”. Cell 113.1, pp. 25–36.
Bridges, Calvin B (1916). “Non-Disjunction as Proof of the Chromosome Theory
of Heredity”. Genetics 1.1, pp. 1–52.
Bridges, Calvin B and Thomas H Morgan (1923). “The third-chromosome group
of mutant characters of Drosophila melanogaster”. Carnegie Institute Publi-
cations 327, p. 130.
Brody, Thomas (1999). “The Interactive Fly: gene networks, development and
the Internet”. Trends in Genetics 15.8, pp. 333–334.
Bulger, Michael and Mark Groudine (2011). “Functional and mechanistic diversity
of distal transcription enhancers”. Cell 144.3, pp. 327–339.
Bush, William S and Jason H Moore (2012). “Chapter 11: Genome-Wide Associ-
ation Studies”. PLoS Computational Biology 8.12.
Bushati, Natascha, Alexander Stark, Julius Brennecke, and Stephen M. Cohen
(2008). “Temporal Reciprocity of miRNAs and Their Targets during the
Maternal-to-Zygotic Transition in Drosophila”. Current Biology 18.7, pp. 501–
506.
Button, Katherine S, John P A Ioannidis, Claire Mokrysz, Brian A Nosek, Jon-
athan Flint, Emma S J Robinson, and Marcus R Munafò (2013). “Power
failure: why small sample size undermines the reliability of neuroscience.”
Nature reviews neuroscience 14.May, pp. 365–76.
Campos-Ortega, José A and Volker Hartenstein (1997). The Embryonic Devel-
opment of Drosophila melanogaster. Berlin, Heidelberg: Springer Berlin Hei-
delberg, pp. 1–405.
202
Cannavo, Enrico, Nils Kölling, Dermot Harnett, David Garfield, Francesco P
Casale, Jacob F Degner, Hilary E Gustafson, Matt Davis, Oliver Stegle, et
al. (2015). “Genetic and developmental regulation of expression levels and
isoform diversity during embryogenesis”. Submitted.
Carswell, Susan and James C Alwine (1989). “Efficiency of utilization of the
simian virus 40 late polyadenylation site: effects of upstream sequences.”
Molecular and cellular biology 9.10, pp. 4248–58.
Cartegni, Luca, Shern L Chew, and Adrian R Krainer (2002). “Listening to silence
and understanding nonsense: exonic mutations that affect splicing.” Nature
Reviews Genetics 3.4, pp. 285–298.
Casanova, Jordi and Gary Struhl (1989). “Localized surface activity of torso,
a receptor tyrosine kinase, specifies terminal body pattern in Drosophila.”
Genes & development 3.12B, pp. 2025–38.
Castle, W E, F W Carpenter, A H Clark, S O Mast, and W M Barrows (1906).
“The Effects of Inbreeding, Cross-Breeding, and Selection upon the Fertility
and Variability of Drosophila”. Proceedings of the American Academy of Arts
and Sciences 41.33, p. 731.
Cavaloc, Yvon, Cyril F Bourgeois, Liliane Kister, and James Stévenin (1999).
“The splicing factors 9G8 and SRp20 transactivate splicing through different
and specific enhancers.” RNA (New York, N.Y.) 5.3, pp. 468–483.
Champely, Stephane (2015). pwr: Basic Functions for Power Analysis. R package
version 1.1-2.
Chia, Ruth, Francesca Achilli, Michael F W Festing, and Elizabeth M C Fisher
(2005). “The origins and uses of mouse outbred stocks.” Nature genetics 37.11,
pp. 1181–6.
Cho-Park, Park F and Hermann Steller (2013). “Proteasome regulation by ADP-
ribosylation”. Cell 153.3, pp. 614–627.
Churchill, G A and R W Doerge (1994). “Empirical threshold values for quanti-
tative trait mapping”. Genetics 138.3, pp. 963–971.
203
Cingolani, Pablo, Adrian Platts, Le Lily Wang, Melissa Coon, Tung Nguyen, Luan
Wang, Susan J Land, Xiangyi Lu, and Douglas M Ruden (2012). “A program
for annotating and predicting the effects of single nucleotide polymorphisms,
SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2;
iso-3.” Fly 6.2, pp. 80–92.
Colgan, Diana F and James L Manley (1997). “Mechanism and regulation of
mRNA polyadenylation”. Genes & Development 11.21, pp. 2755–2766.
Conaway, Ronald C and Joan Weliky Conaway (2011). “Function and regulation
of the Mediator complex”. Current Opinion in Genetics and Development
21.2, pp. 225–230.
Corder, E, A Saunders, W Strittmatter, D Schmechel, P Gaskell, G Small, A
Roses, J Haines, and M Pericak-Vance (1993). “Gene dose of apolipoprotein
E type 4 allele and the risk of Alzheimer’s disease in late onset families”.
Science 261.5123, pp. 921–923.
Csárdi, Gábor, Alexander Franks, David S Choi, Edoardo M Airoldi, and D Al-
lan Drummond (2015). “Accounting for Experimental Noise Reveals That
mRNA Levels, Amplified by Post-Transcriptional Processes, Largely Deter-
mine Steady-State Protein Levels in Yeast”. PLOS Genetics 11.5. Ed. by
Michael Snyder, e1005206.
Darwin, Charles (1859). On the origin of species by means of natural selection.
London: John Murray.
Davis, Matthew P A, Stijn van Dongen, Cei Abreu-Goodger, Nenad Bartonicek,
and Anton J Enright (2013). “Kraken: A set of tools for quality control and
analysis of high-throughput sequence data”. Methods 63.1, pp. 41–49.
Decker, Carolyn J and Roy Parker (1993). “A turnover pathway for both stable
and unstable mRNAs in yeast: evidence for a requirement for deadenylation.”
Genes & Development 7.8, pp. 1632–1643.
Degner, Jacob F, Athma A Pai, Roger Pique-Regi, Jean-Baptiste Veyrieras, Daniel
J Gaffney, Joseph K Pickrell, Sherryl De Leon, Katelyn Michelini, Noah
Lewellen, et al. (2012). “DNase I sensitivity QTLs are a major determinant
of human expression variation.” Nature 482.7385, pp. 390–4.
204
Degner, Jacob F, John C Marioni, Athma A Pai, Joseph K Pickrell, Everlyne
Nkadori, Yoav Gilad, and Jonathan K Pritchard (2009). “Effect of read-
mapping biases on detecting allele-specific expression from RNA-sequencing
data”. Bioinformatics 25.24, pp. 3207–3212.
Dembeck, Lauren M, Wen Huang, Michael M Magwire, Faye Lawrence, Richard F
Lyman, and Trudy F C Mackay (2015). “Genetic Architecture of Abdomi-
nal Pigmentation in Drosophila melanogaster”. PLOS Genetics 11.5. Ed. by
Corbin D. Jones, e1005163.
Denny, Paul, Sally Swift, Frances Connor, and Alan Ashworth (1992). “An
SRY-related gene expressed during spermatogenesis in the mouse encodes a
sequence-specific DNA-binding protein.” The EMBO journal 11.10, pp. 3705–
3712.
Di Giammartino, Dafne Campigli, Kensei Nishida, and James L Manley (2011).
“Mechanisms and consequences of alternative polyadenylation.”Molecular cell
43.6, pp. 853–66.
Dimas, Antigone S, Samuel Deutsch, Barbara E Stranger, Stephen B Montgomery,
Christelle Borel, Homa Attar-Cohen, Catherine Ingle, Claude Beazley, Maria
Gutierrez Arcelus, et al. (2009). “Common regulatory variation impacts
gene expression in a cell type-dependent manner.” Science (New York, N.Y.)
325.5945, pp. 1246–1250.
Ding, Zhihao, Yunyun Ni, Sander W Timmer, Bum-kyu Lee, Anna Battenhouse,
Sandra Louzada, Fengtang Yang, Ian Dunham, Gregory E Crawford, et al.
(2014). “Quantitative Genetics of CTCF Binding Reveal Local Sequence
Effects and Different Modes of X-Chromosome Association”. PLoS Genetics
10.11. Ed. by Greg Gibson, e1004798.
Dixon, Anna L, Liming Liang, Miriam F Moffatt, Wei Chen, Simon Heath, Kenny
C C Wong, Jenny Taylor, Edward Burnett, Ivo Gut, et al. (2007). “A
genome-wide association study of global gene expression.” Nature genetics
39.10, pp. 1202–7.
Djuranovic, Sergej, Ali Nahvi, and Rachel Green (2012). “miRNA-mediated gene
silencing by translational repression followed by mRNA deadenylation and
decay.” Science (New York, N.Y.) 336.6078, pp. 237–40.
205
Dobin, Alexander, Carrie A Davis, Felix Schlesinger, Jorg Drenkow, Chris Zaleski,
Sonali Jha, Philippe Batut, Mark Chaisson, and Thomas R Gingeras (2013).
“STAR: Ultrafast universal RNA-seq aligner”. Bioinformatics 29.1, pp. 15–21.
Dunn, Olive Jean (1959). “Estimation of the Medians for Dependent Variables”.
The Annals of Mathematical Statistics 30.1, pp. 192–197.
Easton, Douglas F, Karen A Pooley, Alison M Dunning, Paul D P Pharoah, Debo-
rah Thompson, Dennis G Ballinger, Jeffery P Struewing, Jonathan Morrison,
Helen Field, et al. (2007). “Genome-wide association study identifies novel
breast cancer susceptibility loci.” Nature 447.7148, pp. 1087–1093.
Edery, Isaac, Laurence J Zwiebel, Marie E Dembinska, and Michael Rosbash
(1994). “Temporal phosphorylation of the Drosophila period protein.” Pro-
ceedings of the National Academy of Sciences of the United States of America
91.6, pp. 2260–2264.
Edgar, Bruce A and Gerold Schubiger (1986). “Parameters controlling transcrip-
tional activation during early drosophila development”. Cell 44.6, pp. 871–
877.
Ettwiller, Laurence, Benedict Paten, Mirana Ramialison, Ewan Birney, and Jo-
achimWittbrodt (2007). “Trawler: de novo regulatory motif discovery pipeline
for chromatin immunoprecipitation.” Nature methods 4.7, pp. 563–565.
Faust, Joseph E, Avani Verma, Chengwei Peng, and James A Mcnew (2012). “An
inventory of peroxisomal proteins and pathways in drosophila melanogaster”.
Traffic 13.10, pp. 1378–1392.
Felsenfeld, Gary and Mark Groudine (2003). “Controlling the double helix”. Na-
ture 421.6921, pp. 448–453.
Feuk, Lars, Andrew R Carson, and Stephen W Scherer (2006). “Structural vari-
ation in the human genome.” Nature Reviews Genetics 7.2, pp. 85–97.
Fisher, Ronald Aylmer (1921). “Studies in crop variation. I. An examination of the
yield of dressed grain from Broadbalk”. The Journal of Agricultural Science
11.02, p. 107.
206
Fisher, Ronald Aylmer (1918). “The Correlation between Relatives on the Sup-
position of Mendelian Inheritance”. Philosophical Transactions of the Royal
Society of Edinburgh 52, pp. 399–433.
Fisher, Ronald Aylmer (1930). The genetical theory of natural selection. London:
Oxford University Press.
Fisher, Ronald Aylmer and W A Mackenzie (1923). “Studies in crop variation.
II. The manurial response of different potato varieties”. The Journal of Agri-
cultural Science 13.03, p. 311.
Foe, Victoria E and Bruce M Alberts (1983). “Studies of nuclear and cyto-
plasmic behaviour during the five mitotic cycles that precede gastrulation
in Drosophila embryogenesis.” Journal of cell science 61, pp. 31–70.
Francesconi, Mirko and Ben Lehner (2014). “The effects of genetic variation on
gene expression dynamics during development.” Nature 505.7482, pp. 208–11.
Fuda, Nicholas J, M Behfar Ardehali, and John T Lis (2009). “Defining mecha-
nisms that regulate RNA polymerase II transcription in vivo.”Nature 461.7261,
pp. 186–92.
Gaffney, Daniel J, Jean-Baptiste Veyrieras, Jacob F Degner, Roger Pique-Regi,
Athma a Pai, Gregory E Crawford, Matthew Stephens, Yoav Gilad, and Jon-
athan K Pritchard (2012). “Dissecting the regulatory architecture of gene
expression QTLs.” Genome biology 13.1, R7.
Gallo, Steven M, Dave T Gerrard, David Miner, Michael Simich, Benjamin Des
Soye, Casey M Bergman, and Marc S Halfon (2011). “REDfly v3.0: Toward a
comprehensive database of transcriptional regulatory elements in Drosophila”.
Nucleic Acids Research 39.SUPPL. 1, pp. 1–6.
Galton, Francis (1909). Memories of my life. London, Methuen & co.
Gautier, Laurent, Leslie Cope, Benjamin M Bolstad, and Rafael A Irizarry (2004).
“affy–analysis of Affymetrix GeneChip data at the probe level.” Bioinformat-
ics (Oxford, England) 20.3, pp. 307–15.
207
Gawande, Bharat, Mark D Robida, Andrew Rahn, and Ravinder Singh (2006).
“Drosophila Sex-lethal protein mediates polyadenylation switching in the fe-
male germline.” The EMBO journal 25.6, pp. 1263–1272.
Gaziova, Ivana, Peter C Bonnette, Vincent C Henrich, and Marek Jindra (2004).
“Cell-autonomous roles of the ecdysoneless gene in Drosophila development
and oogenesis.” Development (Cambridge, England) 131.11, pp. 2715–2725.
Gerrits, Alice, Yang Li, Bruno M. Tesson, Leonid V. Bystrykh, Ellen Weersing, Al-
bertina Ausema, Bert Dontje, Xusheng Wang, Rainer Breitling, et al. (2009).
“Expression quantitative trait loci are highly sensitive to cellular differentia-
tion state”. PLoS Genetics 5.10.
Ghavi-Helm, Yad, Felix A Klein, Tibor Pakozdi, Lucia Ciglar, Daan Noordermeer,
Wolfgang Huber, and Eileen E M Furlong (2014). “Enhancer loops appear
stable during development and are associated with paused polymerase”. Na-
ture 512.7512, pp. 96–100.
Ghildiyal, Megha and Phillip D Zamore (2009). “Small silencing RNAs: an ex-
panding universe.” Nature Reviews Genetics 10.2, pp. 94–108.
Gibson, Ursula E, Christian A Heid, and P Mickey Williams (1996). “A novel
method for real time quantitative RT-PCR.” Genome Research 6.10, pp. 995–
1001.
Gil, Anna and Nick J Proudfoot (1987). “Position-dependent sequence elements
downstream of AAUAAA are required for efficient rabbit beta-globin mRNA
3’ end formation.” Cell 49.3, pp. 399–406.
Goncalves, Angela, Sarah Leigh-Brown, David Thybert, Klara Stefflova, Ernest
Turro, Paul Flicek, Alvis Brazma, Duncan T Odom, and John C Marioni
(2012). “Extensive compensatory cis-trans regulation in the evolution of
mouse gene expression”. Genome Research 22.12, pp. 2376–2384.
Goode, Scott, Michael Melnick, Tze-Bin Chou, and Norbert Perrimon (1996).
“The neurogenic genes egghead and brainiac define a novel signaling pathway
essential for epithelial morphogenesis during Drosophila oogenesis.” Develop-
ment (Cambridge, England) 122.12, pp. 3863–79.
208
Graveley, Brenton R, Angela N Brooks, Joseph W Carlson, Michael O Duff, Jane
M Landolin, Li Yang, Carlo G Artieri, Marijke J van Baren, Nathan Boley,
et al. (2011). “The developmental transcriptome of Drosophila melanogaster.”
Nature 471.7339, pp. 473–9.
Gross, David S and William T Garrard (1988). “Nuclease hypersensitive sites in
chromatin.” Annual review of biochemistry 57, pp. 159–197.
Gudbjartsson, Daniel F, G Bragi Walters, Gudmar Thorleifsson, Hreinn Ste-
fansson, Bjarni V Halldorsson, Pasha Zusmanovich, Patrick Sulem, Steinunn
Thorlacius, Arnaldur Gylfason, et al. (2008). “Many sequence variants affect-
ing diversity of adult human height.” Nature genetics 40.5, pp. 609–15.
Gundelfinger, Eckart D and Norbert Hess (1992). “Nicotinic acetylcholine recep-
tors of the central nervous system of Drosophila”. Biochimica et Biophysica
Acta (BBA) - Molecular Cell Research 1137.3, pp. 299–308.
Gusella, James F, Nancy S Wexler, P Michael Conneally, Susan L Naylor, Mary
Anne Anderson, Rudolph E Tanzi, Paul C Watkins, Kathleen Ottina, Mar-
garet RWallace, et al. (1983). “A polymorphic DNA marker genetically linked
to Huntington’s disease”. Nature 306.5940, pp. 234–238.
Halsey, Lewis G, Douglas Curran-Everett, Sarah L Vowler, and Gordon B Drum-
mond (2015). “The fickle P value generates irreproducible results”. Nature
Methods 12.3, pp. 179–185.
Harbison, Susan T, Lenovia J McCoy, and Trudy F C Mackay (2013). “Genome-
wide association study of sleep in Drosophila melanogaster.” BMC genomics
14, p. 281.
Harding, Katherine, Timothy Hoey, Rahul Warrior, and Michael Levine (1989).
“Autoregulatory and gap gene response elements of the even-skipped pro-
moter of Drosophila.” The EMBO journal 8.4, pp. 1205–12.
Heinz, Sven, Christopher Benner, Nathanael Spann, Eric Bertolino, Yin C Lin,
Peter Laslo, Jason X Cheng, Cornelis Murre, Harinder Singh, and Christopher
K Glass (2010). “Simple Combinations of Lineage-Determining Transcription
Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell
Identities”. Molecular Cell 38.4, pp. 576–589.
209
Hentges, Kathryn E and Monica J Justice (2004). “Checks and balancers: balancer
chromosomes to facilitate genome annotation.” Trends in genetics : TIG 20.6,
pp. 252–9.
Herranz, Héctor, Ginés Morata, and Marco Milán (2006). “calderón encodes an
organic cation transporter of the major facilitator superfamily required for
cell growth and proliferation of Drosophila tissues.” Development (Cambridge,
England) 133.14, pp. 2617–2625.
Hsu, Patrick D, Eric S Lander, and Feng Zhang (2014). “Development and ap-
plications of CRISPR-Cas9 for genome engineering”. Cell 157.6, pp. 1262–
1278.
Huang, Guo-Jen Jen, Sagiv Shifman, William Valdar, Martina Johannesson, Bin-
naz Yalcin, Martin S Taylor, Jennifer M Taylor, Richard Mott, and Jonathan
Flint (2009). “High resolution mapping of expression QTLs in heterogeneous
stock mice in multiple tissues.” Genome research 19.6, pp. 1133–1140.
Huang, Wen, Andreas Massouras, Yutaka Inoue, Jason Peiffer, Miquel Ràmia,
Aaron M Tarone, Lavanya Turlapati, Thomas Zichner, Dianhui Zhu, et al.
(2014). “Natural variation in genome architecture among 205 Drosophila
melanogaster Genetic Reference Panel lines.” Genome research 24.7, pp. 1193–
208.
Huang, Xuehui, Yan Zhao, Xinghua Wei, Canyang Li, Ahong Wang, Qiang Zhao,
Wenjun Li, Yunli Guo, Liuwei Deng, et al. (2011). “Genome-wide association
study of flowering time and grain yield traits in a worldwide collection of rice
germplasm”. Nature Genetics 44.1, pp. 32–39.
Innocenti, Federico, Gregory M Cooper, Ian B Stanaway, Eric R Gamazon, Joshua
D Smith, Snezana Mirkov, Jacqueline Ramirez, Wanqing Liu, Yvonne S Lin,
et al. (2011). “Identification, replication, and functional fine-mapping of ex-
pression quantitative trait loci in primary human liver tissue.” PLoS genetics
7.5, e1002078.
Ivanov, Dobril K, Valentina Escott-Price, Matthias Ziehm, Michael M Magwire,
Trudy F C Mackay, Linda Partridge, and Janet M Thornton (2015). “Lon-
gevity GWAS Using the Drosophila Genetic Reference Panel”. The Journals
of Gerontology Series A: Biological Sciences and Medical Sciences.
210
Jan, Calvin H, Robin C Friedman, J Graham Ruby, and David P Bartel (2011).
“Formation, regulation and evolution of Caenorhabditis elegans 3’UTRs.” Na-
ture 469.7328, pp. 97–101.
Ji, Zhe, Ju Youn Lee, Zhenhua Pan, Bingjun Jiang, and Bin Tian (2009). “Progres-
sive lengthening of 3’ untranslated regions of mRNAs by alternative polyade-
nylation during mouse embryonic development.” Proceedings of the National
Academy of Sciences of the United States of America 106.17, pp. 7028–33.
Jonas, Stefanie and Elisa Izaurralde (2015). “Towards a molecular understand-
ing of microRNA-mediated gene silencing”. Nature Reviews Genetics 16.7,
pp. 421–433.
Kalinka, Alex T, Karolina M Varga, Dave T Gerrard, Stephan Preibisch, David L
Corcoran, Julia Jarrells, Uwe Ohler, Casey M Bergman, and Pavel Tomancak
(2010). “Gene expression divergence recapitulates the developmental hour-
glass model.” Nature 468.7325, pp. 811–814.
Kim-Ha, Jeongsil, Karen Kerr, and Paul M Macdonald (1995). “Translational
regulation of oskar mRNA by Bruno, an ovarian RNA-binding protein, is
essential”. Cell 81.3, pp. 403–412.
Klein, Robert J, Caroline Zeiss, Emily Y Chew, Jen-Yue Tsai, Richard S Sackler,
Chad Haynes, Alice K Henning, John Paul SanGiovanni, Shrikant M Mane,
et al. (2005). “Complement factor H polymorphism in age-related macular
degeneration.” Science (New York, N.Y.) 308.5720, pp. 385–9.
Knezetic, Joseph A and Donal S Luse (1986). “The presence of nucleosomes on a
DNA template prevents initiation by RNA polymerase II in vitro”. Cell 45.1,
pp. 95–104.
Kornblihtt, Alberto R, Ignacio E Schor, Mariano Alló, Gwendal Dujardin, Eze-
quiel Petrillo, and Manuel J Muñoz (2013). “Alternative splicing: a pivotal
step between eukaryotic transcription and translation.” Nature reviews molec-
ular cell biology 14.3, pp. 153–65.
Korte, Arthur, Bjarni J Vilhjálmsson, Vincent Segura, Alexander Platt, Quan
Long, and Magnus Nordborg (2012). “A mixed-model approach for genome-
211
wide association studies of correlated traits in structured populations.” Nature
genetics 44.9, pp. 1066–71.
Lappalainen, Tuuli, Michael Sammeth, Marc R Friedländer, Peter A C ’t Hoen,
Jean Monlong, Manuel A Rivas, Mar Gonzàlez-Porta, Natalja Kurbatova,
Thasso Griebel, et al. (2013). “Transcriptome and genome sequencing uncov-
ers functional variation in humans.” Nature 501.7468, pp. 506–11.
Lawlor, Debbie A, Roger M Harbord, Jonathan A C Sterne, Nic Timpson, and
George Davey Smith (2008). “Mendelian randomization: Using genes as in-
struments for making causal inferences in epidemiology”. Statistics in Medi-
cine 27.8, pp. 1133–1163.
Leek, Jeffrey T, Robert B Scharpf, Héctor Corrada Bravo, David Simcha, Ben-
jamin Langmead, W Evan Johnson, Donald Geman, Keith Baggerly, and
Rafael a Irizarry (2010). “Tackling the widespread and critical impact of batch
effects in high-throughput data.” Nature Reviews Genetics 11.10, pp. 733–739.
Leptin, Maria (1999). “Gastrulation in Drosophila: the logic and the cellular
mechanisms”. The EMBO Journal 18.12, pp. 3187–3192.
Lettre, Guillaume, Christoph Lange, and Joel N. Hirschhorn (2007). “Genetic
model testing and statistical power in population-based association studies of
quantitative traits”. Genetic Epidemiology 31.4, pp. 358–362.
Levsky, Jeffrey M and Robert H Singer (2003). “Fluorescence in situ hybridization:
past, present and future.” Journal of cell science 116.Pt 14, pp. 2833–2838.
Li, Bo and Colin N Dewey (2011). “RSEM: accurate transcript quantification from
RNA-Seq data with or without a reference genome.” BMC bioinformatics 12,
p. 323.
Li, Heng and Richard Durbin (2009). “Fast and accurate short read alignment
with Burrows-Wheeler transform.” Bioinformatics (Oxford, England) 25.14,
pp. 1754–60.
Li, Yang, Olga Alda Alvarez, Evert W Gutteling, Marcel Tijsterman, Jingyuan
Fu, Joost A G Riksen, Esther Hazendonk, Pjotr Prins, Ronald H A Plasterk,
212
et al. (2006). “Mapping determinants of gene expression plasticity by genetical
genomics in C. elegans.” PLoS genetics 2.12, e222.
Link, Nichole, Paula Kurtz, Melissa O’Neal, Gianella Garcia-Hughes, and John
M Abrams (2013). “A p53 enhancer region regulates target genes through
chromatin conformations in cis and in trans”. Genes & Development 27.22,
pp. 2433–2438.
Lippert, Christoph, Francesco Paolo Casale, Barbara Rakitsch, and Oliver Stegle
(2014). “LIMIX: genetic analysis of multiple traits”. bioRxiv, pp. 0–26.
Listgarten, Jennifer, Carl Kadie, Eric E Schadt, and David Heckerman (2010).
“Correction for hidden confounders in the genetic analysis of gene expression.”
Proceedings of the National Academy of Sciences of the United States of
America 107, pp. 16465–16470.
Love, Michael I, Wolfgang Huber, and Simon Anders (2014). “Moderated estima-
tion of fold change and dispersion for RNA-seq data with DESeq2”. Genome
Biology 15.12, p. 550.
Luschnig, Stefan, Tilmann Bätz, Kristina Armbruster, and Mark a. Krasnow
(2006). “serpentine and vermiform encode matrix proteins with chitin bind-
ing and deacetylation domains that limit tracheal tube length in Drosophila”.
Current Biology 16.2, pp. 186–194.
Ma, Yue, Emily L Niemitz, Patricia A Nambu, Xiaoliang Shan, Charles Sackerson,
Miki Fujioka, Tadaatsu Goto, and John R Nambu (1998). “Gene regulatory
functions of Drosophila Fish-hook, a high mobility group domain Sox protein”.
Mechanisms of Development 73.2, pp. 169–182.
MacArthur, Daniel G, Suganthi Balasubramanian, Adam Frankish, Ni Huang,
James Morris, Klaudia Walter, Luke Jostins, Lukas Habegger, Joseph K Pick-
rell, et al. (2012). “A Systematic Survey of Loss-of-Function Variants in Hu-
man Protein-Coding Genes”. Science 335.6070, pp. 823–828.
Mackay, Trudy F C, Stephen Richards, Eric A Stone, Antonio Barbadilla, Julien
F Ayroles, Dianhui Zhu, Sònia Casillas, Yi Han, Michael M Magwire, et
al. (2012). “The Drosophila melanogaster Genetic Reference Panel.” Nature
482.7384, pp. 173–8.
213
Macosko, Evan Z, Anindita Basu, Rahul Satija, James Nemesh, Karthik Shekhar,
Melissa Goldman, Itay Tirosh, Allison R Bialas, Nolan Kamitaki, et al. (2015).
“Highly Parallel Genome-wide Expression Profiling of Individual Cells Using
Nanoliter Droplets”. Cell 161.5, pp. 1202–1214.
Magnani, Luca, Jérôme Eeckhoute, and Mathieu Lupien (2011). “Pioneer fac-
tors: Directing transcriptional regulators within the chromatin environment”.
Trends in Genetics 27.11, pp. 465–474.
Magwire, Michael M, Daniel K Fabian, Hannah Schweyen, Chuan Cao, Ben Long-
don, Florian Bayer, and Francis M Jiggins (2012). “Genome-wide associa-
tion studies reveal a simple genetic basis of resistance to naturally coevolving
viruses in Drosophila melanogaster.” PLoS genetics 8.11, e1003057.
Maquat, Lynne E and Gordon G Carmichael (2001). “Quality control of mRNA
function”. Cell 104.2, pp. 173–176.
Marioni, John C, Christopher E Mason, Shrikant M Mane, Matthew Stephens,
and Yoav Gilad (2008). “RNA-seq: an assessment of technical reproducibil-
ity and comparison with gene expression arrays.” Genome research 18.9,
pp. 1509–17.
Massouras, Andreas, Sebastian M Waszak, Monica Albarca-Aguilera, Korneel
Hens, Wiebke Holcombe, Julien F Ayroles, Emmanouil T Dermitzakis, Eric a
Stone, Jeffrey D Jensen, et al. (2012). “Genomic variation and its impact on
gene expression in Drosophila melanogaster.” PLoS genetics 8.11, e1003055.
McGinnis, William, Richard L Garber, Johannes Wirz, Atsushi Kuroiwa, andWal-
ter J Gehring (1984). “A homologous protein-coding sequence in drosophila
homeotic genes and its conservation in other metazoans”. Cell 37.2, pp. 403–
408.
McManus, C Joel, Joseph D Coolon, Michael O Duff, Jodi Eipper-Mains, Bren-
ton R Graveley, and Patricia J Wittkopp (2010). “Regulatory divergence in
Drosophila revealed by mRNA-seq”. Genome Research 20.6, pp. 816–825.
Mendel, Gregor (1866). “Versuche über Pflanzenhybriden”. Verhandlungen des
Naturforschenden Vereines, Brünn IV, pp. 3–47.
214
Montgomery, Stephen B, Micha Sammeth, Maria Gutierrez-Arcelus, Radoslaw P
Lach, Catherine Ingle, James Nisbett, Roderic Guigo, and Emmanouil T Der-
mitzakis (2010). “Transcriptome genetics using second generation sequencing
in a Caucasian population.” Nature 464.7289, pp. 773–7.
Moore, Melissa J and Nick J Proudfoot (2009). “Pre-mRNA processing reaches
back to transcription and ahead to translation.” Cell 136.4, pp. 688–700.
Morgan, Thomas H (1911a). “An attempt to analyze the constitution of the
chromosomes on the basis of sex-limited inheritance in Drosophila”. Journal
of Experimental Zoology 11.4, pp. 365–413.
Morgan, Thomas H (1911b). “Random segregation versus coupling in Mendelian
inheritance”. Science (New York, N.Y.) 34.873, p. 384.
Morgan, Thomas H (1910). “Sex limited inheritance in Drosophila”. Science (New
York, N.Y.) 32.812, pp. 120–122.
Morgan, Thomas H, Alfred H Sturtevant, Hermann J Muller, and Calvin B
Bridges (1915). The mechanism of Mendelian heredity. New York: H. Holt
and company, p. 288.
Mortazavi, Ali, Brian AWilliams, Kenneth McCue, Lorian Schaeffer, and Barbara
Wold (2008). “Mapping and quantifying mammalian transcriptomes by RNA-
Seq.” Nature methods 5.7, pp. 621–628.
Mullaney, Julienne M, Ryan E Mills, W Stephen Pittard, and Scott E Devine
(2010). “Small insertions and deletions (INDELs) in human genomes”. Human
Molecular Genetics 19.R2, pp. 131–136.
Muller, Hermann J (1927). “Artificial transmutation of the gene”. Science (New
York, N.Y.) 66.1699, pp. 84–87.
Müller, Reto, Friedrich Altmann, Dapeng Zhou, and Thierry Hennet (2002). “The
Drosophila melanogaster brainiac protein is a glycolipid-specific beta 1,3N-
acetyl-glucosaminyltransferase.” The Journal of Biological Chemistry 277.36,
pp. 32417–20.
215
Murre, Cornelis, Patrick Schonleber McCaw, and David Baltimore (1989). “A new
DNA binding and dimerization motif in immunoglobulin enhancer binding,
daughterless, MyoD, and myc proteins”. Cell 56.5, pp. 777–783.
Nam, Douglas Kyung, Sanggyu Lee, Guolin Zhou, Xiaohong Cao, Clarence Wang,
Terry Clark, Jianjun Chen, Janet D Rowley, and San Ming Wang (2002).
“Oligo(dT) primer generates a high frequency of truncated cDNAs through
internal poly(A) priming during reverse transcription.” Proceedings of the Na-
tional Academy of Sciences of the United States of America 99.9, pp. 6152–
6156.
Newton-Cheh, Christopher, Toby Johnson, Vesela Gateva, Martin D Tobin, Mu-
rielle Bochud, Lachlan Coin, Samer S Najjar, Jing Hua Zhao, Simon C Heath,
et al. (2009). “Genome-wide association study identifies eight loci associated
with blood pressure.” Nature genetics 41.6, pp. 666–76.
Nica, Alexandra C, Leopold Parts, Daniel Glass, James Nisbet, Amy Barrett,
Magdalena Sekowska, Mary Travers, Simon Potter, Elin Grundberg, et al.
(2011). “The architecture of gene regulatory variation across multiple human
tissues: The muTHER study”. PLoS Genetics 7.2, pp. 1–9.
Noyes, Marcus B, Xiangdong Meng, AtsuyaWakabayashi, Saurabh Sinha, Michael
H Brodsky, and Scot AWolfe (2008). “A systematic characterization of factors
that regulate Drosophila segmentation via a bacterial one-hybrid system”.
Nucleic Acids Research 36.8, pp. 2547–2560.
Nüsslein-Volhard, Christiane and Eric Wieschaus (1980). “Mutations affecting
segment number and polarity in Drosophila”. Nature 287.5785, pp. 795–801.
Ostrowski, Stephen, Herman A Dierick, and Amy Bejsovec (2002). “Genetic con-
trol of cuticle formation during embryonic development of Drosophila mela-
nogaster”. Genetics 161.1, pp. 171–182.
Padgett, Richard A, Paula J Grabowski, Maria M Konarska, Sharon Seiler, and
Phillip A Sharp (1986). “Splicing of Messenger RNA Precursors”. Annual
Review of Biochemistry 55.1, pp. 1119–1150.
Painter, T. S. (1933). “A new method for the study of chromosome rearrangements
and the plotting of chromosome maps”. Science 78.2034, pp. 585–586.
216
Parker, Roy and Haiwei Song (2004). “The enzymes and control of eukaryotic
mRNA turnover.” Nature structural & molecular biology 11.2, pp. 121–127.
Pauli, Andrea, John L Rinn, and Alexander F Schier (2011). “Non-coding RNAs
as regulators of embryogenesis.” Nature Reviews Genetics 12.2, pp. 136–49.
Pearson, Karl (1901). “On lines and planes of closest fit to systems of points
in space”. The London, Edinburgh, and Dublin Philosophical Magazine and
Journal of Science 2, pp. 559–572.
Pearson, Karl (1900). “On the criterion that a given system of deviations from
the probable in the case of a correlated system of variables is such that it can
be reasonably supposed to have arisen from random sampling”. Philosophical
Magazine Series 5 50.302, pp. 157–175.
Petretto, Enrico, Jonathan Mangion, Nicholas J Dickens, Stuart A Cook, Mande
K Kumaran, Han Lu, Judith Fischer, Henrike Maatz, Vladimir Kren, et al.
(2006). “Heritability and tissue specificity of expression quantitative trait
loci.” PLoS genetics 2.10, e172.
Phatnani, Hemali P and Arno L Greenleaf (2006). “Phosphorylation and functions
of the RNA polymerase II CTD”. Genes & Development 20.21, pp. 2922–2936.
Poulson, Donald F (1937). “Chromosomal Deficiencies and the Embryonic Devel-
opment of Drosophila Melanogaster.” Proceedings of the National Academy of
Sciences of the United States of America 23.3, pp. 133–7.
Proudfoot, Nick J (2011). “Ending the message : poly ( A ) signals then and now”.
Genes & development 25, pp. 1770–1782.
Proudfoot, Nick J, Andre Furger, and Michael J Dye (2002). “Integrating mRNA
processing with transcription”. Cell 108.4, pp. 501–512.
Ptashne, Mark (2013). “Epigenetics: core misconcept.” Proceedings of the National
Academy of Sciences of the United States of America 110.18, pp. 7101–3.
R Core Team (2013). R: A Language and Environment for Statistical Computing.
R Foundation for Statistical Computing. Vienna, Austria.
217
Ravi, Dashnamoorthy, Amy M Wiles, Selvaraj Bhavani, Jianhua Ruan, Philip
Leder, and Alexander J R Bishop (2009). “A network of conserved damage
survival pathways revealed by a genomic RNAi screen”. PLoS Genetics 5.6.
Rifkin, Scott A, David Houle, Junhyong Kim, and Kevin P White (2005). “A
mutation accumulation assay reveals a broad capacity for rapid evolution of
gene expression.” Nature 438.7065, pp. 220–223.
Rifkin, Scott A, Junhyong Kim, and Kevin P White (2003). “Evolution of gene
expression in the Drosophila melanogaster subgroup.” Nature genetics 33.2,
pp. 138–44.
Ringrose, Leonie and Renato Paro (2004). “Epigenetic regulation of cellular mem-
ory by the Polycomb and Trithorax group proteins.” Annual review of genetics
38, pp. 413–443.
Ronderos, David S, Chun-Chieh Lin, Christopher J Potter, and Dean P Smith
(2014). “Farnesol-detecting olfactory neurons in Drosophila.” J Neurosc 34.11,
pp. 3959–68.
Russell, Steven R H, Natalia Sanchez-Soriano, Charles R Wright, and Michael
Ashburner (1996). “The Dichaete gene of Drosophila melanogaster encodes
a SOX-domain protein required for embryonic segmentation.” Development
(Cambridge, England) 122.11, pp. 3669–3676.
Samuels, Mark E, Paul Schedl, and Thomas W Cline (1991). “The complex set of
late transcripts from the Drosophila sex determination gene sex-lethal encodes
multiple related polypeptides.” Molecular and cellular biology 11.7, pp. 3584–
3602.
Sax, Karl (1923). “The Association of Size Differences with Seed-Coat Pattern
and Pigmentation in Phaseolus vulgaris.” Genetics 8.6, pp. 552–560.
Schadt, Eric E, Stephanie A Monks, Thomas A Drake, Aldons J Lusis, Nam Che,
Veronica Colinayo, Thomas G Ruff, Stephen B Milligan, John R Lamb, et al.
(2003). “Genetics of gene expression surveyed in maize, mouse and man.”
Nature 422.6929, pp. 297–302.
218
Schena, Mark, Dari Shalon, Ronald W Davis, and Patrick O Brown (1995).
“Quantitative Monitoring of Gene Expression Patterns with a Complemen-
tary DNA Microarray”. Science 270.5235, pp. 467–470.
Shin, Chanseok and James L Manley (2004). “Cell signalling and the control of
pre-mRNA splicing.” Nature reviews molecular cell biology 5.9, pp. 727–738.
Skaer, Nick and Pat Simpson (2000). “Genetic Analysis of Bristle Loss in Hybrids
between Drosophila melanogaster and D. simulans Provides Evidence for Di-
vergence of cis-Regulatory Sequences in the achaete–scute Gene Complex”.
Developmental Biology 221.1, pp. 148–167.
Smale, Stephen T and James T Kadonaga (2003). “The RNA polymerase II core
promoter.” Annual review of biochemistry 72, pp. 449–479.
Small, Stephen, Adrienne Blair, and Michael Levine (1992). “Regulation of even-
skipped stripe 2 in the Drosophila embryo.” The EMBO journal 11.11, pp. 4047–
57.
Smibert, Peter, Pedro Miura, Jakub O Westholm, Sol Shenker, Gemma May,
Michael O Duff, Dayu Zhang, Brian D Eads, Joe Carlson, et al. (2012).
“Global patterns of tissue-specific alternative polyadenylation in Drosophila.”
Cell reports 1.3, pp. 277–89.
Spitz, François and Eileen E M Furlong (2012). “Transcription factors: from
enhancer binding to developmental control”. Nature Reviews Genetics 13.9,
pp. 613–626.
St Johnston, Daniel and Christiane Nüsslein-Volhard (1992). “The origin of pat-
tern and polarity in the Drosophila embryo.” Cell 68.2, pp. 201–219.
Stefani, Giovanni and Frank J Slack (2008). “Small non-coding RNAs in animal
development.” Nature reviews molecular cell biology 9.3, pp. 219–230.
Stegle, Oliver, Leopold Parts, Richard Durbin, and John Winn (2010). “A Bayes-
ian framework to account for complex non-genetic factors in gene expression
levels greatly increases power in eQTL studies.” PLoS computational biology
6.5, e1000770.
219
Stegle, Oliver, Leopold Parts, Matias Piipari, John Winn, and Richard Durbin
(2012). “Using probabilistic estimation of expression residuals (PEER) to ob-
tain increased power and interpretability of gene expression analyses.” Nature
protocols 7.3, pp. 500–7.
Stranger, Barbara E, Alexandra C Nica, Matthew S Forrest, Antigone Dimas,
Christine P Bird, Claude Beazley, Catherine E Ingle, Mark Dunning, Paul
Flicek, et al. (2007). “Population genomics of human gene expression.” Nature
Genet 39.10, pp. 1217–1224.
Struhl, Gary (1982). “Genes controlling segmental specification in the Drosophila
thorax.” Proceedings of the National Academy of Sciences of the United States
of America 79.23, pp. 7380–4.
Sturtevant, Alfred H (1921). “A Case of Rearrangement of Genes in Drosophila.”
Proceedings of the National Academy of Sciences of the United States of
America 7.8, pp. 235–7.
Sturtevant, Alfred H (1913). “The linear arrangement of six sex-linked factors in
Drosophila, as shown by their mode of association”. Journal of Experimental
Zoology 14.1, pp. 43–59.
Sturtevant, Alfred H (1959). Thomas Hunt Morgan. Washington D.C.: National
Academy of Sciences, p. 293.
Stutz, Françoise and Elisa Izaurralde (2003). “The interplay of nuclear mRNP as-
sembly, mRNA surveillance and export”. Trends in Cell Biology 13.6, pp. 319–
327.
Sul, Jae Hoon, Towfique Raj, Simone de Jong, Paul IW de Bakker, Soumya Ray-
chaudhuri, Roel A Ophoff, Barbara E Stranger, Eleazar Eskin, and Buhm Han
(2015). “Accurate and Fast Multiple-Testing Correction in eQTL Studies”.
The American Journal of Human Genetics, pp. 1–12.
Sutton, Walter S (1903). “The chromosomes in heredity”. Biological Bulletin 4,
pp. 231–251.
Takagaki, Yoshio, Rebecca L Seipelt, Martha L Peterson, and James L Manley
(1996). “The polyadenylation factor CstF-64 regulates alternative process-
220
ing of IgM heavy chain pre-mRNA during B cell differentiation”. Cell 87.5,
pp. 941–952.
Tang, Fuchou, Catalin Barbacioru, Yangzhou Wang, Ellen Nordman, Clarence
Lee, Nanlan Xu, Xiaohui Wang, John Bodeau, Brian B Tuch, et al. (2009).
“mRNA-Seq whole-transcriptome analysis of a single cell.” Nature methods
6.5, pp. 377–82.
The 1000 Genomes Project Consortium (2012). “An integrated map of genetic
variation from 1,092 human genomes.” Nature 491.7422, pp. 56–65.
The FlyBase Consortium (2014). “FlyBase 102 - Advanced approaches to inter-
rogating FlyBase”. Nucleic Acids Research 42.November 2013, pp. 780–788.
The Gene Ontology Consortium (2000). “Gene ontology: tool for the unification
of biology. The Gene Ontology Consortium.” Nature genetics 25.1, pp. 25–29.
The GTEx Consortium (2013). “The Genotype-Tissue Expression (GTEx) project.”
Nature genetics 45.6, pp. 580–5.
The International HapMap Consortium (2005). “A haplotype map of the human
genome.” Nature 437.7063, pp. 1299–320.
The International HapMap Consortium (2007). “A second generation human
haplotype map of over 3.1 million SNPs.” Nature 449.7164, pp. 851–61.
The Wellcome Trust Case Control Consortium (2007). “Genome-wide association
study of 14,000 cases of seven common diseases and 3,000 shared controls.”
Nature 447.7145, pp. 661–78.
Thisse, B, C Stoetzel, C Gorostiza-Thisse, and F Perrin-Schmitt (1988). “Se-
quence of the twist gene and nuclear localization of its protein in endomeso-
dermal cells of early Drosophila embryos.” The EMBO journal 7.7, pp. 2175–
83.
Thomas, Sean, Xiao-Yong Li, Peter J Sabo, Richard Sandstrom, Robert E Thur-
man, Theresa K Canfield, Erika Giste, William Fisher, Ann Hammonds,
et al. (2011). “Dynamic reprogramming of chromatin accessibility during
Drosophila embryo development”. Genome Biology 12.5, R43.
221
Trapnell, Cole, Adam Roberts, Loyal Goff, Geo Pertea, Daehwan Kim, David R
Kelley, Harold Pimentel, Steven L Salzberg, John L Rinn, and Lior Pachter
(2012). “Differential gene and transcript expression analysis of RNA-seq ex-
periments with TopHat and Cufflinks.” Nature protocols 7, pp. 562–78.
Tung, Jenny, Xiang Zhou, Susan C Alberts, Matthew Stephens, and Yoav Gilad
(2015). “The genetic architecture of gene expression levels in wild baboons”.
eLife 4, pp. 1–22.
Turner, F Rudolf and A P Mahowald (1976). “Scanning electron microscopy of
Drosophila embryogenesis”. Developmental Biology 50.1, pp. 95–108.
Ulitsky, Igor, Alena Shkumatava, Calvin H Jan, Alexander O Subtelny, David
Koppstein, George W Bell, Hazel Sive, and David P Bartel (2012). “Extensive
alternative polyadenylation during zebrafish development.” Genome research
22.10, pp. 2054–66.
Valdar, William, Leah C Solberg, Dominique Gauguier, Stephanie Burnett, Paul
Klenerman, William O Cookson, Martin S Taylor, J Nicholas P Rawlins,
Richard Mott, and Jonathan Flint (2006). “Genome-wide genetic association
of complex traits in heterogeneous stock mice.” Nature genetics 38.8, pp. 879–
87.
Valencia-Sanchez, Marco Antonio, Jidong Liu, Gregory J. Hannon, and Roy Parker
(2006). “Control of translation and mRNA degradation by miRNAs and siR-
NAs”. Genes and Development 20.5, pp. 515–524.
Veyrieras, Jean-Baptiste, Daniel J Gaffney, Joseph K Pickrell, Yoav Gilad, Mat-
thew Stephens, and Jonathan K Pritchard (2012). “Exon-specific QTLs skew
the inferred distribution of expression QTLs detected using gene expression
array data.” PloS one 7.2, e30629.
Veyrieras, Jean-Baptiste, Sridhar Kudaravalli, Su Yeon Kim, Emmanouil T Der-
mitzakis, Yoav Gilad, Matthew Stephens, and Jonathan K Pritchard (2008).
“High-resolution mapping of expression-QTLs yields insight into human gene
regulation.” PLoS genetics 4.10, e1000214.
222
Vogel, Christine and Edward M Marcotte (2012). “Insights into the regulation
of protein abundance from proteomic and transcriptomic analyses”. Nature
Reviews Genetics 13.4, pp. 227–232.
Vonesch, Sibylle Chantal, David Lamparter, Trudy FC Mackay, Sven Bergmann,
and Ernst Hafen (2015). “Genome-wide analysis reveals novel regulators of
growth in Drosophila melanogaster”. bioRxiv, pp. 1–15.
Wang, David G, Jian-Bing Fan, Chia-Jen Siao, Anthony Berno, Peter Young, Ron
Sapolsky, Ghassan Ghandour, Nancy Perkins, Ellen Winchester, et al. (1998).
“Large-Scale Identification, Mapping, and Genotyping of Single-Nucleotide
Polymorphisms in the Human Genome”. Science 280.5366, pp. 1077–1082.
Wang, Shenqiu, Satish Arcot Jayaram, Johanna Hemphälä, Kirsten-André Senti,
Vasilios Tsarouhas, Haining Jin, and Christos Samakovlis (2006). “Septate-
junction-dependent luminal deposition of chitin deacetylases restricts tube
elongation in the Drosophila trachea.” Current biology : CB 16.2, pp. 180–5.
Weatherbee, Scott D, Georg Halder, Jaeseob Kim, Angela Hudson, and Sean
Carroll (1998). “Ultrabithorax regulates genes at several levels of the wing-
patterning hierarchy to shape the development of the Drosophila haltere.”
Genes & development 12.10, pp. 1474–82.
Weigmann, Katrin, Robert Klapper, Thomas Strasser, Christof Rickert, Gerd
Technau, Herbert Jäckle, Wilfried Janning, and Christian Klämbt (2003).
“FlyMove–a new way to look at development of Drosophila.” Trends in ge-
netics : TIG 19.6, pp. 310–1.
Welter, Danielle, Jacqueline MacArthur, Joannella Morales, Tony Burdett, Peggy
Hall, Heather Junkins, Alan Klemm, Paul Flicek, Teri Manolio, et al. (2014).
“The NHGRI GWAS Catalog, a curated resource of SNP-trait associations.”
Nucleic acids research 42.Database issue, pp. D1001–6.
Wilkening, Stefan, Vicent Pelechano, Aino I Järvelin, Manu M Tekkedil, Simon
Anders, Vladimir Benes, and Lars M Steinmetz (2013). “An efficient method
for genome-wide polyadenylation site mapping and RNA quantification.” Nu-
cleic acids research 41.5.
223
Wittkopp, Patricia J and Gizem Kalay (2011). “Cis-regulatory elements: molec-
ular mechanisms and evolutionary processes underlying divergence”. Nature
Reviews Genetics 13.1, pp. 59–69.
Wray, Gregory A (2007). “The evolutionary significance of cis-regulatory muta-
tions.” Nature Reviews Genetics 8.3, pp. 206–216.
Yalcin, Binnaz, Jérôme Nicod, Amarjit Bhomra, Stuart Davidson, James Cleak,
Laurent Farinelli, Magne Oesteraas, Adam Whitley, Wei Yuan, et al. (2010).
“Commercially available outbred mice for genome-wide association studies”.
PLoS Genetics 6.9.
Yin, Dingzi, Ping Huang, Jiarui Wu, and Haiyun Song (2014). “Drosophila protein
phosphatase V regulates lipid homeostasis via the AMPK pathway”. Journal
of Molecular Cell Biology 6.1, pp. 100–102.
Yip, M L Richard, L Michele Lamka, and Howard D Lipshitz (1997). “Control of
germ-band retraction in Drosophila by the zinc-finger protein HINDSIGHT.”
Development (Cambridge, England) 124.11, pp. 2129–2141.
Yoon, Oh Kyu and Rachel B Brem (2010). “Noncanonical transcript forms in
yeast and their regulation during environmental stress.” RNA (New York,
N.Y.) 16.6, pp. 1256–67.
Yu, Jianming, Gael Pressoir, William H Briggs, Irie Vroh Bi, Masanori Yamasaki,
John F Doebley, Michael D McMullen, Brandon S Gaut, Dahlia M Nielsen,
et al. (2006). “A unified mixed-model method for association mapping that
accounts for multiple levels of relatedness.” Nature genetics 38.2, pp. 203–8.
Zhang, Zhiwu, Elhan Ersoz, Chao-Qiang Lai, Rory J Todhunter, Hemant K Ti-
wari, Michael A Gore, Peter J Bradbury, Jianming Yu, Donna K Arnett, et al.
(2010). “Mixed linear model approach adapted for genome-wide association
studies.” Nature genetics 42.4, pp. 355–60.
Zhou, Qiang, Tiandao Li, and David H Price (2012). “RNA polymerase II elon-
gation control.” Annual review of biochemistry 81, pp. 119–43.
224
Zhou, Xiang and Matthew Stephens (2014). “Efficient multivariate linear mixed
model algorithms for genome-wide association studies.” Nature methods 11.4,
pp. 407–9.
225
